CN106715101B - 用于在硅酮水凝胶接触镜片上施用稳定的涂层的方法 - Google Patents
用于在硅酮水凝胶接触镜片上施用稳定的涂层的方法 Download PDFInfo
- Publication number
- CN106715101B CN106715101B CN201580045379.0A CN201580045379A CN106715101B CN 106715101 B CN106715101 B CN 106715101B CN 201580045379 A CN201580045379 A CN 201580045379A CN 106715101 B CN106715101 B CN 106715101B
- Authority
- CN
- China
- Prior art keywords
- methyl
- poly
- acid
- silicone hydrogel
- contact lens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920001296 polysiloxane Polymers 0.000 title claims abstract description 110
- 239000000017 hydrogel Substances 0.000 title claims abstract description 90
- 238000000576 coating method Methods 0.000 title claims abstract description 85
- 239000011248 coating agent Substances 0.000 title claims abstract description 84
- 238000000034 method Methods 0.000 title claims abstract description 60
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 63
- 229920001577 copolymer Polymers 0.000 claims abstract description 62
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 30
- 229920001519 homopolymer Polymers 0.000 claims abstract description 27
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 20
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims abstract description 14
- -1 3- Acryloyl amino -1- propyl Chemical group 0.000 claims description 132
- 239000000178 monomer Substances 0.000 claims description 87
- 229920002554 vinyl polymer Polymers 0.000 claims description 52
- 239000000243 solution Substances 0.000 claims description 50
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 42
- 239000005977 Ethylene Substances 0.000 claims description 40
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 35
- 238000004806 packaging method and process Methods 0.000 claims description 34
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 33
- 238000007789 sealing Methods 0.000 claims description 33
- 150000001875 compounds Chemical class 0.000 claims description 29
- 230000001954 sterilising effect Effects 0.000 claims description 29
- 239000002253 acid Substances 0.000 claims description 26
- 229920000642 polymer Polymers 0.000 claims description 25
- 239000002861 polymer material Substances 0.000 claims description 25
- 230000010148 water-pollination Effects 0.000 claims description 25
- 238000004132 cross linking Methods 0.000 claims description 22
- 238000004659 sterilization and disinfection Methods 0.000 claims description 21
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 20
- 125000002393 azetidinyl group Chemical group 0.000 claims description 17
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 17
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- 239000002953 phosphate buffered saline Substances 0.000 claims description 17
- 229920001223 polyethylene glycol Polymers 0.000 claims description 17
- 229920002125 Sokalan® Polymers 0.000 claims description 13
- 239000004584 polyacrylic acid Substances 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 12
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims description 11
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 150000001336 alkenes Chemical class 0.000 claims description 8
- BDERNNFJNOPAEC-UHFFFAOYSA-N n-propyl alcohol Natural products CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 5
- 230000007062 hydrolysis Effects 0.000 claims description 5
- 238000006460 hydrolysis reaction Methods 0.000 claims description 5
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 5
- KEMYALYETOKJCG-UHFFFAOYSA-N 1-butyl-3-methylidenepyrrolidin-2-one Chemical compound CCCCN1CCC(=C)C1=O KEMYALYETOKJCG-UHFFFAOYSA-N 0.000 claims description 3
- AFXKUUDFKHVAGI-UHFFFAOYSA-N 1-methyl-3-methylidenepyrrolidin-2-one Chemical compound CN1CCC(=C)C1=O AFXKUUDFKHVAGI-UHFFFAOYSA-N 0.000 claims description 3
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 claims description 3
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 claims description 3
- VDORPYPVQAFLTR-UHFFFAOYSA-N 5-methyl-3-methylidenepyrrolidin-2-one Chemical class CC1CC(=C)C(=O)N1 VDORPYPVQAFLTR-UHFFFAOYSA-N 0.000 claims description 3
- 229920000307 polymer substrate Polymers 0.000 claims description 3
- CXNYYQBHNJHBNH-UHFFFAOYSA-N 1-ethyl-5-methylidenepyrrolidin-2-one Chemical compound CCN1C(=C)CCC1=O CXNYYQBHNJHBNH-UHFFFAOYSA-N 0.000 claims description 2
- ZZDBHIVVDUTWJC-UHFFFAOYSA-N 1-methyl-5-methylidenepyrrolidin-2-one Chemical compound CN1C(=C)CCC1=O ZZDBHIVVDUTWJC-UHFFFAOYSA-N 0.000 claims description 2
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 claims description 2
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 claims description 2
- XVGZUJYMDCFKIZ-UHFFFAOYSA-N 3-methylidene-1-propylpyrrolidin-2-one Chemical compound CCCN1CCC(=C)C1=O XVGZUJYMDCFKIZ-UHFFFAOYSA-N 0.000 claims description 2
- YNQNQJPLBDEVRW-UHFFFAOYSA-N 5-methylidene-1-propan-2-ylpyrrolidin-2-one Chemical compound CC(C)N1C(=C)CCC1=O YNQNQJPLBDEVRW-UHFFFAOYSA-N 0.000 claims description 2
- RRUNPGIXAGEPSW-UHFFFAOYSA-N 5-methylidene-1-propylpyrrolidin-2-one Chemical compound CCCN1C(=C)CCC1=O RRUNPGIXAGEPSW-UHFFFAOYSA-N 0.000 claims description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 2
- QRWZCJXEAOZAAW-UHFFFAOYSA-N n,n,2-trimethylprop-2-enamide Chemical compound CN(C)C(=O)C(C)=C QRWZCJXEAOZAAW-UHFFFAOYSA-N 0.000 claims description 2
- UUORTJUPDJJXST-UHFFFAOYSA-N n-(2-hydroxyethyl)prop-2-enamide Chemical compound OCCNC(=O)C=C UUORTJUPDJJXST-UHFFFAOYSA-N 0.000 claims description 2
- RQAKESSLMFZVMC-UHFFFAOYSA-N n-ethenylacetamide Chemical compound CC(=O)NC=C RQAKESSLMFZVMC-UHFFFAOYSA-N 0.000 claims description 2
- ZQXSMRAEXCEDJD-UHFFFAOYSA-N n-ethenylformamide Chemical compound C=CNC=O ZQXSMRAEXCEDJD-UHFFFAOYSA-N 0.000 claims description 2
- KYKIFKUTBWKKRE-UHFFFAOYSA-N n-ethenylpropan-2-amine Chemical compound CC(C)NC=C KYKIFKUTBWKKRE-UHFFFAOYSA-N 0.000 claims description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 claims 2
- WZAPDMOCOACDGU-UHFFFAOYSA-N 1-tert-butyl-3-methylidenepyrrolidin-2-one Chemical compound CC(C)(C)N1CCC(=C)C1=O WZAPDMOCOACDGU-UHFFFAOYSA-N 0.000 claims 1
- SNCMCDMEYCLVBO-UHFFFAOYSA-N 3-aminopropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCN SNCMCDMEYCLVBO-UHFFFAOYSA-N 0.000 claims 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 claims 1
- ACOUENYDWAONBH-UHFFFAOYSA-N 3-methylidene-1-propan-2-ylpyrrolidin-2-one Chemical compound CC(C)N1CCC(=C)C1=O ACOUENYDWAONBH-UHFFFAOYSA-N 0.000 claims 1
- XVUWMCJNMDQXKX-UHFFFAOYSA-N 5-ethyl-3-methylidenepyrrolidin-2-one Chemical compound CCC1CC(=C)C(=O)N1 XVUWMCJNMDQXKX-UHFFFAOYSA-N 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 claims 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- QMMOXUPEWRXHJS-UHFFFAOYSA-N pent-2-ene Chemical group CCC=CC QMMOXUPEWRXHJS-UHFFFAOYSA-N 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 22
- 239000000463 material Substances 0.000 description 41
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 34
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 29
- 230000005855 radiation Effects 0.000 description 26
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 25
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 19
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 19
- 239000001301 oxygen Substances 0.000 description 19
- 229910052760 oxygen Inorganic materials 0.000 description 19
- 239000012744 reinforcing agent Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 14
- 230000035699 permeability Effects 0.000 description 14
- 229920005573 silicon-containing polymer Polymers 0.000 description 14
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- 229910052710 silicon Inorganic materials 0.000 description 12
- 239000010703 silicon Substances 0.000 description 12
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 229910052757 nitrogen Inorganic materials 0.000 description 11
- QRUDEWIWKLJBPS-UHFFFAOYSA-N benzotriazole Chemical compound C1=CC=C2N[N][N]C2=C1 QRUDEWIWKLJBPS-UHFFFAOYSA-N 0.000 description 10
- 125000000524 functional group Chemical group 0.000 description 10
- 125000003396 thiol group Chemical class [H]S* 0.000 description 10
- 125000000217 alkyl group Chemical group 0.000 description 9
- 230000002209 hydrophobic effect Effects 0.000 description 9
- 239000003999 initiator Substances 0.000 description 9
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 239000012964 benzotriazole Substances 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 8
- 238000000465 moulding Methods 0.000 description 8
- WHNPOQXWAMXPTA-UHFFFAOYSA-N 3-methylbut-2-enamide Chemical compound CC(C)=CC(N)=O WHNPOQXWAMXPTA-UHFFFAOYSA-N 0.000 description 7
- YCUVUDODLRLVIC-UHFFFAOYSA-N Sudan black B Chemical compound C1=CC(=C23)NC(C)(C)NC2=CC=CC3=C1N=NC(C1=CC=CC=C11)=CC=C1N=NC1=CC=CC=C1 YCUVUDODLRLVIC-UHFFFAOYSA-N 0.000 description 7
- 238000005266 casting Methods 0.000 description 7
- 238000007334 copolymerization reaction Methods 0.000 description 7
- 239000003431 cross linking reagent Substances 0.000 description 7
- 150000003254 radicals Chemical class 0.000 description 7
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 6
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Natural products CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 5
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 229920000962 poly(amidoamine) Polymers 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000004926 polymethyl methacrylate Substances 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- QYBWIXBVMQYFIL-UHFFFAOYSA-N 2-chlorobenzotriazole Chemical compound C1=CC=CC2=NN(Cl)N=C21 QYBWIXBVMQYFIL-UHFFFAOYSA-N 0.000 description 4
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 4
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 125000003545 alkoxy group Chemical group 0.000 description 4
- AOJOEFVRHOZDFN-UHFFFAOYSA-N benzyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1=CC=CC=C1 AOJOEFVRHOZDFN-UHFFFAOYSA-N 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000001273 butane Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229910000078 germane Inorganic materials 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000000314 lubricant Substances 0.000 description 4
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 150000002894 organic compounds Chemical group 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 230000003252 repetitive effect Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- NGDNVOAEIVQRFH-UHFFFAOYSA-N 2-nonanol Chemical compound CCCCCCCC(C)O NGDNVOAEIVQRFH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- OLLAWVHBMFOSAC-UHFFFAOYSA-N [2-methoxy-2-[oxido(2-prop-2-enoyloxyethyl)phosphaniumylidene]ethyl]-trimethylazanium Chemical compound COC(C[N+](C)(C)C)=P(=O)CCOC(C=C)=O OLLAWVHBMFOSAC-UHFFFAOYSA-N 0.000 description 3
- 150000001335 aliphatic alkanes Chemical class 0.000 description 3
- 125000001118 alkylidene group Chemical group 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 3
- REOJLIXKJWXUGB-UHFFFAOYSA-N mofebutazone Chemical group O=C1C(CCCC)C(=O)NN1C1=CC=CC=C1 REOJLIXKJWXUGB-UHFFFAOYSA-N 0.000 description 3
- 229940088644 n,n-dimethylacrylamide Drugs 0.000 description 3
- YLGYACDQVQQZSW-UHFFFAOYSA-N n,n-dimethylprop-2-enamide Chemical group CN(C)C(=O)C=C YLGYACDQVQQZSW-UHFFFAOYSA-N 0.000 description 3
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 3
- 229920000768 polyamine Polymers 0.000 description 3
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 3
- 238000005507 spraying Methods 0.000 description 3
- KAKFZMMRKBQABS-UHFFFAOYSA-N trimethyl(silyloxysilyloxy)silane Chemical compound C[Si](C)(C)O[SiH2]O[SiH3] KAKFZMMRKBQABS-UHFFFAOYSA-N 0.000 description 3
- 125000002348 vinylic group Chemical group 0.000 description 3
- 239000000080 wetting agent Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- KOMNUTZXSVSERR-UHFFFAOYSA-N 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione Chemical compound C=CCN1C(=O)N(CC=C)C(=O)N(CC=C)C1=O KOMNUTZXSVSERR-UHFFFAOYSA-N 0.000 description 2
- VIESAWGOYVNHLV-UHFFFAOYSA-N 1,3-dihydropyrrol-2-one Chemical class O=C1CC=CN1 VIESAWGOYVNHLV-UHFFFAOYSA-N 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- LPCWIFPJLFCXRS-UHFFFAOYSA-N 1-ethylcyclopentan-1-ol Chemical compound CCC1(O)CCCC1 LPCWIFPJLFCXRS-UHFFFAOYSA-N 0.000 description 2
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- BJELTSYBAHKXRW-UHFFFAOYSA-N 2,4,6-triallyloxy-1,3,5-triazine Chemical compound C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1 BJELTSYBAHKXRW-UHFFFAOYSA-N 0.000 description 2
- IEJPPSMHUUQABK-UHFFFAOYSA-N 2,4-diphenyl-4h-1,3-oxazol-5-one Chemical compound O=C1OC(C=2C=CC=CC=2)=NC1C1=CC=CC=C1 IEJPPSMHUUQABK-UHFFFAOYSA-N 0.000 description 2
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 2
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 2
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 2
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 2
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 2
- GISWNRNUVGGVOS-UHFFFAOYSA-N 3,4-dihydroxybutan-2-yl prop-2-enoate Chemical compound OCC(O)C(C)OC(=O)C=C GISWNRNUVGGVOS-UHFFFAOYSA-N 0.000 description 2
- DLHQZZUEERVIGQ-UHFFFAOYSA-N 3,7-dimethyl-3-octanol Chemical compound CCC(C)(O)CCCC(C)C DLHQZZUEERVIGQ-UHFFFAOYSA-N 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 2
- MXLMTQWGSQIYOW-UHFFFAOYSA-N 3-methyl-2-butanol Chemical compound CC(C)C(C)O MXLMTQWGSQIYOW-UHFFFAOYSA-N 0.000 description 2
- JEWXYDDSLPIBBO-UHFFFAOYSA-N 3-methyl-3-octanol Chemical compound CCCCCC(C)(O)CC JEWXYDDSLPIBBO-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000004713 Cyclic olefin copolymer Substances 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229920004943 Delrin® Polymers 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229930186217 Glycolipid Natural products 0.000 description 2
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000001723 curing Methods 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 2
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 2
- 208000030533 eye disease Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- QNVRIHYSUZMSGM-UHFFFAOYSA-N hexan-2-ol Chemical compound CCCCC(C)O QNVRIHYSUZMSGM-UHFFFAOYSA-N 0.000 description 2
- ZOCHHNOQQHDWHG-UHFFFAOYSA-N hexan-3-ol Chemical compound CCCC(O)CC ZOCHHNOQQHDWHG-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 229960004958 ketotifen Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N monobenzene Natural products C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N n-Nonyl alcohol Natural products CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- RMQLWXQTAOCGHL-UHFFFAOYSA-N n-ethoxy-n-methylprop-2-enamide Chemical compound CCON(C)C(=O)C=C RMQLWXQTAOCGHL-UHFFFAOYSA-N 0.000 description 2
- YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 description 2
- JFNLZVQOOSMTJK-KNVOCYPGSA-N norbornene Chemical compound C1[C@@H]2CC[C@H]1C=C2 JFNLZVQOOSMTJK-KNVOCYPGSA-N 0.000 description 2
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- PGMYKACGEOXYJE-UHFFFAOYSA-N pentyl acetate Chemical compound CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 2
- 229950004354 phosphorylcholine Drugs 0.000 description 2
- PYJNAPOPMIJKJZ-UHFFFAOYSA-N phosphorylcholine chloride Chemical compound [Cl-].C[N+](C)(C)CCOP(O)(O)=O PYJNAPOPMIJKJZ-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- KOUKXHPPRFNWPP-UHFFFAOYSA-N pyrazine-2,5-dicarboxylic acid;hydrate Chemical compound O.OC(=O)C1=CN=C(C(O)=O)C=N1 KOUKXHPPRFNWPP-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 229910052594 sapphire Inorganic materials 0.000 description 2
- 239000010980 sapphire Substances 0.000 description 2
- 150000003335 secondary amines Chemical group 0.000 description 2
- 238000006884 silylation reaction Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 229920006301 statistical copolymer Polymers 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- RVEZZJVBDQCTEF-UHFFFAOYSA-N sulfenic acid Chemical class SO RVEZZJVBDQCTEF-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- LDDMACCNBZAMSG-BDVNFPICSA-N (2r,3r,4s,5r)-3,4,5,6-tetrahydroxy-2-(methylamino)hexanal Chemical compound CN[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO LDDMACCNBZAMSG-BDVNFPICSA-N 0.000 description 1
- JCZPMGDSEAFWDY-SQOUGZDYSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanamide Chemical compound NC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO JCZPMGDSEAFWDY-SQOUGZDYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YTWATCPYACYCLY-UHFFFAOYSA-N 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-6-(1,1,2,2,2-pentafluoroethylsulfanyl)hexane Chemical compound C(C(C(C(F)(F)SC(C(F)(F)F)(F)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F YTWATCPYACYCLY-UHFFFAOYSA-N 0.000 description 1
- FMQPBWHSNCRVQJ-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-yl 2-methylprop-2-enoate Chemical class CC(=C)C(=O)OC(C(F)(F)F)C(F)(F)F FMQPBWHSNCRVQJ-UHFFFAOYSA-N 0.000 description 1
- CYIGRWUIQAVBFG-UHFFFAOYSA-N 1,2-bis(2-ethenoxyethoxy)ethane Chemical compound C=COCCOCCOCCOC=C CYIGRWUIQAVBFG-UHFFFAOYSA-N 0.000 description 1
- NAOLWIGVYRIGTP-UHFFFAOYSA-N 1,3,5-trihydroxyanthracene-9,10-dione Chemical compound C1=CC(O)=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1 NAOLWIGVYRIGTP-UHFFFAOYSA-N 0.000 description 1
- VTBOTOBFGSVRMA-UHFFFAOYSA-N 1-Methylcyclohexanol Chemical compound CC1(O)CCCCC1 VTBOTOBFGSVRMA-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RMSGQZDGSZOJMU-UHFFFAOYSA-N 1-butyl-2-phenylbenzene Chemical group CCCCC1=CC=CC=C1C1=CC=CC=C1 RMSGQZDGSZOJMU-UHFFFAOYSA-N 0.000 description 1
- JNOZGFXJZQXOSU-UHFFFAOYSA-N 1-chloro-2-methylpropan-2-ol Chemical compound CC(C)(O)CCl JNOZGFXJZQXOSU-UHFFFAOYSA-N 0.000 description 1
- VZPULCFQAMRUMH-UHFFFAOYSA-N 1-ethyl-3-methylidenepyrrolidin-2-one Chemical compound CCN1CCC(=C)C1=O VZPULCFQAMRUMH-UHFFFAOYSA-N 0.000 description 1
- QIGOESOMEANKQI-UHFFFAOYSA-N 1-methylcyclopentane-1,3-diol Chemical compound CC1(O)CCC(O)C1 QIGOESOMEANKQI-UHFFFAOYSA-N 0.000 description 1
- FENFUOGYJVOCRY-UHFFFAOYSA-N 1-propoxypropan-2-ol Chemical compound CCCOCC(C)O FENFUOGYJVOCRY-UHFFFAOYSA-N 0.000 description 1
- QTKPMCIBUROOGY-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(F)(F)F QTKPMCIBUROOGY-UHFFFAOYSA-N 0.000 description 1
- PIZHFBODNLEQBL-UHFFFAOYSA-N 2,2-diethoxy-1-phenylethanone Chemical compound CCOC(OCC)C(=O)C1=CC=CC=C1 PIZHFBODNLEQBL-UHFFFAOYSA-N 0.000 description 1
- IKECULIHBUCAKR-UHFFFAOYSA-N 2,3-dimethylbutan-2-ol Chemical compound CC(C)C(C)(C)O IKECULIHBUCAKR-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- WMDZKDKPYCNCDZ-UHFFFAOYSA-N 2-(2-butoxypropoxy)propan-1-ol Chemical compound CCCCOC(C)COC(C)CO WMDZKDKPYCNCDZ-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- CUDYYMUUJHLCGZ-UHFFFAOYSA-N 2-(2-methoxypropoxy)propan-1-ol Chemical compound COC(C)COC(C)CO CUDYYMUUJHLCGZ-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- RBUACGOFWUSJNX-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-ethenylphenol Chemical compound OC1=CC=C(C=C)C=C1N1N=C2C=CC=CC2=N1 RBUACGOFWUSJNX-UHFFFAOYSA-N 0.000 description 1
- RUHFUZYHRCJBHA-UHFFFAOYSA-N 2-(ethoxyamino)ethanesulfonic acid Chemical compound CCONCCS(O)(=O)=O RUHFUZYHRCJBHA-UHFFFAOYSA-N 0.000 description 1
- QNVRIHYSUZMSGM-LURJTMIESA-N 2-Hexanol Natural products CCCC[C@H](C)O QNVRIHYSUZMSGM-LURJTMIESA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 1
- JDSQBDGCMUXRBM-UHFFFAOYSA-N 2-[2-(2-butoxypropoxy)propoxy]propan-1-ol Chemical compound CCCCOC(C)COC(C)COC(C)CO JDSQBDGCMUXRBM-UHFFFAOYSA-N 0.000 description 1
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 1
- XXJWUZQJPJLUNE-UHFFFAOYSA-N 2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethyl 3-methylbut-2-enoate Chemical compound CC(=CC(=O)OCCOCCOCCOCCO)C XXJWUZQJPJLUNE-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- UFYKDFXCZBTLOO-TXICZTDVSA-N 2-amino-2-deoxy-D-gluconic acid Chemical compound [O-]C(=O)[C@H]([NH3+])[C@@H](O)[C@H](O)[C@H](O)CO UFYKDFXCZBTLOO-TXICZTDVSA-N 0.000 description 1
- MSWZFWKMSRAUBD-CBPJZXOFSA-N 2-amino-2-deoxy-D-mannopyranose Chemical compound N[C@@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-CBPJZXOFSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- QKQSNQYQVSEURS-UHFFFAOYSA-N 2-fluorobenzotriazole Chemical compound FN1N=C2C(=N1)C=CC=C2 QKQSNQYQVSEURS-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- ICBJBNAUJWZPBY-UHFFFAOYSA-N 2-hydroxyethyl 3-methylbut-2-enoate Chemical group CC(=CC(=O)OCCO)C ICBJBNAUJWZPBY-UHFFFAOYSA-N 0.000 description 1
- BQZJOQXSCSZQPS-UHFFFAOYSA-N 2-methoxy-1,2-diphenylethanone Chemical group C=1C=CC=CC=1C(OC)C(=O)C1=CC=CC=C1 BQZJOQXSCSZQPS-UHFFFAOYSA-N 0.000 description 1
- WFRBDWRZVBPBDO-UHFFFAOYSA-N 2-methyl-2-pentanol Chemical compound CCCC(C)(C)O WFRBDWRZVBPBDO-UHFFFAOYSA-N 0.000 description 1
- TURITJIWSQEMDB-UHFFFAOYSA-N 2-methyl-n-[(2-methylprop-2-enoylamino)methyl]prop-2-enamide Chemical compound CC(=C)C(=O)NCNC(=O)C(C)=C TURITJIWSQEMDB-UHFFFAOYSA-N 0.000 description 1
- UPTHZKIDNHJFKQ-UHFFFAOYSA-N 2-methylprop-2-enoic acid;propane-1,2,3-triol Chemical compound CC(=C)C(O)=O.CC(=C)C(O)=O.OCC(O)CO UPTHZKIDNHJFKQ-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NMRPBPVERJPACX-QMMMGPOBSA-N 3-Octanol Natural products CCCCC[C@@H](O)CC NMRPBPVERJPACX-QMMMGPOBSA-N 0.000 description 1
- NWBTXZPDTSKZJU-UHFFFAOYSA-N 3-[dimethyl(trimethylsilyloxy)silyl]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC[Si](C)(C)O[Si](C)(C)C NWBTXZPDTSKZJU-UHFFFAOYSA-N 0.000 description 1
- LUTFTISESXWDHG-UHFFFAOYSA-N 3-aminopropyl 2-methylprop-2-enoate;hydrochloride Chemical compound Cl.CC(=C)C(=O)OCCCN LUTFTISESXWDHG-UHFFFAOYSA-N 0.000 description 1
- UOQHWNPVNXSDDO-UHFFFAOYSA-N 3-bromoimidazo[1,2-a]pyridine-6-carbonitrile Chemical compound C1=CC(C#N)=CN2C(Br)=CN=C21 UOQHWNPVNXSDDO-UHFFFAOYSA-N 0.000 description 1
- WNDLTOTUHMHNOC-UHFFFAOYSA-N 3-ethylhexan-3-ol Chemical compound CCCC(O)(CC)CC WNDLTOTUHMHNOC-UHFFFAOYSA-N 0.000 description 1
- AMULJSVDIHMAOX-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate;prop-2-enoic acid Chemical compound OC(=O)C=C.OCCCOC(=O)C=C AMULJSVDIHMAOX-UHFFFAOYSA-N 0.000 description 1
- KYWJZCSJMOILIZ-UHFFFAOYSA-N 3-methylhexan-3-ol Chemical compound CCCC(C)(O)CC KYWJZCSJMOILIZ-UHFFFAOYSA-N 0.000 description 1
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- RXSIKQJQLQRQQY-UHFFFAOYSA-N 4-methyloctan-4-ol Chemical compound CCCCC(C)(O)CCC RXSIKQJQLQRQQY-UHFFFAOYSA-N 0.000 description 1
- GLSKMRNRRMNAQS-UHFFFAOYSA-N 5-(trifluoromethyl)-2h-benzotriazole Chemical compound C1=C(C(F)(F)F)C=CC2=NNN=C21 GLSKMRNRRMNAQS-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- PZBQVZFITSVHAW-UHFFFAOYSA-N 5-chloro-2h-benzotriazole Chemical compound C1=C(Cl)C=CC2=NNN=C21 PZBQVZFITSVHAW-UHFFFAOYSA-N 0.000 description 1
- IZSRJDGCGRAUAR-MROZADKFSA-N 5-dehydro-D-gluconic acid Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O IZSRJDGCGRAUAR-MROZADKFSA-N 0.000 description 1
- CDTYDMKRNQVPFQ-UHFFFAOYSA-N 5-ethenyl-2h-benzotriazole Chemical compound C1=C(C=C)C=CC2=NNN=C21 CDTYDMKRNQVPFQ-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N 8beta-(2,3-epoxy-2-methylbutyryloxy)-14-acetoxytithifolin Natural products COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- VLSVUPIXPZOJCF-UHFFFAOYSA-N C(=O)(C=C)NC(=O)C=C.C(CN)N Chemical compound C(=O)(C=C)NC(=O)C=C.C(CN)N VLSVUPIXPZOJCF-UHFFFAOYSA-N 0.000 description 1
- WKTPWBMBJFHTMV-UHFFFAOYSA-N C(C(C)C)#N.[N] Chemical compound C(C(C)C)#N.[N] WKTPWBMBJFHTMV-UHFFFAOYSA-N 0.000 description 1
- VDLATOUWUCIWFU-UHFFFAOYSA-N C(C=C)(=O)OCCC[SiH2]OCC.C(C(=C)C)(=O)O Chemical compound C(C=C)(=O)OCCC[SiH2]OCC.C(C(=C)C)(=O)O VDLATOUWUCIWFU-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- 229920001730 Moisture cure polyurethane Polymers 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- VULXNJHRVYGPSQ-UHFFFAOYSA-N N=NC=NN.N=NC=NN.CC(COC(C)CO)O Chemical compound N=NC=NN.N=NC=NN.CC(COC(C)CO)O VULXNJHRVYGPSQ-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- HLJYBXJFKDDIBI-UHFFFAOYSA-N O=[PH2]C(=O)C1=CC=CC=C1 Chemical compound O=[PH2]C(=O)C1=CC=CC=C1 HLJYBXJFKDDIBI-UHFFFAOYSA-N 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920002396 Polyurea Polymers 0.000 description 1
- 241001415846 Procellariidae Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- ALLWOAVDORUJLA-UHFFFAOYSA-N Rebamipida Chemical compound C=1C(=O)NC2=CC=CC=C2C=1CC(C(=O)O)NC(=O)C1=CC=C(Cl)C=C1 ALLWOAVDORUJLA-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- IAXXETNIOYFMLW-COPLHBTASA-N [(1s,3s,4s)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@]2(C)[C@@H](OC(=O)C(=C)C)C[C@H]1C2(C)C IAXXETNIOYFMLW-COPLHBTASA-N 0.000 description 1
- CKIDCRFWPRVLEU-UHFFFAOYSA-N [3-(benzotriazol-2-yl)-4-hydroxyphenyl] prop-2-enoate Chemical compound OC1=CC=C(OC(=O)C=C)C=C1N1N=C2C=CC=CC2=N1 CKIDCRFWPRVLEU-UHFFFAOYSA-N 0.000 description 1
- JIMPAYYJPMENLQ-UHFFFAOYSA-N acetic acid;2-(2-methoxypropoxy)propan-1-ol Chemical class CC(O)=O.COC(C)COC(C)CO JIMPAYYJPMENLQ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 125000005012 alkyl thioether group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- GMWFCJXSQQHBPI-UHFFFAOYSA-N azetidin-3-ol Chemical compound OC1CNC1 GMWFCJXSQQHBPI-UHFFFAOYSA-N 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- QUZSUMLPWDHKCJ-UHFFFAOYSA-N bisphenol A dimethacrylate Chemical compound C1=CC(OC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OC(=O)C(C)=C)C=C1 QUZSUMLPWDHKCJ-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- FJMKECANSIPFJO-UHFFFAOYSA-N carbamic acid ethenyl acetate Chemical compound C(=C)OC(C)=O.NC(=O)O FJMKECANSIPFJO-UHFFFAOYSA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004651 carbonic acid esters Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- WROHVVIPQXODQM-LYSKQWNXSA-N carboxymethyl-β-cyclodextrin sodium salt Chemical compound O([C@@H]([C@H]([C@@H]1O)O)O[C@H]2[C@@H](O)[C@@H]([C@@H](O[C@@H]3[C@@H](COCC(O)=O)O[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3[C@@H](COCC(O)=O)O[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3[C@@H](COCC(O)=O)O[C@@H]([C@H]([C@@H]3O)O)O[C@@H]3[C@@H](COCC(O)=O)O[C@@H]([C@H]([C@@H]3O)O)O3)O[C@@H]2COCC(O)=O)O)[C@H](COCC(O)=O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O)[C@H]3[C@@H](COCC(O)=O)O1 WROHVVIPQXODQM-LYSKQWNXSA-N 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- YACLQRRMGMJLJV-UHFFFAOYSA-N chloroprene Chemical compound ClC(=C)C=C YACLQRRMGMJLJV-UHFFFAOYSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- CLRLHXKNIYJWAW-QBTAGHCHSA-N deaminoneuraminic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@@H]1OC(O)(C(O)=O)C[C@H](O)[C@H]1O CLRLHXKNIYJWAW-QBTAGHCHSA-N 0.000 description 1
- ACUZDYFTRHEKOS-UHFFFAOYSA-N decan-2-ol Chemical compound CCCCCCCCC(C)O ACUZDYFTRHEKOS-UHFFFAOYSA-N 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- AFABGHUZZDYHJO-UHFFFAOYSA-N dimethyl butane Natural products CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- ODQWQRRAPPTVAG-GZTJUZNOSA-N doxepin Chemical compound C1OC2=CC=CC=C2C(=C/CCN(C)C)/C2=CC=CC=C21 ODQWQRRAPPTVAG-GZTJUZNOSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- FFYWKOUKJFCBAM-UHFFFAOYSA-N ethenyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC=C FFYWKOUKJFCBAM-UHFFFAOYSA-N 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- BLZSRIYYOIZLJL-UHFFFAOYSA-N ethenyl pentanoate Chemical compound CCCCC(=O)OC=C BLZSRIYYOIZLJL-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- UJOLYBGCVQJVLI-UHFFFAOYSA-N ethenyl propyl carbonate Chemical compound CCCOC(=O)OC=C UJOLYBGCVQJVLI-UHFFFAOYSA-N 0.000 description 1
- JGENYNHRIOHZOP-UHFFFAOYSA-N ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCOP([O-])(=O)OCC[N+](C)(C)C JGENYNHRIOHZOP-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- ZQTYQMYDIHMKQB-UHFFFAOYSA-N exo-norborneol Chemical compound C1CC2C(O)CC1C2 ZQTYQMYDIHMKQB-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 231100000013 eye irritation Toxicity 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 244000144992 flock Species 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 235000012209 glucono delta-lactone Nutrition 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEKANFGSDXODPD-UHFFFAOYSA-N glyphosate-isopropylammonium Chemical compound CC(C)N.OC(=O)CNCP(O)(O)=O ZEKANFGSDXODPD-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000010220 ion permeability Effects 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940119545 isobornyl methacrylate Drugs 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940099563 lactobionic acid Drugs 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229960001120 levocabastine Drugs 0.000 description 1
- ZCGOMHNNNFPNMX-KYTRFIICSA-N levocabastine Chemical compound C1([C@@]2(C(O)=O)CCN(C[C@H]2C)[C@@H]2CC[C@@](CC2)(C#N)C=2C=CC(F)=CC=2)=CC=CC=C1 ZCGOMHNNNFPNMX-KYTRFIICSA-N 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- 229960004305 lodoxamide Drugs 0.000 description 1
- RVGLGHVJXCETIO-UHFFFAOYSA-N lodoxamide Chemical compound OC(=O)C(=O)NC1=CC(C#N)=CC(NC(=O)C(O)=O)=C1Cl RVGLGHVJXCETIO-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940057867 methyl lactate Drugs 0.000 description 1
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- MBHINSULENHCMF-UHFFFAOYSA-N n,n-dimethylpropanamide Chemical compound CCC(=O)N(C)C MBHINSULENHCMF-UHFFFAOYSA-N 0.000 description 1
- RKISUIUJZGSLEV-UHFFFAOYSA-N n-[2-(octadecanoylamino)ethyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCNC(=O)CCCCCCCCCCCCCCCCC RKISUIUJZGSLEV-UHFFFAOYSA-N 0.000 description 1
- AYGYHGXUJBFUJU-UHFFFAOYSA-N n-[2-(prop-2-enoylamino)ethyl]prop-2-enamide Chemical compound C=CC(=O)NCCNC(=O)C=C AYGYHGXUJBFUJU-UHFFFAOYSA-N 0.000 description 1
- QQZOPKMRPOGIEB-UHFFFAOYSA-N n-butyl methyl ketone Natural products CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 1
- MWKFXSUHUHTGQN-UHFFFAOYSA-N n-decyl alcohol Natural products CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 1
- PNLUGRYDUHRLOF-UHFFFAOYSA-N n-ethenyl-n-methylacetamide Chemical compound C=CN(C)C(C)=O PNLUGRYDUHRLOF-UHFFFAOYSA-N 0.000 description 1
- QJQAMHYHNCADNR-UHFFFAOYSA-N n-methylpropanamide Chemical compound CCC(=O)NC QJQAMHYHNCADNR-UHFFFAOYSA-N 0.000 description 1
- CNPHCSFIDKZQAK-UHFFFAOYSA-N n-prop-2-enylprop-2-enamide Chemical compound C=CCNC(=O)C=C CNPHCSFIDKZQAK-UHFFFAOYSA-N 0.000 description 1
- 229960004398 nedocromil Drugs 0.000 description 1
- RQTOOFIXOKYGAN-UHFFFAOYSA-N nedocromil Chemical compound CCN1C(C(O)=O)=CC(=O)C2=C1C(CCC)=C1OC(C(O)=O)=CC(=O)C1=C2 RQTOOFIXOKYGAN-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 229960004114 olopatadine Drugs 0.000 description 1
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 description 1
- 150000002918 oxazolines Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- RPQRDASANLAFCM-UHFFFAOYSA-N oxiran-2-ylmethyl prop-2-enoate Chemical compound C=CC(=O)OCC1CO1 RPQRDASANLAFCM-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 125000004817 pentamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- FZGSCNQUWMMDIG-UHFFFAOYSA-N phenyl(phosphanyl)methanone Chemical compound PC(=O)C1=CC=CC=C1 FZGSCNQUWMMDIG-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- UBYZGUWQNIEQMH-SBBOJQDXSA-M potassium;(2s,3s,4s,5r)-2,3,4,5,6-pentahydroxy-6-oxohexanoate Chemical compound [K+].OC(=O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O UBYZGUWQNIEQMH-SBBOJQDXSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- OCAAZRFBJBEVPS-UHFFFAOYSA-N prop-2-enyl carbamate Chemical compound NC(=O)OCC=C OCAAZRFBJBEVPS-UHFFFAOYSA-N 0.000 description 1
- QTECDUFMBMSHKR-UHFFFAOYSA-N prop-2-enyl prop-2-enoate Chemical compound C=CCOC(=O)C=C QTECDUFMBMSHKR-UHFFFAOYSA-N 0.000 description 1
- HJWLCRVIBGQPNF-UHFFFAOYSA-N prop-2-enylbenzene Chemical compound C=CCC1=CC=CC=C1 HJWLCRVIBGQPNF-UHFFFAOYSA-N 0.000 description 1
- KIWATKANDHUUOB-UHFFFAOYSA-N propan-2-yl 2-hydroxypropanoate Chemical compound CC(C)OC(=O)C(C)O KIWATKANDHUUOB-UHFFFAOYSA-N 0.000 description 1
- LYBIZMNPXTXVMV-UHFFFAOYSA-N propan-2-yl prop-2-enoate Chemical compound CC(C)OC(=O)C=C LYBIZMNPXTXVMV-UHFFFAOYSA-N 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N propyl ethylene Natural products CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- UIDUKLCLJMXFEO-UHFFFAOYSA-N propylsilane Chemical compound CCC[SiH3] UIDUKLCLJMXFEO-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 229920013730 reactive polymer Polymers 0.000 description 1
- 229950004535 rebamipide Drugs 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 1
- 238000010106 rotational casting Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000008149 soap solution Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002352 surface water Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- IXSPLXSQNNZJJU-UHFFFAOYSA-N trimethyl(silyloxy)silane Chemical compound C[Si](C)(C)O[SiH3] IXSPLXSQNNZJJU-UHFFFAOYSA-N 0.000 description 1
- QNWOFLWXQGHSRH-UHFFFAOYSA-N trimethyl-[methyl(trimethylsilyloxy)silyl]oxysilane Chemical class C[Si](C)(C)O[SiH](C)O[Si](C)(C)C QNWOFLWXQGHSRH-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/043—Improving the adhesiveness of the coatings per se, e.g. forming primers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D3/00—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials
- B05D3/04—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by exposure to gases
- B05D3/0466—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by exposure to gases the gas being a non-reacting gas
- B05D3/0473—Pretreatment of surfaces to which liquids or other fluent materials are to be applied; After-treatment of applied coatings, e.g. intermediate treating of an applied coating preparatory to subsequent applications of liquids or other fluent materials by exposure to gases the gas being a non-reacting gas for heating, e.g. vapour heating
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D5/00—Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D7/00—Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
- B05D7/02—Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials to macromolecular substances, e.g. rubber
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05D7/00—Processes, other than flocking, specially adapted for applying liquids or other fluent materials to particular surfaces or for applying particular liquids or other fluent materials
- B05D7/50—Multilayers
- B05D7/56—Three layers or more
- B05D7/57—Three layers or more the last layer being a clear coat
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00009—Production of simple or compound lenses
- B29D11/00038—Production of contact lenses
- B29D11/00048—Production of contact lenses composed of parts with dissimilar composition
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29D—PRODUCING PARTICULAR ARTICLES FROM PLASTICS OR FROM SUBSTANCES IN A PLASTIC STATE
- B29D11/00—Producing optical elements, e.g. lenses or prisms
- B29D11/00865—Applying coatings; tinting; colouring
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/0427—Coating with only one layer of a composition containing a polymer binder
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/056—Forming hydrophilic coatings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/08—Heat treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/12—Chemical modification
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/10—Optical coatings produced by application to, or surface treatment of, optical elements
- G02B1/18—Coatings for keeping optical surfaces clean, e.g. hydrophobic or photo-catalytic films
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2339/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Derivatives of such polymers
- C08J2339/04—Homopolymers or copolymers of monomers containing heterocyclic rings having nitrogen as ring member
- C08J2339/06—Homopolymers or copolymers of N-vinyl-pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2433/02—Homopolymers or copolymers of acids; Metal or ammonium salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Mechanical Engineering (AREA)
- Manufacturing & Machinery (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Thermal Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Eyeglasses (AREA)
- Coating Of Shaped Articles Made Of Macromolecular Substances (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- General Health & Medical Sciences (AREA)
Abstract
本发明涉及一种用于生产在其上具有稳定的涂层的硅酮水凝胶接触镜片的方法。本发明的方法包括用于在硅酮水凝胶接触镜片上形成丙烯酸或C1‑C3烷基丙烯酸的均聚物或共聚物的相对稳定的基底涂层的水基涂覆过程(步骤),该硅酮水凝胶接触镜片是由包含按重量计从约35%至约60%的N‑乙烯基吡咯烷酮的镜片配制品制成的。
Description
本发明总体上涉及一种用于生产在其上具有稳定的涂层的硅酮水凝胶接触镜片的方法,该方法涉及以成本有效且时间有效的方式进行的涂覆步骤。此外,本发明提供了根据本发明的方法生产的硅酮水凝胶接触镜片。
背景
软硅酮水凝胶接触镜片因为它们的高透氧性和舒适性变得越来越流行。但是,硅酮水凝胶材料典型地具有是疏水性的(不可润湿的)并容易受到从眼睛环境吸附脂质或蛋白质的影响并且可能附着到眼睛上的表面、或至少其表面的一些区域。因此,硅酮水凝胶接触镜片总体上将需要表面改性。
用于改性相对疏水性的接触镜片材料的亲水性的已知方法是通过使用等离子体处理,例如,商业镜片如Focus NIGHT&DAYTM和O2OPTIXTM(视康(CIBA VISION)),以及PUREVISIONTM(博士伦(Bausch&Lomb))在其生产过程中利用这这种方法。等离子体涂层的优点,例如像,用Focus NIGHT&DAYTM可以发现的那些,些,是它的耐久性、相对高的亲水性/可润湿性)、以及对脂质和蛋白质沉积和吸附的低敏感性。但是,硅酮水凝胶接触镜片的等离子体处理可能不是成本有效的,因为预成形的接触镜片典型地必须在等离子体处理之前被干燥并且因为与等离子体处理设备相关联的相对高的资本投资。
各种其他方法被提出和/或用于改性硅酮水凝胶接触镜片的表面亲水性。这样的方法的实例包括:将湿润剂(亲水性聚合物)结合到用于制造硅酮水凝胶接触镜片的镜片配制品中(参见,例如,美国专利号6,367,929、6,822,016、7,052,131、以及7,249,848);逐层(LbL)聚离子材料沉积技术(参见,例如,美国专利号6,451,871;6,719,929;6,793,973;6,884,457;6,896,926;6,926,965;6,940,580;和7,297,725,以及美国专利申请公开号2007/0229758A1;2008/0174035A1和2008/0152800A1);接触镜片上的LbL涂层的交联已在共同拥有的共同未决的美国专利申请公开号2008/0226922 A1和2009/0186229 A1中提出;以及根据各种机制将亲水性聚合物附着到接触镜片上(参见例如,美国专利号6,099,122、6,436,481、6,440,571、6,447,920、6,465,056、6,521,352、6,586,038、6,623,747、6,730,366、6,734,321、6,835,410、6,878,399、6,923,978、6,440,571、以及6,500,481,美国专利申请公开号2009/0145086 A1、2009/0145091A1、2008/0142038A1、以及2007/0122540A1)。虽然那些技术可以在使硅酮水凝胶材料可润湿中使用,在那些技术中存在一些缺点。例如,润湿剂可能因为它们与镜片配制品中的其他硅酮组分的不相容性赋予所得镜片浑浊度并且可能不能提供耐久的亲水性表面用于长期佩戴的目的。LbL涂层可能不像等离子体涂层那样耐久并且可能具有相对高的表面电荷密度;这可能干扰接触镜片清洁和消毒溶液。交联的LbL涂层可以具有比初始LbL涂层(交联之前)更差的亲水性和/或可润湿性并且仍然具有相对高的表面电荷密度。另外,它们对于在大量生产环境中实施可能不是成本有效的和/或时间有效的,因为它们典型地需要相对长的时间和/或涉及费力的多个步骤来获得亲水性涂层。
最近,在美国专利申请公开号2012/0026457 A1中已经描述了一种新的成本有效的方法(通过引用以其全文结合于此)用于将非硅酮水凝胶涂层施用到硅酮水凝胶接触镜片上,其中在硅酮水凝胶接触镜片上形成稳定的、互相渗透的基底涂层中涉及基于有机溶剂的涂覆溶液,并且然后将部分交联的亲水性聚合物材料在高压灭菌期间直接在镜片包装中共价附着到硅酮水凝胶接触镜片的该基底涂层上。虽然这种新方法可以提供在其上具有耐久的亲水性涂层的硅酮水凝胶接触镜片,该方法可能不是环境友好的涂覆过程,因为它涉及在涂覆过程中使用有机溶剂。
因此,仍然存在对于以环境友好的方式在硅酮水凝胶接触镜片上形成稳定的基底涂层的新涂覆的需要。
发明概述
在一个方面,本发明提供了一种用于生产各自在其上具有交联的亲水性涂层的硅酮水凝胶接触镜片的方法,本发明的方法包括以下步骤:(a)从可聚合组合物获得硅酮水凝胶接触镜片,该可聚合组合物包含至少一种含有硅氧烷的乙烯单体或大分子单体和相对于可聚合组分的总量按重量计从约30%至约60%的N-乙烯基吡咯烷酮;以及(b)使该硅酮水凝胶接触镜片与丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液接触以在该硅酮水凝胶接触镜片上形成基底涂层,其中在该硅酮水凝胶接触镜片已经在具有从约6.5至约7.5的pH的磷酸盐缓冲盐水中在115℃至125℃下高压灭菌持续约30分钟之后该基底涂层表现出约20秒或更长的水破裂时间(WBUT)。
在另一个方面,本发明提供了根据本发明的方法获得的一种硅酮水凝胶接触镜片,其中该硅酮水凝胶接触镜片具有至少约40barrers的透氧性、特征在于约100度或更小的水接触角的表面可润湿性、以及特征在于经受得住手指摩擦试验的涂层耐久性。
本发明的这些和其他方面将从当前优选实施例的以下描述变得明显。详细描述仅仅是本发明的说明并且不限制本发明的范围,本发明的范围由所附权利要求书及其等效物限定。如将对本领域技术人员显而易见的,本发明的许多变型和修改可以在不脱离本披露内容的新颖概念的精神和范围的情况下实现。
本发明的实施方式的详细说明
除非另外定义,在此使用的所有技术和科学术语具有如本发明所属的领域中的普通技术人员通常理解的相同的含义。通常,在此使用的命名法和实验室程序是众所周知的并且在本领域中通常使用的。常规方法被用于这些程序,如在本领域和各种一般参考文献中提供的那些。在术语以单数提供时,诸位发明人也考虑该术语的复数。在此所使用的命名法和以下所述的实验室程序是那些众所周知的和本领域中通常使用的。
“接触镜片”指的是可以放置在佩戴者的眼睛上或内的结构。接触镜片可以校正、改善、或改变使用者的视力,但是不必是这种情况。接触镜片可以是由本领域中已知的或后来开发的任何适当的材料制成,并且可以是软镜片(例如,水凝胶或硅酮镜片)、硬镜片或混合镜片。“硅酮水凝胶接触镜片”指的是包括硅酮水凝胶本体(芯)材料的接触镜片。
“水凝胶”或“水凝胶材料”指的是不溶于水,但当它被完全水合时在其三维聚合物网络(即聚合物基质)中可以保留至少10重量百分比的水的交联聚合物材料。
“硅酮水凝胶”指的是通过包含至少一种含硅酮的单体或至少一种含硅酮的大分子单体或至少一种可交联的含硅酮的预聚物的可聚合组合物的共聚获得的含硅酮的水凝胶。
如本申请中所使用的,术语“非硅酮水凝胶”指的是理论上没有硅的水凝胶。
“亲水性的”,如在此所使用的,描述了相比与脂类缔合更容易与水缔合的材料或其一部分。
“乙烯基单体”指的是具有一个唯一烯键式不饱和基团、可溶于溶剂中、并且可以光化聚合或热聚合的化合物。
术语“可溶的”,关于在溶剂中的化合物或材料,意指该化合物或材料可以溶解在该溶剂中以产生在室温(即约22℃至约28℃的温度)下具有按重量计至少约0.5%的浓度的溶液。
术语“不可溶的”,关于在溶剂中的化合物或材料,意指该化合物或材料可以溶解在该溶剂中以产生在室温下具有按重量计小于0.005%的浓度的溶液(如以上所定义)。
如在本申请中使用的,术语“烯键式不饱和基团”在此在广义上使用并且旨在包括含有至少一个>C=C<基团的任何基团。示例性的烯键式不饱和基团包括但不限于(甲基)丙烯酰基烯丙基、乙烯基、苯乙烯基、或其他含有C=C的基团。
术语“(甲基)丙烯酰胺”指的是甲基丙烯酰胺和/或丙烯酰胺。
术语“(甲基)丙烯酸酯”指的是甲基丙烯酸酯和/或丙烯酸酯。
如在此所使用的,关于可聚合组合物、预聚物或材料的固化、交联或聚合的“光化地”意指固化(例如,交联的和/或聚合的)是通过光化辐射,例如像,紫外/可见光辐射、电离辐射(例如γ射线或X射线辐射)、微波辐射等进行的。热固化或光化固化方法是本领域的技术人员众所周知的。
“亲水性乙烯单体”,如在此所使用的,指的是作为均聚物典型地产生是水溶性的或可以吸收至少10重量百分比的水的聚合物的乙烯单体。
“疏水性乙烯单体”,如在此所使用的,指的是作为均聚物典型地产生不溶于水并且可以吸收小于10重量百分比的水的聚合物的乙烯单体。
“大分子”或“预聚物”指的是含有烯键式不饱和基团并且具有大于700道尔顿的平均分子量的化合物或聚合物。
如在本申请中所使用的,术语“交联剂”指的是具有至少两个烯键式不饱和基团的化合物。“交联剂”指的是具有700道尔顿或更小的分子量的交联剂。
如在本申请中所使用的,术语“聚合物”意指通过聚合/交联一种或多种单体或大分子单体或预聚物或其组合形成的材料。
如在本申请中所使用的,术语聚合物材料(包括单体或大分子单体材料)的“分子量”指的是重均分子量,除非另外特别指出或除非测试条件另外指示。
“聚硅氧烷”指的是含有的聚硅氧烷链段的化合物,其中m1和m2彼此独立地是从0至500的整数,并且(m1+m2)是从2至500,R1’、R2’、R3’、R4’、R5’、R6’、R7’和R8’彼此独立地是C1-C10烷基、C1-C4烷基-或C1-C4-烷氧取代的苯基、C1-C10氟烷基、C1-C10氟醚、C6-C18芳基、–alk–(OC2H4)m3–OR’(其中是C1-C6烷基双基,R’是H或C1-C4烷基并且m3是从1至10的整数),或直链亲水性聚合物链。
“聚碳硅氧烷”指的是含有的聚碳硅氧烷链段的化合物,其中n1是2或3的整数,n2是从2至100(优选从2至20、更优选从2至10、甚至更优选从2至6)的整数,R1”、R2”、R3”、R4”、R5”和R6”彼此独立地是C1-C6烷基(优(优选甲基)。
如在此所用的术语“流体”表示材料能够像液体一样流动。
术语“烷基”指的是通过从直链或支链的烷烃化合物移除氢原子得到的单价基团。烷基(自由基)与有机化合物中的另一个基团形成一个键。
术语“亚烷基二价基团”或“亚烷基双基”或“烷基双基”可互换地指的是通过从烷基中移除一个氢原子得到的二价基团。亚烷基二价基团与有机化合物中的其他基团形成两个键。
术语“烷基三基”指的是通过从烷基中移除两个氢原子得到的三价基团。烷基三基与有机化合物中的其他基团形成三个键。
术语“烷氧基”或“烷氧基的”指的是通过从直链或支链的烷基醇的羟基中移除氢原子得到的单价基团。烷氧基(自由基)与有机化合物中的另一个基团形成一个键。
在本申请中,关于烷基双基或烷基的术语“取代的”意指烷基双基或烷基包括至少一个取代烷基双基或烷基的一个氢原子并且选自下组的取代基,该组由以下各项组成:羟基(-OH)、羧基(-COOH)、-NH2、巯基(-SH)、C1-C4烷基、C1-C4烷氧基、C1-C4烷硫基(烷基硫醚)、C1-C4酰氨基、C1-C4烷氨基、二-C1-C4烷氨基、卤素原子(Br或Cl)、以及它们的组合。
在本申请中,“噁唑啉”指的是的化合物,其中:R1是氢、甲基、乙基、N-吡咯烷酮基甲基、N-吡咯烷酮基乙基、N-吡咯烷酮基丙基、或–alk–(OC2H4)m3–OR”的单价基团,其中alk是C1-C4烷基双基;R”是C1-C4烷基(优选甲基);并且m3是从1至10(优选1至5)的整数。
在本申请中,术语“聚噁唑啉”指的是在一种或多种噁唑啉的开环聚合中获得的并且总体上具有的式的线性聚合物,其中:T1和T2是两个端基;R1是氢、甲基、乙基、N-吡咯烷酮基甲基、N-吡咯烷酮基乙基、N-吡咯烷酮基丙基、或–alk–(OC2H4)m3–OR”的单价基团,其中alk是C1-C4烷基双基;R”是C1-C4烷基(优选甲基);m3是从1至10(优选1至5)的整数;x是从5至500的整数。聚噁唑啉链段具有的式的二价聚合物链,其中R1和x是如上所定义的。
在本申请中,术语“聚(2-噁唑啉-共-乙烯亚胺)”指的是具有的式的统计共聚物,其中:T1和T2是端基;R1是氢、甲基、乙基、N-吡咯烷酮基甲基、N-吡咯烷酮基乙基、N-吡咯烷酮基丙基、或–alk–(OC2H4)m3–OR”的单价基团,其中alk是C1-C4烷基双基;R”是C1-C4烷基(优选甲基);m3是从1至10(优选1至5)的整数;x是从5至500的整数;z是等于或小于x的整数。聚(2-噁唑啉-共-乙烯亚胺)是通过水解聚噁唑啉获得的。
在本申请中,术语“聚(2-噁唑啉-共-乙烯亚胺)-表氯醇”指的是通过使聚(2-噁唑啉-共-乙烯亚胺)与表氯醇反应以将聚(2-噁唑啉-共-乙烯亚胺)的仲胺基团的全部或相当大的百分比(≥90%)转化为氮杂环丁烷鎓基团而得到的聚合物。聚(2-噁唑啉-共-乙烯亚胺)-表氯醇的实例在2014年8月26日提交的共同未决的美国专利申请号62/041,762中披露(通过引用以其全文结合于此)。
“表氯醇-官能化的聚胺”或“表氯醇-官能化的聚酰氨基胺”指的是通过使聚胺或聚酰氨基胺与表氯醇反应以将聚胺或聚酰氨基胺的仲胺基团的全部或相当大的百分比转化为氮杂环丁烷鎓基团而得到的聚合物。
术语“聚酰氨基胺-表氯醇”指的是表氯醇-官能化的己二酸-二亚乙基三胺共聚物。
在本申请中,术语“氮杂环丁烷鎓”或“3-羟基氮杂环丁烷鎓”指的是的带正电的二价自由基(或基团或部分)。
关于聚合物材料或官能团的术语“可热交联的”意指该聚合物材料或该官能团可经历在相对升高的温度(从约40℃至约140℃)下与另一种材料或官能团的交联(或偶联)反应,而该聚合物材料或官能团不能经历在室温(即,从约22℃至约28℃,优选从约24℃至约26℃、特别是在约25℃下)与另一种材料或官能团的相同的交联反应(或偶联反应)持续约一小时的时间至可检测的程度。
术语“吖内酯”指的是式的单价基团,其中p是0或1;3R和4R彼此独立地是C1-C8烷基(优选甲基)。
如在本申请中所使用的,术语“磷酰胆碱”指的是的单价两性离子基团,其中t1是1至5的整数并且R1”、R2”和R3”彼此独立地是C1-C8烷基C1-C8羟烷基。
如在本申请中所使用的,术语“反应性乙烯单体”指的是具有至少一种选自下组的反应性官能团的任何乙烯单体,该组由以下各项组成:羧基、伯氨基、和仲氨基。
如在本申请中所使用的,术语“非反应性乙烯单体”指的是不含羧基、伯氨基、仲氨基、环氧基、异氰酸酯基、吖内酯基、或氮丙啶基的任何乙烯单体(亲水性或疏水性的乙烯单体)。非反应性乙烯单体可以包括羟基或叔氨基或季氨基。
自由基引发剂可以是光引发剂或热引发剂。“光引发剂”指的是通过使用光引发自由基交联/聚合反应的化学品。“热引发剂”指的是通过使用热能引发自由基交联/聚合反应的化学品。
“光化辐射的空间限制”指的是一种作用或过程,其中呈射线形式的能量辐射通过例如掩模或筛网或其组合被引导,从而以空间上受限的方式照射到具有轮廓分明的外围边界的区域上。UV辐射的空间限制是通过使用具有辐射(例如,UV)可透过区域、围绕该辐射可透过区域的辐射(例如,UV)不可透过区域、以及作为该辐射不可透过区域与该辐射可透过区域之间的边界的投影轮廓的掩模或筛网得到的,如在美国专利号6,800,225(图1-11),和6,627,124(图1-9),7,384,590(图1-6),和7,387,759(图1-6)的附图中示意性地示出的,所有这些通过引用以其全文结合于此。该掩模或筛网允许在空间上投射具有由该掩模或筛网的投影轮廓限定的横截面轮廓的辐射(例如,UV辐射)束。投射的辐射(例如,UV辐射)束限制照射在位于从模具的第一成型表面到第二成型表面的投射光束的路径中的镜片配制品上的辐射(例如,UV辐射)。所得接触镜片包括由第一成型表面限定的前表面,由第二成型表面限定的相反的后表面,以及由投射的UV光束的截面轮廓限定的镜片边缘(即,辐射的空间限制)。用于交联的辐射是辐射能,尤其是UV辐射、γ辐射、电子辐射或热辐射,该辐射能优选呈基本上平行光束的形式以便在一方面实现能量的良好限制以及在另一方面能量的有效利用。
“水接触角”指的是在室温下的平均水接触角(即,通过座滴法测量的接触角),其是通过将至少3个单独的接触镜片的接触角的测量值取平均值获得的。
关于硅酮水凝胶接触镜片上的涂层的术语“完整性”旨在描述在实例1中描述的苏丹黑着色试验中接触镜片可被苏丹黑着色的程度。硅酮水凝胶接触镜片上的涂层的良好完整性意指实际上不存在接触镜片的苏丹黑着色。
关于硅酮水凝胶接触镜片上的涂层的术语“耐久性”旨在描述该硅酮水凝胶接触镜片上的涂层可以经受得住手指摩擦试验。
如在此所使用的,关于接触镜片上的涂层的“经受得住手指摩擦试验”或“经受得住耐久性试验”意指在根据实例1中描述的程序对该镜片进行手指摩擦之后,在手指摩擦过的镜片上的水接触角仍然是约100度或更小、优选约90度或更小、更优选约80度或更小、最优选约70度或更小。
材料的本征“透氧性”,Dk,是氧穿过材料的速率。如在本申请中所使用的,关于水凝胶(硅酮或非硅酮)或接触镜片的术语“透氧性(Dk)”意指所测得的透氧性(Dk),其根据在2012/0026457 A1(通过引用以其全文结合于此)的实例1中描述的程序对于由边界层效应引起的对氧气通量的表面阻力进行校正。透氧性常规地以barrers为单位表示,其中“barrers”被定义为[(cm3氧)(mm)/(cm2)(秒)(mm Hg)]×10-10。
镜片或材料的“氧透过率”,Dk/t,是氧气在所测量的面积上通过具有t[以mm为单位]的平均厚度的特定镜片或材料的速率。氧透过率常规地以barrers/mm为单位表示,其中“barrers/mm”被定义为[(cm3氧)/(cm2)(秒)(mm Hg)]×10-9。
通过镜片的“离子渗透性”与Ionoflux扩散系数相关。Ionoflux扩散系数D(以[mm2/min]为单位)通过应用菲克定律如下确定:
D=-n’/(A×dc/dx)
其中n’=离子传输速率[mol/min];A=暴露的镜片面积[mm2];dc=浓度差[mol/L];dx=镜片的厚度[mm]。
“眼科上相容的”,如在此所使用的,是指可以与眼睛环境密切接触延长的时间段而不显著损害眼睛环境且没有显著的使用者不适的材料或材料的表面。
关于用于灭菌和储存接触镜片的包装溶液的术语“眼科上安全的”意指储存在该溶液中的接触镜片对于直接放在眼睛上是安全的而无需在高压灭菌之后冲洗,并且该溶液对于经由接触镜片与眼睛每日接触而言是安全且足够舒适的。高压灭菌之后的眼科上安全的包装溶液具有与眼睛相容的张力和PH并且根据国际ISO标准和美国FDA法规基本上不含眼睛刺激性或眼睛细胞毒性材料。
关于接触镜片或材料的术语“模量”或“弹性模量”意指拉伸模量或杨氏模量,其是接触镜片或材料的刚度的量度。模量可以使用根据ANSI Z80.20标准的方法测量。本领域技术人员熟知如何确定硅酮水凝胶材料或接触镜片的弹性模量。例如,所有的商业接触镜片已经报道了弹性模量的值。
“有机基溶液”指的是一种溶液,该溶液是由有机基溶剂和溶于该有机基溶剂中的一种或多种溶质组成的均匀混合物。有机基涂覆溶液指的是含有至少一种聚合物涂覆材料作为溶液中的溶质的有机基溶液。
“有机基溶剂”旨在描述一种溶剂体系,该溶剂体系由一种或多种有机溶剂和相对于该溶剂体系的重量任选地按重量计约40%或更少、优选约30%或更少、更优选约20%或更少、甚至更优选约10%或更少、特别是约5%或更少的水组成。
本发明总体上涉及一种用于生产在其上具有非硅酮水凝胶涂层的硅酮水凝胶接触镜片的方法,该方法包括用于形成相对稳定的基底涂层的水基涂覆过程(步骤)。本发明部分基于以下发现:通过将足够量(例如,按重量计从约30%至约60%、优选从约35%至约56%、更优选从约40%至约52%)的N-乙烯基吡咯烷酮结合到硅酮水凝胶镜片配制品中用于形成硅酮水凝胶接触镜片,相对稳定的基底涂层可以从丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液在这样得到的硅酮水凝胶接触镜片上形成。据信,通过将足够量(例如,按重量计从约30%至约60%、优选从约35%至约56%、更优选从约40%至约52%)的N-乙烯基吡咯烷酮结合到硅酮水凝胶镜片配制品中用于形成硅酮水凝胶接触镜片,所得硅酮水凝胶接触镜片的聚合物基质可含有聚乙烯吡咯烷酮(PVP)链段,这些链段可在水溶液中与丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物形成牢固的互聚物络合物。这样得到的互聚物络合物可以是稳定的,以便在高压灭菌期间经受得住具有中性pH(从约6.5至7.5)的镜片包装溶液。具有在水基涂覆过程中形成的如此稳定的基底涂层,在该硅酮水凝胶接触镜片上的耐久的非硅酮水凝胶涂层可以根据涉及氮杂环丁烷鎓基团和羧基、伯氨基或仲氨基的热诱发的反应机理通过共价连接部分交联的亲水性聚合物材料如下所示形成:
其中X1是–S–*、–OC(=O)–*、或–NR’–*,其中R’是氢、C1-C20未取代的或取代的直链或支链烷基;*表示有机基团。这样的反应可方便地且直接地在镜片包装中在高压灭菌(即,在压力下约115℃至约125℃加热具有在包装溶液中的镜片的镜片包装持续约20-40分钟)期间进行,该高压灭菌是在接触镜片行业中通常使用的灭菌方法。不与羧基、伯氨基或仲氨基反应的任何氮杂环丁烷鎓基团将在高压灭菌期间如下所示水解
在一个方面,本发明提供了一种用于生产各自在其上具有交联的亲水性涂层的硅酮水凝胶接触镜片的方法,本发明的方法包括以下步骤:(a)从可聚合组合物获得硅酮水凝胶接触镜片,该可聚合组合物包含至少一种含有硅酮的乙烯单体或大分子单体和相对于可聚合组分的总量按重量计从约30%至约60%、优选从约35%至约56%、更优选从约40%至约52%的N-乙烯基吡咯烷酮;以及(b)使该硅酮水凝胶接触镜片与丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液接触以在该硅酮水凝胶接触镜片上形成基底涂层,其中在该硅酮水凝胶接触镜片已经在具有从约6.5至约7.5的pH的磷酸盐缓冲盐水中在115℃至125℃下高压灭菌持续约30分钟之后该基底涂层表现出约20秒或更长的水破裂时间(WBUT)。优选地,本发明的方法进一步包括以下步骤:将具有氮杂环丁烷鎓基团的水溶性的、可热交联的亲水性聚合物材料共价连接并且交联到该基底涂层上以在该硅酮水凝胶接触镜片上形成非硅酮水凝胶涂层。更优选地,该共价连接和交联的步骤是在从约115℃至约125℃的温度下持续至少约20分钟通过高压釜灭菌过程中直接在含有包括该水溶性、可热交联的亲水性聚合物材料的包装溶液的密封镜片包装中进行的,从而在该硅酮水凝胶接触镜片上形成非硅酮水凝胶涂层。
本领域技术人员非常熟知如何制造硅酮水凝胶(SiHy)接触镜片。例如,SiHy接触镜片可在如例如在美国专利号3,408,429中描述的常规的“旋转铸模”中,或通过如在美国专利号4,347,198;5,508,317;5,583,463;5,789,464;以及5,849,810中描述的呈静态形式的实型铸造模制方法,或通过如在制造定制的接触镜片中使用的硅酮水凝胶钮扣的车床切割生产。在铸造模制中,镜片配制品典型地被分配到模具中并在模具中固化(即聚合和/或交联)用于制造接触镜片。对于硅酮水凝胶(SiHy)接触镜片的生产,用于铸造模制或旋转铸造模制或用于制造在接触镜片的车床切割中使用的SiHy棒的SiHy镜片形成组合物(或SiHy镜片配制品)总体上包含至少一种选自下组的组分,该组由以下各项组成:含硅酮的乙烯单体、含硅酮的乙烯大分子单体、含硅酮的预聚物、亲水性乙烯单体、疏水性乙烯单体、交联剂(具有约700道尔顿或更小的分子量并且含有至少两个烯键式不饱和基团的化合物)、自由基引发剂(光引发剂或热引发剂)、亲水性乙烯大分子单体/预聚物、以及其组合,如本领域技术人员熟知的。SiHy接触镜片配制品还可以包括本领域技术人员已知的其他必需组分,例如像,UV吸收剂(即,UV吸收乙烯单体)、可见性着色剂(例如染料、颜料、或它们的混合物)、抗微生物剂(例如,优选银纳米颗粒)、生物活性剂、可浸出的润滑剂、可浸出的眼泪稳定剂、以及它们的混合物,如本领域技术人员已知的。然后可使所得SiHy接触镜片经受用萃取溶剂的萃取以从所得镜片上除去未聚合的组分并且经受水合过程,如本领域技术人员已知的。另外,预成型的SiHy接触镜片可以是有色接触镜片(即具有至少一种印刷于其上的有色图案的SiHy接触镜片,如本领域技术人员熟知的)。
任何合适的含硅酮的乙烯单体可在本发明中使用。优选的含硅酮的乙烯单体的实例包括但不限于:N-[三(三甲基甲硅烷氧基)甲硅烷基丙基]-(甲基)丙烯酰胺、N-[三(二甲基丙基甲硅烷氧基)-甲硅烷基丙基]-(甲基)丙烯酰胺、N-[三(二甲基苯基甲硅烷氧基)甲硅烷基丙基](甲基)丙烯酰胺、N-[三(二甲基乙基甲硅烷氧基)甲硅烷基丙基](甲基)丙烯酰胺、N-(2-羟基-3-(3-(双(三甲基甲硅烷氧基)甲基甲硅烷基)丙氧基)丙基)-2-甲基丙烯酰胺;N-(2-羟基-3-(3-(双(三甲基甲硅烷氧基)甲基甲硅烷基)丙氧基)丙基)丙烯酰胺;N,N-双[2-羟基-3-(3-(双(三甲基甲硅烷氧基)甲基甲硅烷基)丙氧基)丙基]-2-甲基丙烯酰胺;N,N-双[2-羟基-3-(3-(双(三甲基甲硅烷氧基)甲基甲硅烷基)丙氧基)丙基]丙烯酰胺;N-(2-羟基-3-(3-(三(三甲基甲硅烷氧基)甲硅烷基)丙氧基)丙基)-2-甲基丙烯酰胺;N-(2-羟基-3-(3-(三(三甲基甲硅烷氧基)甲硅烷基)丙氧基)丙基)丙烯酰胺;N,N-双[2-羟基-3-(3-(三(三甲基甲硅烷氧基)甲硅烷基)丙氧基)丙基]-2-甲基丙烯酰胺;N,N-双[2-羟基-3-(3-(三(三甲基甲硅烷氧基)甲硅烷基)丙氧基)丙基]丙烯酰胺;N-[2-羟基-3-(3-(叔丁基二甲基甲硅烷基)丙氧基)丙基]-2-甲基丙烯酰胺;N-[2-羟基-3-(3-(叔丁基二甲基甲硅烷基)丙氧基)丙基]丙烯酰胺;N,N-双[2-羟基-3-(3-(叔丁基二甲基甲硅烷基)丙氧基)丙基]-2-甲基丙烯酰胺;N,N-双[2-羟基-3-(3-(叔丁基二甲基甲硅烷基)丙氧基)丙基]丙烯酰胺;3-甲基丙烯酰氧基丙基五甲基二硅氧烷、三(三甲基甲硅烷氧基)甲硅烷基丙基甲基丙烯酸酯(TRIS)、(3-甲基丙烯酰氧基-2-羟基丙氧基)丙基双(三甲基甲硅烷氧基)甲基硅烷)、(3-甲基丙烯酰氧基-2-羟基丙氧基)丙基三(三甲基甲硅烷氧基)硅烷、3-甲基丙烯酰氧基-2-(2-羟基乙氧基)-丙氧基)丙基双(三甲基甲硅烷氧基)甲基硅烷、N-2-甲基丙烯酰氧基乙基-O-(甲基-双-三甲基甲硅烷氧基-3-丙基)甲硅烷基氨基甲酸酯、3-(三甲基甲硅烷基)丙基乙烯基碳酸酯、3-(乙烯基氧基羰基硫基)丙基-三(三甲基-甲硅烷氧基)硅烷、3-[三(三甲基甲硅烷氧基)甲硅烷基]丙基乙烯基氨基甲酸酯、3-[三(三甲基甲硅烷氧基)甲硅烷基]丙基烯丙基氨基甲酸酯、3-[三(三甲基甲硅烷氧基)甲硅烷基]丙基乙烯基碳酸酯、叔丁基二甲基-甲硅烷氧基乙基乙烯基碳酸酯;三甲基甲硅烷基乙基乙烯基碳酸酯,和三甲基甲硅烷基甲基乙烯基碳酸酯)。最优选的具有式(1)的含硅氧烷的(甲基)丙烯酰胺单体是N-[三(三甲基甲硅烷氧基)甲硅烷基丙基]丙烯酰胺、TRIS、N-[2-羟基-3-(3-(叔丁基二甲基甲硅烷基)丙氧基)丙基]丙烯酰胺、或它们的组合。
一类优选的含硅氧烷的乙烯单体是聚碳硅氧烷乙烯单体(或碳硅氧烷乙烯单体)。此类聚碳硅氧烷乙烯单体或大分子单体的实例是在美国专利号7915323和8420711中、在美国专利申请公开号2012/244088和2012/245249中、以及在共同未决的美国专利申请号61/984,101(标题为“碳硅氧烷乙烯单体”)和61/984,117(标题为“亲水化的碳硅氧烷乙烯单体”)中描述的那些(通过引用以其全文结合于此)。
一类优选的含硅酮的乙烯单体或大分子单体是含聚硅氧烷的乙烯单体或大分子单体。此类含聚硅氧烷的乙烯单体或大分子单体的实例是具有各种分子量的单甲基丙烯酸酯化的或单丙烯酸酯化的聚二甲基硅氧烷(例如单-3-甲基丙烯酰氧基丙基封端的、单丁基封端的聚二甲基硅氧烷或单-(3-甲基丙烯酰氧基-2-羟基丙氧基)丙基封端的、单丁基封端的聚二甲基硅氧烷);具有各种分子量的二甲基丙烯酸酯化的或二丙烯酸酯化的聚二甲基硅氧烷;碳酸乙烯酯封端的聚二甲基硅氧烷;氨基甲酸乙烯酯封端的聚二甲基硅氧烷;具有各种分子量的乙烯基封端的聚二甲基硅氧烷;甲基丙烯酰胺封端的聚二甲基硅氧烷;丙烯酰胺封端的聚二甲基硅氧烷;丙烯酸酯封端的聚二甲基硅氧烷;甲基丙烯酸酯封端的聚二甲基硅氧烷;双-3-甲基丙烯酰氧基-2-羟基丙氧基丙基聚二甲基硅氧烷;N,N,N’,N’-四(3-甲基丙烯酰氧基-2-羟丙基)-α,ω-双-3-氨基丙基-聚二甲基硅氧烷;聚硅氧烷基烷基(甲基)丙烯酸单体;选自由在US 5,760,100(通过引用以其全文结合于此)中所描述的大分子单体A、大分子单体B、大分子单体C和大分子单体D组成的组的含硅氧烷的大分子单体;甲基丙烯酸缩水甘油酯与氨基官能的聚二甲基硅氧烷的反应产物;羟基官能化的含硅氧烷的乙烯单体或大分子单体;在美国专利号4,136,250、4,153,641、4,182,822、4,189,546、4,343,927、4,254,248、4,355,147、4,276,402、4,327,203、4,341,889、4,486,577、4,543,398、4,605,712、4,661,575、4,684,538、4,703,097、4,833,218、4,837,289、4,954,586、4,954,587、5,010,141、5,034,461、5,070,170、5,079,319、5039,761、5,346,946、5,358,995、5,387,632、5,416,132、5,451,617、5,486,579、5,962,548、5,981,675、6,039,913、以及6,762,264(通过引用以其全文结合于此)中披露的含聚硅氧烷的大分子单体;在美国专利号4,259,467、4,260,725、以及4,261,875(通过引用以其全文结合于此)中披露的含聚硅氧烷的大分子单体。由聚二甲基硅氧烷和聚氧化烯组成的二嵌段和三嵌段大分子单体也可以是实用的。例如,可使用甲基丙烯酸酯封端的聚氧化乙烯-嵌段-聚二甲基硅氧烷-嵌段-聚氧化乙烯以增强透氧性。合适的单官能羟基官能化的含硅氧烷的乙烯单体/大分子单体和合适的多官能羟基官能化的含硅氧烷的乙烯单体/大分子单体可商购自宾夕法尼亚州莫里斯维尔Gelest公司(Gelest,Inc,Morrisville,PA)。
另一类优选的含硅酮的乙烯大分子单体是包含亲水性链段和疏水性链段的含硅预聚物。任何合适的具有亲水性链段和疏水性链段的含硅酮的预聚物可在本发明中使用。此类含硅酮的预聚物的实例包括在以下专利中描述的那些:共同拥有的美国专利号6,039,913、7,091,283、7,268,189和7,238,750、7,521,519;共同拥有的美国专利申请公开号US2008-0015315 A1、US 2008-0143958 A1、US 2008-0143003 A1、US2008-0234457 A1、US2008-0231798 A1,以及共同拥有的美国专利申请号61/180,449和61/180,453;所有这些专利通过引用以其全文结合于此。
除了N-乙烯基吡咯烷酮,用于制造本发明的SiHy接触镜片的镜片配制品可进一步包括除N-乙烯基吡咯烷酮外的一种或多种亲水性乙烯单体。优选的此类亲水性乙烯单体的实例是N,N-二甲基丙烯酰胺(DMA)、N,N-二甲基甲基丙烯酰胺(DMMA)、2-丙烯酰氨基乙醇酸、3-丙烯酰基氨基-1-丙醇、N-羟乙基丙烯酰胺、N-[三(羟甲基)甲基]-丙烯酰胺、N-甲基-3-亚甲基-2-吡咯烷酮、1-乙基-3-亚甲基-2-吡咯烷酮、1-甲基-5-亚甲基-2-吡咯烷酮、1-乙基-5-亚甲基-2-吡咯烷酮、5-甲基-3-亚甲基-2-吡咯烷酮、5-乙基-3-亚甲基-2-吡咯烷酮、1-正丙基-3-亚甲基-2-吡咯烷酮、1-正丙基-5-亚甲基-2-吡咯烷酮、1-异丙基-3-亚甲基-2-吡咯烷酮、1-异丙基-5-亚甲基-2-吡咯烷酮、1-正丁基-3-亚甲基-2-吡咯烷酮、1-叔丁基-3-亚甲基-2-吡咯烷酮、甲基丙烯酸2-羟乙酯(HEMA)、丙烯酸2-羟乙酯(HEA)、丙烯酸羟丙酯、甲基丙烯酸羟丙酯(HPMA)、三甲基铵2-羟基丙基甲基丙烯酸酯氢氯化物、氨基丙基甲基丙烯酸酯氢氯化物、二甲基氨基乙基甲基丙烯酸酯(DMAEMA)、甲基丙烯酸甘油酯(GMA)、具有最高达1500的重均分子量的C1-C4-烷氧基聚乙二醇(甲基)丙烯酸酯、甲基丙烯酸、N-乙烯基甲酰胺、N-乙烯基乙酰胺、N-乙烯基异丙基酰胺、N-乙烯基-N-甲基乙酰胺、烯丙醇、以及它们的混合物。
优选的疏水性乙烯单体的实例包括丙烯酸甲酯、丙烯酸乙酯、丙烯酸丙酯、丙烯酸异丙酯、丙烯酸环己酯、丙烯酸2-乙基己酯、甲基丙烯酸甲酯、甲基丙烯酸乙酯、甲基丙烯酸丙酯、乙酸乙烯酯、丙酸乙烯酯、丁酸乙烯酯、戊酸乙烯酯、苯乙烯、氯丁二烯、氯乙烯、偏二氯乙烯、丙烯腈、1-丁烯、丁二烯、甲基丙烯腈、乙烯基甲苯、乙烯基乙醚、全氟己基乙基-硫代-羰基-氨基乙基-甲基丙烯酸酯、甲基丙烯酸异冰片基酯、甲基丙烯酸三氟乙基酯、甲基丙烯酸六氟-异丙基酯、甲基丙烯酸六氟丁基酯。
优选的交联剂的实例包括但不限于:四乙二醇二丙烯酸酯、三乙二醇二丙烯酸酯、二乙二醇二丙烯酸酯、乙二醇二丙烯酸酯、四乙二醇二甲基丙烯酸酯、三乙二醇二甲基丙烯酸酯、二乙二醇二甲基丙烯酸酯、乙二醇二甲基丙烯酸酯、四乙二醇二乙烯基酯、三乙二醇二乙烯基酯、二乙二醇二乙烯基酯、乙二醇二乙烯基酯、三羟甲基丙烷三甲基丙烯酸酯、季戊四醇四甲基丙烯酸酯、双酚A二甲基丙烯酸酯、甲基丙烯酸乙烯酯、乙二胺二甲基丙烯酰胺、乙二胺二丙烯酰胺、甘油二甲基丙烯酸酯、异氰脲酸三烯丙酯、氰脲酸三烯丙酯、甲基丙烯酸烯丙酯、丙烯酸烯丙酯、N-烯丙基-甲基丙烯酰胺、N-烯丙基-丙烯酰胺、1,3-双(甲基丙烯酰氨基丙基)-1,1,3,3-四(三甲基甲硅烷氧基)二硅氧烷、N,N’-亚甲基双丙烯酰胺、N,N’-亚甲基双甲基丙烯酰胺、N,N’-亚乙基双丙烯酰胺、N,N’-亚乙基双甲基丙烯酰胺、1,3-双(N-甲基丙烯酰氨基丙基)-1,1,3,3-四-(三甲基甲硅烷氧基)二硅氧烷、1,3-双(甲基丙烯酰氨基丁基)-1,1,3,3-四(三甲基甲硅烷氧基)-二硅氧烷、1,3-双(丙烯酰氨基丙基)-1,1,3,3-四(三甲基甲硅烷氧基)二硅氧烷、1,3-双(甲基丙烯酰氧基乙基脲基丙基)-1,1,3,3-四(三甲基甲硅烷氧基)二硅氧烷、以及它们的组合。优选的交联剂是四(乙二醇)二丙烯酸酯、三(乙二醇)二丙烯酸酯、乙二醇二丙烯酸酯、二(乙二醇)二丙烯酸酯、亚甲基双丙烯酰胺、异氰脲酸三烯丙酯、或氰脲酸三烯丙酯。所使用的交联剂的量相对于总聚合物以重量含量表示并且优选地在从约0.05%至约3%的范围内、并且更优选在从约0.1%至约2%的范围内。
具有多个丙烯酰基或甲基丙烯酰基的亲水性预聚物的实例包括,但不限于,在美国专利号5,583,163和6,303,687中描述的水溶性可交联的聚(乙烯醇)预聚物;在美国专利申请公开号2004/0082680中描述的水溶性乙烯基封端的聚氨酯预聚物;在美国专利号5,849,841中披露的聚乙烯醇、聚乙烯亚胺或聚乙烯胺的衍生物;在美国专利号6,479,587和美国公开申请号2005/0113549中描述的水溶性可交联的聚脲预聚物;可交联的聚丙烯酰胺;在EP 655,470和美国专利号5,712,356中披露的乙烯基内酰胺、MMA和共聚单体的可交联的统计共聚物;在EP 712,867和美国专利号5,665,840中披露的乙烯基内酰胺、乙酸乙烯酯和乙烯醇的可交联的共聚物;在EP 932,635和美国专利号6,492,478中披露的具有可交联的侧链的聚醚-聚酯共聚物;在EP 958,315和美国专利号6,165,408中披露的支链聚亚烷基二醇-氨基甲酸乙酯预聚物;在EP 961,941和美国专利号6,221,303中披露的聚亚烷基二醇-四(甲基)丙烯酸酯预聚物;和在国际申请号WO 2000/31150和美国专利号6,472,489中披露的可交联的聚烯丙胺葡糖酸内酯预聚物。
任何合适的UV吸收乙烯单体可以在用于制备本发明的聚合物的可聚合组合物中使用。优选的UV吸收和UV/HEVL吸收的含有苯并三唑的乙烯单体的实例包括但不限于:2-(2-羟基-5-乙烯基苯基)-2H-苯并三唑、2-(2-羟基-5-丙烯酰氧基苯基)-2H-苯并三唑、2-(2-羟基-3-甲基丙烯酰氨基甲基-5-叔辛基苯基)苯并三唑、2-(2’-羟基-5’-甲基丙烯酰氨基苯基)-5-氯苯并三唑、2-(2’-羟基-5’-甲基丙烯酰氨基苯基)-5-甲氧基苯并三唑、2-(2’-羟基-5’-甲基丙烯酰氧基丙基-3’-叔丁基-苯基)-5-氯苯并三唑、2-(2’-羟基甲基丙烯酰氧基丙基苯基)苯并三唑、2-羟基-5-甲氧基-3-(5-(三氟甲基)-2H-苯并[d][1,2,3]三唑-2-基)苄基甲基丙烯酸酯(WL-1)、2-羟基-5-甲氧基-3-(5-甲氧基-2H-苯并[d][1,2,3]三唑-2-基)苄基甲基丙烯酸酯(WL-5)、3-(5-氟-2H-苯并[d][1,2,3]三唑-2-基)-2-羟基-5-甲氧基苄基甲基丙烯酸酯(WL-2)、3-(2H-苯并[d][1,2,3]三唑-2-基)-2-羟基-5-甲氧基苄基甲基丙烯酸酯(WL-3)、3-(5-氯-2H-苯并[d][1,2,3]三唑-2-基)-2-羟基-5-甲氧基苄基甲基丙烯酸酯(WL-4)、2-羟基-5-甲氧基-3-(5-甲基-2H-苯并[d][1,2,3]三唑-2-基)苄基甲基丙烯酸酯(WL-6)、2-羟基-5-甲基-3-(5-(三氟甲基)-2H-苯并[d][1,2,3]三唑-2-基)苄基甲基丙烯酸酯(WL-7)、4-烯丙基-2-(5-氯-2H-苯并[d][1,2,3]三唑-2-基)-6-甲氧基苯酚(WL-8)、2-{2’-羟基-3’-叔-5’[3”-(4”-乙烯基苄基氧基)丙氧基]苯基}-5-甲氧基-2H-苯并三唑、苯酚、2-(5-氯-2H-苯并三唑-2-基)-6-(1,1-二甲基乙基)-4-乙烯基-(UVAM)、2-(2’-羟基-5’-甲基丙烯酰氧基乙基苯基)苯并三唑(2-丙烯酸,2-甲基-,2-[3-(2H-苯并三唑-2-基)-4-羟基苯基]乙基酯,Norbloc)、2-{2’-羟基-3’-叔丁基-5’-[3’-甲基丙烯酰氧基丙氧基]苯基}-5-甲氧基-2H-苯并三唑(UV13)、2-[2’-羟基-3’-叔丁基-5’-(3’-丙烯酰氧基丙氧基)苯基]-5-三氟甲基-2H-苯并三唑(CF3-UV13)、2-(2’-羟基-5-甲基丙烯酰氨基苯基)-5-甲氧基苯并三唑(UV6)、2-(3-烯丙基-2-羟基-5-甲基苯基)-2H-苯并三唑(UV9)、2-(2-羟基-3-甲基烯丙基-5-甲基苯基)-2H-苯并三唑(UV12)、2-3’-叔丁基-2’-羟基-5’-(3”-二甲基乙烯基甲硅烷基丙氧基)-2'-羟基-苯基)-5-甲氧基苯并三唑(UV15)、2-(2’-羟基-5’-甲基丙烯酰基丙基-3’-叔丁基-苯基)-5-甲氧基-2H-苯并三唑(UV16)、2-(2’-羟基-5’-丙烯酰基丙基-3’-叔丁基-苯基)-5-甲氧基-2H-苯并三唑(UV16A)、2-甲基丙烯酸3-[3-叔丁基-5-(5-氯苯并三唑-2-基)-4-羟基苯基]-丙基酯(16-100,CAS号96478-15-8)、2-(3-(叔丁基)-4-羟基-5-(5-甲氧基-2H-苯并[d][1,2,3]三唑-2-基)苯氧基)乙基甲基丙烯酸酯(16-102);苯酚,2-(5-氯-2H-苯并三唑-2-基)-6-甲氧基-4-(2-丙烯-1-基)(CAS号1260141-20-5);2-[2-羟基-5-[3-(甲基丙烯酰氧基)丙基]-3-叔丁基苯基]-5-氯-2H-苯并三唑;苯酚,2-(5-乙烯基-2H-苯并三唑-2-基)-4-甲基-,均聚物(9CI)(CAS号83063-87-0)。根据本发明,该可聚合组合物包含按重量计约0.2%至约5.0%、优选约0.3%至约2.5%、更优选约0.5%至约1.8%的UV吸收剂。
合适的热引发剂的实例包括但不限于,2,2’-偶氮双(2,4-二甲基戊腈)、2,2’-偶氮(2-甲基丙腈)、2,2’-偶氮双(2-甲基丁腈)、过氧化物如过氧化苯甲酰,等等。优选地,该热引发剂是2,2’-偶氮双(异丁腈)(AIBN)。
合适的光引发剂是苯偶姻甲醚、二乙氧基苯乙酮、苯甲酰氧化膦、1-羟基环己基苯酮和Darocur和Irgacur类型,优选Darocur和Darocur基于锗烷(Germane)的Norrish I型光引发剂。苯甲酰基膦引发剂的实例包括2,4,6-三甲基苯甲酰基二苯基氧化膦;双-(2,6-二氯苯甲酰基)-4-N-丙基苯基氧化膦;和双-(2,6-二氯苯甲酰基)-4-N-丁基苯基氧化膦。可以例如结合到大分子单体中或可用作特种单体的反应性光引发剂也是合适的。反应性光引发剂的实例是在EP 632 329中披露的那些,通过引用以其全文结合于此。聚合然后可通过光化辐射如光,特别是具有合适波长的UV光触发。因此,如果合适的话,可以通过加入合适的光敏剂控制光谱要求。
在能够吸收紫外线辐射和高能紫光(HEVL)的乙烯单体在本发明中使用时,基于锗烷的Norrish I型光引发剂和包括在约400至约550nm区域内的光的光源优选被用于引发自由基聚合。任何基于锗烷的Norrish I型光引发剂可以在本发明中使用,只要它们能够在用包括在约400至约550nm区域内的光的光源照射下引发自由基聚合。基于锗烷的Norrish I型光引发剂的实例是在US 7,605,190(通过引用以其全文结合于此)中所描述的酰基锗化合物。优选地,镜片形成材料的单体包括以下酰基锗化合物中的至少一种。
生物活性剂是可防止眼睛疾病或降低眼睛疾病症状的任何化合物。生物活性剂可以是药物、氨基酸(例如牛磺酸、甘氨酸等)、多肽、蛋白质、核酸、或它们的任意组合。在此有用的药物的实例包括但不限于瑞巴派特、酮替芬、奥洛他定(olaptidine)、色甘酸酯(cromoglycolate)、环孢霉素、奈多罗米、左卡巴斯汀、洛度沙胺、酮替芬、或其药学上可接受的盐或酯。生物活性剂的其他实例包括2-吡咯烷酮-5-羧酸(PCA)、α羟基酸(例如乙醇酸、乳酸、苹果酸、酒石酸、扁桃酸和柠檬酸以及其盐等)、亚油酸和γ亚油酸和维生素(例如B5、A、B6等)。
可浸出润滑剂的实例包括但不限于粘蛋白样材料(聚乙醇酸)和不可交联的亲水性聚合物(即没有烯键式不饱和基团)。没有任何烯键式不饱和基团的任何亲水性聚合物或共聚物可以用作可浸出的润滑剂。不可交联的亲水性聚合物的优选实例包括但不限于聚乙烯醇(PVA)、聚酰胺、聚酰亚胺、聚内酯、乙烯基内酰胺的均聚物、至少一种乙烯基内酰胺在一种或多种亲水性乙烯共聚单体的存在或不存在下的共聚物、丙烯酰胺或甲基丙烯酰胺的均聚物、丙烯酰胺或甲基丙烯酰胺与一种或多种亲水性乙烯单体的共聚物、聚氧化乙烯(即,聚乙二醇(PEG))、聚氧化乙烯衍生物、聚-N-N-二甲基丙烯酰胺、聚丙烯酸、聚2乙基噁唑啉、肝素多糖、多糖、以及它们的混合物。不可交联的亲水性聚合物的重均分子量Mw优选地是从5,000至1,00,000。
可浸出的眼泪稳定剂的实例包括但不限于磷脂、甘油单酯、甘油二酯、甘油三酯、糖脂、甘油糖脂、鞘脂、鞘糖脂、脂肪醇、脂肪酸、矿物油、以及它们的混合物。优选地,眼泪稳定剂是磷脂、甘油单酯、甘油二酯、甘油三酯、糖脂、甘油糖脂、鞘脂、鞘糖脂、具有8至36个碳原子的脂肪酸、具有8至36个碳原子的脂肪醇、或它们的混合物。
根据本发明,SiHy镜片配制品可以在从约20℃至约85℃的温度下是溶液或熔体。优选地,可聚合组合物是所有希望的组分在合适的溶剂或合适的溶剂的混合物中的溶液。
SiHy镜片配制品可以通过将所有希望的组分溶于任何合适的溶剂如水、水与一种或多种与水溶混的有机溶剂的混合物、有机溶剂、或一种或多种有机溶剂的混合物中制备,如本领域技术人员已知的。
优选的有机溶剂的实例包括但不限于,四氢呋喃、三丙二醇甲醚、二丙二醇甲醚、乙二醇正丁醚、酮(例如,丙酮、甲乙酮等)、二乙二醇正丁醚、二乙二醇甲醚、乙二醇苯醚、丙二醇甲醚、丙二醇甲醚乙酸酯、二丙二醇甲醚乙酸酯、丙二醇正丙醚、二丙二醇正丙醚、三丙二醇正丁醚、丙二醇正丁醚、二丙二醇正丁醚、三丙二醇正丁醚、丙二醇苯醚二丙二醇二甲醚、聚乙二醇、聚丙二醇、乙酸乙酯、乙酸丁酯、乙酸戊酯、乳酸甲酯、乳酸乙酯、乳酸异丙酯、二氯甲烷、2-丁醇、1-丙醇、2-丙醇、薄荷醇、环己醇、环戊醇和外降冰片、2-戊醇、3-戊醇、2-己醇、3-己醇、3-甲基-2-丁醇、2-庚醇、2-辛醇、2-壬醇、2-癸醇、3-辛醇、降冰片、叔丁醇、叔戊醇、2-甲基-2-戊醇、2,3-二甲基-2-丁醇、3-甲基-3-戊醇、1-甲基环己醇、2-甲基-2-己醇、3,7-二甲基-3-辛醇、1-氯-2-甲基-2-丙醇、2-甲基-2-庚醇、2-甲基-2-辛醇、2-2-甲基-2-壬醇、2-甲基-2-癸醇、3-甲基-3-己醇、3-甲基-3-庚醇、4-甲基-4-庚醇、3-甲基-3-辛醇、4-甲基-4-辛醇、3-甲基-3-壬醇、4-甲基-4-壬醇、3-甲基-3-辛醇、3-乙基-3-己醇、3-甲基-3-庚醇、4-乙基-4-庚醇、4-丙基-4-庚醇、4-异丙基-4-庚醇、2,4-二甲基-2-戊醇、1-甲基环戊醇、1-乙基环戊醇、1-乙基环戊醇、3-羟基-3-甲基-1-丁烯、4-羟基-4-甲基-1-环戊醇、2-苯基-2-丙醇、2-甲氧基-2-甲基-2-丙醇、2,3,4-三甲基-3-戊醇、3,7-二甲基-3-辛醇、2-苯基-2-丁醇、2-甲基-1-苯基-2-丙醇和3-乙基-3-戊醇、1-乙氧基-2-丙醇、1-甲基-2-丙醇、叔戊醇、异丙醇、1-甲基-2-吡咯烷酮、N,N-二甲基丙酰胺、二甲基甲酰胺、二甲基乙酰胺、二甲基丙酰胺、N-甲基吡咯烷酮、以及它们的混合物。
用于制造接触镜片的镜片模具是本领域技术人员众所周知的,并且,例如,在铸造模制或旋转铸造中使用。例如,模具(用于铸造模制)总体上包括至少两个模具区段(或部分)或半模,即第一和第二半模。第一半模限定第一模制(或光学)表面并且第二半模限定第二模制(或光学)表面。第一和第二半模被配置为接受彼此,使得镜片形成型腔在第一模制表面与第二模制表面之间形成。半模的模制表面是模具的型腔形成表面并且与镜片形成材料直接接触。
制造用于铸造模制接触镜片的模具区段的方法总体上是本领域的普通技术人员众所周知的。本发明的方法并不限于形成模具的任何特定方法。实际上,形成模具的任何方法可以在本发明中使用。第一和第二半模可以通过各种技术,例如注射模制或车床加工来形成。用于形成半模的合适方法的实例在以下专利中披露:Schad的美国专利号4,444,711;Boehm等人的4,460,534;Morrill的5,843,346;和Boneberger等人的5,894,002,这些也通过引用结合于此。
本领域中已知的用于制造模具的几乎所有材料都可以用于制造用于制造接触镜片的模具。例如,可以使用聚合物材料,如聚乙烯、聚丙烯、聚苯乙烯、PMMA、COC等级8007-S10(乙烯和降冰片烯的透明无定形共聚物,来自德国法兰克福和新泽西州萨米特泰科纳有限公司(Ticona GmbH of Frankfurt,Germany and Summit,New Jersey)),等等。可以使用允许UV光透射的其他材料,例如石英玻璃和蓝宝石。
在优选的实施例中,使用可重复使用的模具并且硅酮-水凝胶镜片形成组合物在光化辐射的空间限制下光化固化以形成SiHy接触镜片。优选的可重复使用的模具的实例是在美国专利号6,800,225,7,384,590和7,387,759中披露的那些,将该专利通过引用以其全文结合于此。可重复使用的模具可以由以下项制成:石英、玻璃、蓝宝石、CaF2、环烯烃共聚物(例如像,来自德国法兰克福和新泽西州萨米特泰科纳有限公司的COC等级8007-S10(乙烯和降冰片烯的透明无定形共聚物)、来自肯塔基州路易斯维尔瑞翁化学公司(ZeonChemicals LP,Louisville,KY))的和聚甲基丙烯酸甲酯(PMMA)、来自杜邦的聚甲醛(迭尔林(Delrin))、来自G.E.Plastics的(聚醚酰亚胺)、等等。
根据本发明,可以将可聚合组合物引入(分配)到根据任何已知的方法通过模具形成的型腔中。
在可聚合组合物被分配到模具中后,将其聚合以产生接触镜片。交联可以被热引发或光化引发,优选通过使在模具中的镜片形成组合物暴露于光化辐射的空间限制以交联可聚合组合物中的可聚合组分。
使得模制的物品可以从该模具中移出的模具打开可按照本身已知的方式发生。
模制的接触镜片可经受镜片萃取以除去未聚合的可聚合组分。萃取溶剂可以是本领域技术人员已知的任何溶剂。合适的萃取溶剂的实例是以上描述的那些。优选地,水或水溶液被用作萃取溶剂。萃取后,镜片可在水或润湿剂(如,亲水性聚合物)的水溶液中水合。
用于在硅酮水凝胶接触镜片上形成基底涂层的丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的实例包括但不限于:聚丙烯酸、聚甲基丙烯酸、聚乙基丙烯酸、聚丙基丙烯酸、聚(丙烯酸-共-甲基丙烯酸)、聚[(甲基)丙烯酸-共-乙基丙烯酸]、聚[(甲基)丙烯酸-共-丙基丙烯酸],聚[(甲基)丙烯酸-共-丙烯酰胺],聚[(甲基)丙烯酸-共-乙烯基吡咯烷酮]、聚[乙基丙烯酸-共-丙烯酰胺]、聚[乙基丙烯酸-共-乙烯基吡咯烷酮]、聚[丙基丙烯酸-共-丙烯酰胺]、聚[丙基丙烯酸-共-乙烯基吡咯烷酮]、水解的聚[(甲基)丙烯酸-共-乙酸乙烯酯]、水解的聚[乙基丙烯酸-共-乙酸乙烯酯]、水解的聚[丙基丙烯酸-共-乙酸乙烯酯]、或它们的组合。
根据本发明,用于在硅酮水凝胶接触镜片上形成基底涂层的丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的重均分子量Mw是至少约10,000道尔顿、优选至少约50,000道尔顿、更优选从约100,000道尔顿至约5,000,000道尔顿。
用于在硅酮水凝胶接触镜片上形成基底涂层的丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液可以通过将该均聚物或共聚物溶解在水中来制备。该水溶液的pH是约2.5或更高、优选从约2.5至约5.5、更优选从约3.0至约5。
SiHy接触镜片与丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的涂覆溶液的接触可以通过将该镜片浸渍到该涂覆溶液中或通过用该涂覆溶液喷涂该镜片而发生。一种接触过程涉及只将SiHy接触镜片浸渍在涂覆溶液的浴中持续一段时间或可替代地将SiHy接触镜片顺序浸渍在一系列的涂覆溶液的浴中对于每个浴持续固定较短的时间。另一种接触过程涉及只喷涂涂覆溶液。然而,本领域中的普通技术人员可设计出涉及喷涂步骤和浸渍步骤的各种组合的许多替代方案。SiHy接触镜片与反应性聚合物的涂覆溶液的接触时间可持续长达约20分钟。
根据本发明,基底涂层在SiHy接触镜片上的稳定性(或耐久性)通过在115℃至125℃下在具有从约6.5至约7.5的pH的磷酸盐缓冲盐水中高压灭菌持续约30分钟后测量在其上具有基底涂层的SiHy接触镜片的水破裂时间(WBUT)而确定的(表征的)。
根据本发明,具有氮杂环丁烷鎓基团和任选地(但优选地)氨基或羧基基团的水溶性且可热交联的亲水性聚合物材料可以是聚(2-噁唑啉-共-乙烯亚胺)-表氯醇或化学改性的聚(2-噁唑啉-共-乙烯亚胺)-表氯醇、化学改性的聚酰氨基胺-表氯醇,或它们的组合。包含(i)按重量计从约20%至约95%的衍生自聚酰氨基胺-表氯醇或聚(2-噁唑啉-共-乙烯亚胺)-表氯醇的第一聚合物链,(ii)按重量计从约5%至约80%的衍生自具有至少一个选自下组的反应性官能团的至少一种亲水性增强剂的亲水性部分或第二聚合物链,该组由以下各项组成:氨基、羧基、硫醇基、以及它们的组合,其中这些亲水性部分或第二聚合物链通过一个或多个共价键共价连接到这些第一聚合物链上,这些共价键各自在聚酰氨基胺-表氯醇或聚(2-噁唑啉-共-乙烯亚胺)-表氯醇的一个氮杂环丁烷鎓基团与该亲水性增强剂的一个氨基、羧基或硫醇基之间形成,以及(iii)氮杂环丁烷鎓基团,其是这些第一聚合物链的部分或共价连接到这些第一聚合物链上的侧基或端基。亲水性聚合物材料的组成是通过根据以上方案I所示的交联反应用于制备可热交联的亲水性聚合物材料的反应物混合物的组成(基于反应物的总重量计)测定的。例如,如果反应混合物包含基于反应物的总重量按重量计约75%的聚酰氨基胺-表氯醇和按重量计约25%的至少一种亲水性增强剂,则所得的亲水性聚合物材料包含按重量计约75%的衍生自聚酰氨基胺-表氯醇的第一聚合物链和按重量约25%的衍生自所述至少一种亲水性增强剂的亲水性部分或第二聚合物链。可热交联的亲水性聚合物材料的氮杂环丁烷鎓基团是不参与用于制备可热交联的亲水性聚合物材料的交联反应的(聚酰氨基胺-表氯醇的)那些氮杂环丁烷鎓基团。
任何合适的亲水性增强剂可以在本发明中使用,只要它们含有至少一个氨基基团、至少一个羧基基团、和/或至少一个硫醇基团。
一类优选的亲水性增强剂包括但不限于:含伯氨基、含仲氨基、含羧基或含硫醇的单糖(例如3-氨基-1,2-丙二醇、1-硫代甘油、5-酮基-D-葡糖酸、半乳糖胺、葡糖胺、半乳糖醛酸、葡糖酸、氨基葡糖酸、甘露糖胺、葡糖二酸1,4-内酯、糖酸、尤罗索尼克酸(Ketodeoxynonulosonic acid)、N-甲基-D-葡糖胺、1-氨基-1-脱氧-β-D-半乳糖、1-氨基-1-脱氧山梨糖醇、1-甲基氨基-1-脱氧山梨糖醇、N-氨基乙基葡糖酰胺);含伯氨基、含仲氨基、含羧基或含硫醇的二糖(例如软骨素二糖钠盐、二(β-D-吡喃木糖基)胺、二半乳糖醛酸、肝素二糖、透明质酸二糖、乳糖酸);和含伯氨基、含仲氨基、含羧基或含硫醇的低聚糖(例如羧甲基-β-环糊精钠盐、三半乳糖醛酸);以及它们的组合。
另一类优选的亲水性增强剂是具有一个或多个(伯或仲)氨基、羧基和/或硫醇基的亲水性聚合物。更优选地,作为亲水性增强剂的亲水性聚合物中的氨基(-NHR’,其中R’如以上定义的)、羧基(-COOH)和/或硫醇(-SH)基团的含量基于该亲水性聚合物的总重量是按重量计小于约40%、优选小于约30%、更优选小于约20%、甚至更优选小于约10%。
一类优选的作为亲水性增强剂的亲水性聚合物是含(伯或仲)氨基或含羧基的多糖,例如像,羧甲基纤维素(具有约40%或更少的羧基含量,其是基于重复单元─[C6H10-mO5(CH2CO2H)m]─(其中m是1至3)的组成估计的)、羧乙基纤维素(具有约36%或更少的羧基含量,其是基于重复单元─[C6H10-mO5(C2H4CO2H)m]─(其中m是1至3)的组成估计的)、羧丙基纤维素(具有约32%或更少的羧基含量,其是基于重复单元─[C6H10-mO5(C3H6CO2H)m]─(其中m是1至3)的组成估计的)、透明质酸(具有约11%的羧基含量,其是基于重复单元─(C13H20O9NCO2H)─的组成估计的)、硫酸软骨素(具有约9.8%的羧基含量,其是基于重复单元─(C12H18O13NS CO2H)─的组成估计的)、或它们的组合。
另一类优选的作为亲水性增强剂的亲水性聚合物包括但不限于:具有单氨基(伯或仲氨基)、羧基或硫醇基团的聚(乙二醇)(PEG)(例如,PEG-NH2、PEG-SH、PEG-COOH);H2N-PEG-NH2;HOOC-PEG-COOH;HS-PEG-SH;H2N-PEG-COOH;HOOC-PEG-SH;H2N-PEG-SH;具有一个或多个氨基(伯或仲)、羧基或硫醇基团的多臂PEG;具有一个或多个氨基(伯或仲)、羧基或硫醇基团的PEG树状聚合物;非反应性亲水性乙烯单体的二氨基(伯或仲)-或二羧基-封端的均聚物或共聚物;非反应性亲水性乙烯单体的单氨基(伯或仲)-或单羧基-封端的均聚物或共聚物;作为包含以下项的组合物的聚合产物的共聚物:(1)按重量计约60%或更少、优选从约0.1%至约30%、更优选从约0.5%至约20%、甚至更优选按重量计从约1%至约15%的一种或多种反应性乙烯单体和(2)至少一种非反应性亲水性乙烯单体;以及它们的组合。一种或多种反应性乙烯单体和一种或多种非反应性亲水性乙烯单体是先前所描述的那些。
更优选地,作为亲水性增强剂的亲水性聚合物是PEG-NH2;PEG-SH;PEG-COOH;H2N-PEG-NH2;HOOC-PEG-COOH;HS-PEG-SH;H2N-PEG-COOH;HOOC-PEG-SH;H2N-PEG-SH;具有一个或多个氨基、羧基或硫醇基团的多臂PEG;具有一个或多个氨基、羧基或硫醇基团的PEG树状聚合物;选自下组的非反应性亲水性乙烯单体的单氨基-、单羧基-、二氨基-或二羧基-封端的均聚物或共聚物,该组由以下各项组成:丙烯酰胺(AAm)、N,N-二甲基丙烯酰胺(DMA)、N-乙烯基吡咯烷酮(NVP)、N-乙烯基-N-甲基乙酰胺、(甲基)丙烯酸甘油酯、(甲基)丙烯酸羟基乙酯、N-羟乙基(甲基)丙烯酰胺、具有最高达400道尔顿的重均分子量的C1-C4-烷氧基聚乙二醇(甲基)丙烯酸酯、乙烯醇、N-甲基-3-亚甲基-2-吡咯烷酮、1-甲基-5-亚甲基-2-吡咯烷酮、5-甲基-3-亚甲基-2-吡咯烷酮、N,N-二甲基氨基乙基(甲基)丙烯酸酯、N,N-二甲基氨基丙基(甲基)丙烯酰胺、(甲基)丙烯酰氧基乙基磷酰胆碱、以及它们的组合;包含以下项的组合物的聚合产物的共聚物:(1)按重量计从约0.1%至约30%、优选从约0.5至约20%、更优选从约1至约15%的丙烯酸、C1-C3烷基丙烯酸、烯丙胺和/或氨基-C2-C4烷基(甲基)丙烯酸酯,和(2)至少一种选自下组的非反应性亲水性乙烯单体,该组由以下各项组成:丙烯酰胺、N,N-二甲基丙烯酰胺、N-乙烯基吡咯烷酮、(甲基)丙烯酰氧基乙基磷酰胆碱、N-乙烯基-N-甲基乙酰胺、(甲基)丙烯酸甘油酯、(甲基)丙烯酸羟乙酯、N-羟乙基(甲基)丙烯酰胺、具有最高达400道尔顿的重均分子量的C1-C4-烷氧基聚乙二醇(甲基)丙烯酸酯、乙烯醇、以及它们的组合。
最优选地,作为亲水性增强剂的亲水性增强剂是PEG-NH2;PEG-SH;PEG-COOH;单氨基-、单羧基-、二氨基-或二羧基-封端的聚乙烯吡咯烷酮;单氨基-、单羧基-、二氨基-或二羧基-封端的聚丙烯酰胺;单氨基-、单羧基-、二氨基-或二羧基-封端的聚(DMA);单氨基-或单羧基-、二氨基-或二羧基-封端的聚(DMA-共-NVP);单氨基-、单羧基-、二氨基-或二羧基-封端的聚(NVP-共-N,N-二甲基氨基乙基(甲基)丙烯酸酯));单氨基-、单羧基-、二氨基-或二羧基-封端的聚(乙烯醇);单氨基-、单羧基-、二氨基-或二羧基-封端的聚[(甲基)丙烯酰氧基乙基磷酰胆碱]均聚物或共聚物;单氨基-、单羧基-、二氨基-或二羧基-封端的聚(NVP-共-乙烯醇);单氨基-、单羧基-、二氨基-或二羧基-封端的聚(DMA-共-乙烯醇);具有按重量计从约0.1%至约30%、优选从约0.5%至约20%、更优选从约1%至约15%的(甲基)丙烯酸的聚[(甲基)丙烯酸-共-丙烯酰胺];具有按重量计从约0.1%至约30%、优选从约0.5%至约20%、更优选从约1%至约15%的(甲基)丙烯酸的聚[(甲基)丙烯酸-共-NVP];包含以下项的组合物的聚合产物的共聚物:(1)(甲基)丙烯酰氧基乙基磷酰胆碱和(2)按重量计从约0.1%至约30%、优选从约0.5%至约20%、更优选从约1%至约15%的丙烯酸、C1-C3烷基丙烯酸、烯丙胺和/或氨基-C2-C4烷基(甲基)丙烯酸酯;以及它们的组合。
具有官能团的PEG和具有官能团的多臂PEG可从不同的商业供应商如Polyscience和Shearwater Polymers公司等获得。
一种或多种非反应性亲水性乙烯单体或含磷酰胆碱的乙烯单体的单氨基-、单羧基-、二氨基-或二羧基-封端的均聚物或共聚物可根据在美国专利号6,218,508中所述的程序制备,该专利通过引用以其全文结合于此。例如,为了制备非反应性亲水性乙烯单体的二氨基-或二羧基-封端的均聚物或共聚物,使非反应性乙烯单体、具有氨基或羧基的链转移剂(例如,2-氨基乙硫醇、2-巯基丙酸、巯基乙酸、硫代乳酸或其他羟基硫醇、氨基硫醇或含羧基的硫醇)和任选地其他乙烯单体与反应性乙烯单体(具有氨基或羧基)在自由基引发剂的存在下共聚(热共聚或光化共聚)。总体上,链转移剂与除反应性乙烯单体外的所有乙烯单体的摩尔比是从约1:5至约1:100,而链转移剂与反应性乙烯单体的摩尔比是1:1。在这样的制备中,具有氨基或羧基的链转移剂用于控制所得亲水性聚合物的分子量并形成所得亲水性聚合物的末端,以便为所得亲水性聚合物提供一个末端氨基或羧基,同时反应性乙烯单体为所得亲水性聚合物提供另一个末端羧基或氨基。类似地,为了制备非反应性亲水性乙烯单体的单氨基-或单羧基-封端的均聚物或共聚物,使非反应性乙烯单体、具有氨基或羧基的链转移剂(例如,2-氨基乙硫醇、2-巯基丙酸、巯基乙酸、硫代乳酸或其他羟基硫醇、氨基硫醇或含羧基的硫醇)和任选地其他乙烯单体在不存在任何反应性乙烯单体下共聚(热共聚或光化共聚)。
如在此所使用的,非反应性亲水性乙烯单体的共聚物指的是非反应性亲水性乙烯单体与一种或多种附加的乙烯单体的聚合产物。包含非反应性亲水性乙烯单体和反应性乙烯单体(例如,含羧基的乙烯单体、含伯氨基的乙烯单体或含仲氨基的乙烯单体)的共聚物可以根据任何众所周知的自由基聚合方法制备或从商业供应商获得。含有甲基丙烯酰氧基乙基磷酰胆碱和含羧基的乙烯单体(或含氨基的乙烯单体)的共聚物可以从NOP公司获得(例如,-A和–AF)。
具有至少一个氨基、羧基或硫醇基的亲水性聚合物(作为亲水性增强剂)的重均分子量Mw优选地是从约500至约1,000,000、更优选从约1,000至约500,000、甚至更优选从约5,000至约250,000道尔顿。
根据本发明,亲水性增强剂与聚(2-噁唑啉-共-乙烯亚胺)-表氯醇共聚物(或聚酰氨基胺-表氯醇或含氮杂环丁烷鎓的乙烯单体的共聚物)之间的反应是在从约40℃至约100℃的温度下进行持续足够长的时间(从约0.3小时至约24小时、优选从约1小时至约12小时、甚至更优选从约2小时至约8小时)以形成含有氮杂环丁烷鎓基团的水溶性且可热交联的亲水性聚合物材料。
根据本发明,必须选择亲水性增强剂相对于聚(2-噁唑啉-共-乙烯亚胺)-表氯醇共聚物(或聚酰氨基胺-表氯醇或含氮杂环丁烷鎓的乙烯单体的共聚物)的浓度以便不使所得亲水性聚合物材料是水不溶性的(即在室温下溶解度小于0.005g/100mL水)且不消耗聚(2-噁唑啉-共-乙烯亚胺)-表氯醇共聚物(或聚酰氨基胺-表氯醇或含氮杂环丁烷鎓的乙烯单体的共聚物)的大于约99%、优选约98%、更优选约97%、甚至更优选约96%的氮杂环丁烷鎓基团。
在一个优选的实施例中,具有氮杂环丁烷鎓基团的水溶性且可热交联的亲水性聚合物材料包括:氮杂环丁烷鎓基团;按重量计从约20%至约95%、优选从约35%至约90%、更优选从约50%至约85%的衍生自聚(2-噁唑啉-共-乙烯亚胺)-表氯醇共聚物或聚酰氨基胺-表氯醇或含氮杂环丁烷鎓的乙烯单体的共聚物的第一聚合物链;和按重量计从约5%至约80%、优选从约10%至约65%、甚至更优选从约15%至约50%的衍生自具有至少一个选自下组的反应性官能团的至少一种亲水性增强剂的亲水性部分或第二聚合物链,该组由以下各项组成:伯氨基、仲氨基、羧基、硫醇基、以及它们的组合。
根据本发明,加热步骤优选通过将浸入在密封镜片包装中的包装溶液(即,缓冲水溶液)中的在其上具有基底涂层的硅酮水凝胶接触镜片在从约115℃至约125℃的温度下高压灭菌持续约20-90分钟进行。根据本发明的这个实施例,该包装溶液是在高压灭菌之后眼科上安全的缓冲水溶液。
镜片包装(或容器)是本领域技术人员众所周知用于高压灭菌和存储软接触镜片。任何镜片包装可以在本发明中使用。优选地,镜片包装是包括底座和覆盖物的泡罩包装,其中该覆盖物被可拆卸地密封到该底座上,其中该底座包括用于接收灭菌包装溶液和接触镜片的空腔。
在分配给使用者之前将镜片包装在单独的包装中,密封并灭菌(例如,通过在压力下在约120℃或更高下高压灭菌至少30分钟)。本领域技术人员将很好地理解如何将镜片包装密封和灭菌。
根据本发明,包装溶液含有本领域技术人员已知的至少一种缓冲剂和一种或多种其他成分。其他成分的实例包括但不限于,张度剂、表面活性剂、抗菌剂、防腐剂和润滑剂(例如,纤维素衍生物、聚乙烯醇、聚乙烯吡咯烷酮)。
该包装溶液含有足以保持包装溶液的pH在所希望的范围内,例如,优选地在约6.5至约7.5的生理上可接受的范围内的量的缓冲剂。可以使用任何已知的、生理上相容的缓冲剂。作为根据本发明的接触镜片护理组合物的成分的合适的缓冲剂是本领域技术人员已知的。实例是硼酸、硼酸盐如硼酸钠、柠檬酸、柠檬酸盐如柠檬酸钾、碳酸氢盐如碳酸氢钠、TRIS(2-氨基-2-羟甲基-1,3-丙二醇)、双-三(双-(2-羟乙基)-亚氨基-三-(羟甲基)-甲烷)、双-氨基多元醇、三乙醇胺、ACES(N-(2-羟乙基)-2-氨基乙磺酸)、BES(N,N-双(2-羟乙基)-2-氨基乙磺酸)、HEPES(4-(2-羟乙基)-1-哌嗪乙磺酸)、MES(2-(N-吗啉)乙磺酸)、MOPS(3-[N-吗啉]-丙磺酸)、PIPES(哌嗪-N,N’-双(2-乙磺酸)、TES(N-[三(羟甲基)甲基]-2-氨基乙磺酸)、其盐、磷酸盐缓冲剂如Na2HPO4、NaH2PO4、和KH2PO4或它们的混合物。优选的双-氨基多元醇是1,3双(三[羟甲基]-甲氨基)丙烷(双-TRIS-丙烷)。在包装溶液中的每种缓冲剂的量优选地是按重量计从0.001%至2%、优选从0.01%至1%、最优选从约0.05%至约0.30%。
包装溶液具有从约200至约450毫渗透摩尔(mOsm),优选从约250至约350mOsm的张度。包装溶液的张度可通过加入影响张度的有机或无机物质调整。合适的眼睛可接受的张度剂包括但不限于氯化钠、氯化钾、甘油、丙二醇、多元醇、甘露糖醇、山梨糖醇、木糖醇以及它们的混合物。
本发明的包装溶液具有在25℃下从约1厘泊至约8厘泊、更优选从约1.5厘泊至约5厘泊的粘度。
在优选的实施例中,该包装溶液包含按重量计优选从约0.01%至约2%、更优选从约0.05%至约1.5%、甚至更优选从约0.1%至约1%、最优选从约0.2%至约0.5%的具有氮杂环丁烷鎓基团的水溶性可热交联的亲水性聚合物材料。
在另一个优选的实施例中,本发明的方法可以进一步包括,在加热步骤之前,以下步骤:在室温下使在其上具有该基底涂层的该硅酮水凝胶接触镜片与具有氮杂环丁烷鎓基团的水溶性可热交联的亲水性聚合物材料的水溶液接触以在该硅酮水凝胶接触镜片的表面上形成该可热交联的亲水性聚合物材料的顶层(即,LbL涂层),将具有该可热交联的亲水性聚合物材料的该顶层的该硅酮水凝胶接触镜片浸渍在镜片包装中的包装溶液中;密封该镜片包装;并且将在其中具有该硅酮水凝胶接触镜片的该镜片包装在从约115℃至约125℃的温度下高压灭菌持续至少约20分钟以在该硅酮水凝胶接触镜片上形成交联的亲水性涂层。由于是带正电荷的,该可热交联的亲水性聚合物材料被认为能够通过物理相互作用在硅酮水凝胶接触镜片的底涂层上形成非共价结合的层。
含有氮杂环丁烷鎓的乙烯单体的全部不同实施例(包括优选实施例)是以上所述的并且可以在本发明的这一方面中使用。
根据本发明的方法获得的硅酮水凝胶接触镜片具有特征在于具有优选约90度或更小、更优选约80度或更小、甚至更优选约70度或更小、最优选约60度或更小的平均水接触角的表面亲水性/可润湿性。
根据本发明的方法获得的硅酮水凝胶接触镜片具有一个选自下组的特性,该组由以下各项组成:至少约40barrers、优选至少约50barrers、更优选至少约60barrers、甚至更优选至少约70barrers的透氧性;约1.5MPa或更小、优选约1.2MPa或更小、更优选约1.0或更小、甚至更优选从约0.3MPa至约1.0MPa的弹性模量;当完全水合时按重量计从约15%至约70%、优选从约20%至约65%、更优选从约25%至约60%、甚至更优选从约30%至约55%的水含量;特征在于经受得住手指摩擦试验的涂层耐久性以及它们的组合;以及它们的组合。
硅酮水凝胶接触镜片的水含量可根据如在US 5,849,811中所披露的本体技术(Bulk Technique)测量。
应当理解,虽然本发明的包括优选实施例的不同实施例可以单独地如上所述,它们可以在本发明的这个方面中按任何期望的方式被组合和/或一起使用。
先前的披露内容将使本领域技术人员能够实践本发明。可作出对在此所述的不同实施例的各种修改、变化和组合。为了更好地使读者理解具体实施例以及其优点,提出参考以下实例。意图是说明书和实例被认为是示例性的。
虽然本发明的各个实施例已经使用具体的术语、装置和方法进行描述,这样的描述仅用于说明的目的。所使用的词语是描述性的、而不是限制性的词语。应当理解本领域技术人员可以在不偏离以下权利要求书中所提出的本发明的精神或范围的情况下作出改变和变化。另外,应当理解不同实施例的多个方面可全部或部分地互换或可以以任何方式组合和/或一起使用。因此,所附权利要求书的精神和范围不应限于其中所含的优选形式的描述。
以下缩写在以下实例中使用:MCR-M07代表单丁基封端的单甲基丙烯酰氧基丙基封端的聚二甲基硅氧烷;SiGMA代表3-(3-甲基丙烯酰氧基-2-羟基丙氧基)丙基双(三甲基甲硅烷氧基)甲基硅烷;Betacon是根据US 5945498(通过引用以其全文结合于此)的实例A1中描述的程序制备的α,ω-甲基丙烯酰氧基封端的聚硅氧烷-全氟聚醚-聚硅氧烷三嵌段共聚物;NVP代表N-乙烯基吡咯烷酮;DMA代表N,N-二甲基丙烯酰胺;MMA代表甲基丙烯酸甲酯;TEGDMA代表三乙二醇二甲基丙烯酸酯;TEGDVE代表三乙二醇二乙烯基醚;EGDMA代表乙二醇二甲基丙烯酸酯;D1173代表2-羟基-2-甲基苯丙酮;VAZO 64代表2,2’-二甲基-2,2’偶氮二丙酰腈;DSM代表使用一次性塑料模具(例如聚丙烯模具)的双面模制;RT代表室温。
实例1
透氧性测量
镜片和镜片材料的表观透氧性(Dkapp)、表观氧透过率(Dk/t)、本征(或边缘校正的)透氧性(DKC)是根据美国专利申请公开号2012/0026457 A1(通过引用以其全文结合于此)的实例1中所描述的程序测定的。
润滑性评估。润滑性等级是定性评级方案,其中0被指定为用聚丙烯酸(PAA)涂覆的对照镜片,1被指定为OasysTM/TruEyeTM商业镜片并且5被指定为商业Air OptixTM镜片。在评估之前将样品用过量DI水冲洗至少三次并且然后转移至PBS中。在评估之前,将手用肥皂溶液冲洗,用DI水充分冲洗并且然后用毛巾干燥。在手指之间触摸样品并且相对于以述的以上标准镜片对各个样品指定数值。例如,如果镜片被测定为仅比Air OptixTM镜片稍微更好,则将它们指定为数字4。为了一致性,性,所有等级独立地由相同的两个操作员收集以避免偏好并且数据迄今为止显示评估中的非常好的定性统一性和一致性。
表面亲水性/可润湿性试验。接触镜片上的水接触角是接触镜片的表面亲水性(或可润湿性)的一般量度。特别地,低的水接触角对应于更亲水的表面。接触镜片的平均接触角(座滴法)是使用来自位于马萨诸塞州波士顿的AST公司的VCA 2500 XE接触角测量设备测量的。该设备能够测量前进或后退接触角或固着(静态)接触角。测量如下在完全水合的接触镜片上并且在吸干-干燥之后立即进行。将接触镜片从小瓶中取出并在约200ml的新鲜DI水中洗涤3次以从镜片表面上除去松散结合的包装添加剂。然后将镜片放在无绒清洁布(Alpha Wipe TX1009)的顶部上,充分地轻拍以除去表面水,安装在接触角测量支座上,用一股干空气吹干并且最后使用生产商提供的软件自动测量座滴接触角。用于测量接触角的DI水具有>18Mcm的电阻率并且且所用的液滴体积是2μl。通常,未涂覆的硅酮水凝胶接触镜片(在高压灭菌之后)具有约120度的座滴接触角。在与接触镜片接触之前将镊子和支座用异丙醇充分地洗涤并用DI水冲洗。
水破裂时间(WBUT)试验。镜片(在高压灭菌之后)的可润湿性还通过测定水膜在镜片表面上开始破裂所需的时间进行评估。简言之,将镜片从小瓶中取出并在约200ml的新鲜DI水中洗涤3次以从镜片表面上除去松散结合的包装添加剂。将镜片从溶液中取出并保持抵靠明亮的光源。视觉上记录水膜破裂(脱湿)暴露下面的镜片材料所需的时间。未涂覆的镜片典型地在从DI水中取出时立即破裂并被指定为0秒的WBUT。展现出WBUT≥5秒的镜片被认为是可润湿的并预期展现出足够的在眼睛上的可润湿性(支持泪膜的能力)。
基底涂层的稳定性(或耐久性)试验。将在其上具有基底的镜片在含有磷酸盐缓冲盐水(pH 7.2,[NaCl]=按重量计0.6%)的包装中在约121℃下高压灭菌持续30分钟。高压灭菌的镜片通过测定水膜在镜片表面上开始破裂所需的时间进行评估。在被高压灭菌后展现出约10秒或更长(优选约15秒或更长、约20秒或更长)的WBUT的镜片的基底涂层被认为是稳定的(或耐久的)。
涂层完整性试验。接触镜片的表面上的涂层的完整性可如下根据苏丹黑着色试验测试。将具有涂层(LbL涂层、等离子体涂层、或任何其他涂层)的接触镜片浸入苏丹黑染料溶液(在维生素E油中的苏丹黑)中。苏丹黑染料是疏水性的并具有被疏水性材料吸附或吸附到疏水性镜片表面或疏水性镜片(例如硅酮水凝胶接触镜片)的部分涂覆的表面上的疏水点上的巨大倾向。如果在疏水性镜片上的涂层是完整的,则在镜片上或中应观察不到着色点。在试验中的所有镜片是完全水合的。
手指摩擦试验。将镜片用多用途镜片护理液手指摩擦(戴着一次性无粉乳胶手套)30次并且然后用盐水冲洗。将上述程序重复给定次数,例如,从1至30次(即,模仿清洗和浸泡循环的连续手指摩擦试验的数目)。然后使镜片经受苏丹黑试验(即,上述涂层完整性试验)以检查涂层是否依然是完整的。为了经受得住手指摩擦试验,没有显著增加的着色点(例如,着色点覆盖总镜片表面的不超过约5%)。测量水接触角以确定非硅酮水凝胶涂层的耐久性。
实例2
为了比较,制备两种具有如表1中所示的组成的配制品,MS05UV和MS02UV。MS02UV主要由作为亲水性乙烯单体的N-乙烯基吡咯烷酮(NVP)构成,而MS05UV主要由作为亲水性单体的DMA构成并且不含NVP。这两种配制品在聚丙烯模具中在UV下固化约一小时,并且得到了良好品质的镜片。它们具有非常相似的水含量和机械特性。这两个镜片用异丙醇(IPA)溶液(30min 50%/50%IPA/水,30min 100%IPA,30min 50%/50%IPA/水,3X10min水)萃取。镜片然后在包装在小瓶中的4mL的PBS中之前用0.5%wt%PAA(聚丙烯酸,Mw=100k)水溶液(没有pH值调整)处理2X10min,紧接着用磷酸盐缓冲盐水(PBS)冲洗处理3X5min。高压灭菌周期是121℃持续30分钟。然后将镜片以20秒的标度对WBUT进行检查。MS02UV具有>20秒的WBUT而MS05UV具有仅约2秒。对照组,未经PAA处理的包装在PBS中的MS02UV和MS05UV的WBUT,是约2秒。显然,MS02UV的可润湿性来自PAA处理并且主要是由于在镜片的表面上附着的PAA。因此,有利的是使用含有NVP的配制品用于表面涂层,因为它会产生更好的PAA底层,因此更好的涂层耐久性。
表1
实例3
为了比较,制备6种具有如表2中所示的组成的配制品。在所有六种配制品中亲水性乙烯单体(NVP和DMA)的总量保持恒定,虽然改变NVP与DMA的量比。这些配制品在聚丙烯模具中在UV(5mW)下固化约45分钟,并且得到了良好品质的镜片。将脱模后每个所得镜片用约4ml的异丙醇(IPA)萃取过夜并且然后用4ml的DI水萃取两次,每次持续约5分钟。将每个经萃取的镜片在被包装在小瓶中的4ml的PBS中之前浸渍在水(pH约2.8)中的4ml的0.5%wt%PAA(聚丙烯酸,Mw=100k)持续约60分钟并且紧接着浸渍在4ml的PBS中两次,每次持续约5分钟。将在其中具有镜片的包装在121℃下高压灭菌持续30分钟。在高压灭菌后,将镜片从小瓶中取出并在WBUT评估之前浸泡在新鲜的4mL的PBS中持续至少1分钟。然后将镜片以20秒的标度对WBUT进行检查。表中的结果表明,当NVP以约30%或更高的量存在于配制品中时,硅酮水凝胶接触镜片上的稳定的PAA涂层是稳定的,如由在高压灭菌后具有大于20秒的WBUT表征的。
表格2
Claims (9)
1.一种用于生产各自在其上具有交联的亲水性涂层的涂覆的硅酮水凝胶接触镜片的方法,该方法包括以下步骤:
(a)从可聚合组合物获得硅酮水凝胶接触镜片,该可聚合组合物包含(i)至少一种含有硅酮的乙烯单体或大分子单体、(ii)相对于可聚合组分的总量按重量计从35%至56%的N-乙烯基吡咯烷酮、和(iii)一种或多种亲水性乙烯单体,其选自N,N-二甲基丙烯酰胺、N,N-二甲基甲基丙烯酰胺、2-丙烯酰氨基乙醇酸、3-丙烯酰基氨基-1-丙醇、N-羟乙基丙烯酰胺、N-[三(羟甲基)甲基]-丙烯酰胺、N-甲基-3-亚甲基-2-吡咯烷酮、1-乙基-3-亚甲基-2-吡咯烷酮、1-甲基-5-亚甲基-2-吡咯烷酮、1-乙基-5-亚甲基-2-吡咯烷酮、5-甲基-3-亚甲基-2-吡咯烷酮、5-乙基-3-亚甲基-2-吡咯烷酮、1-正丙基-3-亚甲基-2-吡咯烷酮、1-正丙基-5-亚甲基-2-吡咯烷酮、1-异丙基-3-亚甲基-2-吡咯烷酮、1-异丙基-5-亚甲基-2-吡咯烷酮、1-正丁基-3-亚甲基-2-吡咯烷酮、1-叔丁基-3-亚甲基-2-吡咯烷酮、甲基丙烯酸2-羟乙酯、丙烯酸2-羟乙酯、丙烯酸羟丙酯、甲基丙烯酸羟丙酯、三甲基铵2-羟基丙基甲基丙烯酸酯氢氯化物、氨基丙基甲基丙烯酸酯氢氯化物、二甲基氨基乙基甲基丙烯酸酯、甲基丙烯酸甘油酯、具有最高达1500的重均分子量的C1-C4-烷氧基聚乙二醇(甲基)丙烯酸酯、甲基丙烯酸、N-乙烯基甲酰胺、N-乙烯基乙酰胺、N-乙烯基异丙基酰胺、N-乙烯基-N-甲基乙酰胺、烯丙醇、以及它们的混合物,其中硅酮水凝胶接触镜片具有含有聚乙烯吡咯烷酮链段的聚合物基质;
(b)使该硅酮水凝胶接触镜片与丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液接触以在该硅酮水凝胶接触镜片上形成基底涂层,其中该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液具有从2.5至5.5的pH,其中聚合物基质的聚乙烯吡咯烷酮链段,与该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物,形成牢固的互聚物络合物,该互聚物络合物是稳定的,其特征在于确保在该其上具有基底涂层的硅酮水凝胶接触镜片已经在具有从6.5至7.5的pH的磷酸盐缓冲盐水中在115℃至125℃下高压灭菌持续30分钟之后,该基底涂层表现出20秒或更长的水破裂时间(WBUT),其中该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的重均分子量Mw是至少50,000道尔顿,并且是聚丙烯酸、聚甲基丙烯酸、聚乙基丙烯酸、聚丙基丙烯酸、聚(丙烯酸-共-甲基丙烯酸)、聚[(甲基)丙烯酸-共-乙基丙烯酸]、聚[(甲基)丙烯酸-共-丙基丙烯酸],聚[(甲基)丙烯酸-共-丙烯酰胺],聚[(甲基)丙烯酸-共-乙烯基吡咯烷酮]、聚[乙基丙烯酸-共-丙烯酰胺]、聚[乙基丙烯酸-共-乙烯基吡咯烷酮]、聚[丙基丙烯酸-共-丙烯酰胺]、聚[丙基丙烯酸-共-乙烯基吡咯烷酮]、水解的聚[(甲基)丙烯酸-共-乙酸乙烯酯]、水解的聚[乙基丙烯酸-共-乙酸乙烯酯]、水解的聚[丙基丙烯酸-共-乙酸乙烯酯]、或它们的组合;并且
(c)将具有氮杂环丁烷鎓基团的水溶性且可热交联的亲水性聚合物材料共价连接并且交联到该基底涂层上以在该硅酮水凝胶接触镜片上形成非硅酮水凝胶涂层。
2.如权利要求1所述的方法,其中该可聚合组合物包含相对于可聚合组分的总量按重量计从40%至52%的N-乙烯基吡咯烷酮。
3.如权利要求1或2所述的方法,其中用于在硅酮水凝胶接触镜片上形成基底涂层的丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的重均分子量Mw是从100,000道尔顿至5,000,000道尔顿。
4.如权利要求1所述的方法,其中该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物是聚丙烯酸、聚甲基丙烯酸、聚乙基丙烯酸、聚丙基丙烯酸、聚(丙烯酸-共-甲基丙烯酸)、聚[(甲基)丙烯酸-共-乙基丙烯酸]、聚[(甲基)丙烯酸-共-丙基丙烯酸]、或它们的组合。
5.如权利要求4所述的方法,其中该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液具有从3.0至5的pH。
6.如权利要求1所述的方法,其中该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液具有从3.0至5的pH。
7.如权利要求3所述的方法,其中该丙烯酸或C1-C3烷基丙烯酸的均聚物或共聚物的水溶液具有从3.0至5的pH。
8.如权利要求4所述的方法,其中该共价连接和交联的步骤是在从115℃至125℃的温度下持续至少20分钟通过高压釜灭菌过程中直接在含有包括该水溶性、可热交联的亲水性聚合物材料的包装溶液的密封镜片包装中进行的。
9.如权利要求4所述的方法,其中共价连接并且交联的步骤通过以下进行:在室温下使在其上具有该基底涂层的该硅酮水凝胶接触镜片与具有氮杂环丁烷鎓基团的水溶性可热交联的亲水性聚合物材料的水溶液接触以在该硅酮水凝胶接触镜片的表面上形成该可热交联的亲水性聚合物材料的顶层;将在其上具有该可热交联的亲水性聚合物材料的该顶层和该基底涂层的该硅酮水凝胶接触镜片浸渍在镜片包装中的包装溶液中;密封该镜片包装;并且将在其中具有该硅酮水凝胶接触镜片的该镜片包装在从115℃至125℃的温度下高压灭菌持续至少20分钟以在该硅酮水凝胶接触镜片上形成该非硅酮水凝胶涂层。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462041771P | 2014-08-26 | 2014-08-26 | |
US62/041,771 | 2014-08-26 | ||
PCT/US2015/046471 WO2016032926A1 (en) | 2014-08-26 | 2015-08-24 | Method for applying stable coating on silicone hydrogel contact lenses |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106715101A CN106715101A (zh) | 2017-05-24 |
CN106715101B true CN106715101B (zh) | 2019-11-05 |
Family
ID=54072987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201580045379.0A Active CN106715101B (zh) | 2014-08-26 | 2015-08-24 | 用于在硅酮水凝胶接触镜片上施用稳定的涂层的方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US11002884B2 (zh) |
EP (1) | EP3186070B1 (zh) |
KR (1) | KR102366047B1 (zh) |
CN (1) | CN106715101B (zh) |
HU (1) | HUE046948T2 (zh) |
MY (1) | MY183678A (zh) |
SG (2) | SG10201901379TA (zh) |
WO (1) | WO2016032926A1 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112019011099A2 (pt) * | 2016-12-02 | 2019-10-01 | Univ Florida | remoção de conservador de colírios |
US10866344B2 (en) * | 2017-06-07 | 2020-12-15 | Alcon Inc. | Silicone hydrogel contact lenses |
TWI640557B (zh) * | 2017-07-05 | 2018-11-11 | 晶碩光學股份有限公司 | 具表面修飾的隱形眼鏡及其製備方法 |
US10962803B2 (en) * | 2018-01-30 | 2021-03-30 | Alcon Inc. | Contact lenses with a lubricious coating thereon |
EP4023261A4 (en) * | 2019-08-27 | 2023-09-20 | Toray Industries, Inc. | METHOD FOR PRODUCING A MEDICAL DEVICE |
US11754753B2 (en) * | 2020-04-27 | 2023-09-12 | Coopervision International Limited | Antioxidant contact lens |
JPWO2022054706A1 (zh) * | 2020-09-14 | 2022-03-17 | ||
EP4296761A4 (en) * | 2021-04-21 | 2025-02-19 | NOF Corporation | MONOMER COMPOSITION FOR CONTACT LENS, POLYMER OF SAID MONOMER COMPOSITION, CONTACT LENS AND PROCESS FOR PRODUCING SAID CONTACT LENS |
KR102528506B1 (ko) | 2021-05-25 | 2023-05-09 | 한국과학기술연구원 | 운동 상태 및 뇌파 분석을 통한 재활 상태 모니터링 시스템 |
KR102545476B1 (ko) * | 2021-12-09 | 2023-06-21 | 문샷옵티컬주식회사 | Mpc를 이용한 기능성이 향상된 실리콘 하이드로겔 콘택트 렌즈의 제조 방법 |
US12282209B1 (en) * | 2023-05-31 | 2025-04-22 | Coopervision International Limited | Contact lens and packaging solution |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3171752A (en) * | 1962-07-11 | 1965-03-02 | Burton Parsons Chemicals Inc | Contact lens treating solution |
CN1376270A (zh) * | 1999-05-20 | 2002-10-23 | 博士伦公司 | 用反应性亲水聚合物进行的医疗器件的表面处理 |
Family Cites Families (484)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2296891A (en) | 1940-11-09 | 1942-09-29 | Celanese Corp | Cement |
US2926154A (en) | 1957-09-05 | 1960-02-23 | Hercules Powder Co Ltd | Cationic thermosetting polyamide-epichlorohydrin resins and process of making same |
US3224986A (en) | 1962-04-18 | 1965-12-21 | Hercules Powder Co Ltd | Cationic epichlorohydrin modified polyamide reacted with water-soluble polymers |
NL128305C (zh) | 1963-09-11 | |||
SE306597B (zh) | 1964-12-17 | 1968-12-02 | Incentive Ab | |
US3434984A (en) | 1966-04-25 | 1969-03-25 | Owens Illinois Inc | Thermosetting cationic resin and method of making same |
DE1745348A1 (de) | 1967-12-01 | 1971-09-09 | Roehm Gmbh | Azlactongruppen enthaltende Mischpolymerisate |
US3598790A (en) | 1966-07-01 | 1971-08-10 | Roehm & Haas Gmbh | Azlactone copolymers |
US3488327A (en) | 1967-06-30 | 1970-01-06 | Roehm & Haas Gmbh | Preparation of coating materials |
US3617344A (en) | 1966-08-05 | 1971-11-02 | Us Health Education & Welfare | Nonthrombogenic plastic surfaces and preparation thereof |
GB1218394A (en) | 1967-03-08 | 1971-01-06 | Toho Kagaku Kogyo Kabushiki Ka | Process for producing water-soluble thermosetting polymer |
US3566874A (en) | 1968-08-13 | 1971-03-02 | Nat Patent Dev Corp | Catheter |
US3639141A (en) | 1968-09-16 | 1972-02-01 | Cordis Corp | Heparinization of plastic |
JPS4813341B1 (zh) | 1969-06-13 | 1973-04-26 | ||
US3663288A (en) | 1969-09-04 | 1972-05-16 | American Cyanamid Co | Physiologically acceptible elastomeric article |
US3772076A (en) | 1970-01-26 | 1973-11-13 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and their use in paper |
US3616935A (en) | 1970-02-05 | 1971-11-02 | Dow Chemical Co | Preparation of antithrombogenic surfaces |
US3925178A (en) | 1970-04-17 | 1975-12-09 | Hymie D Gesser | Contact lenses |
US3700623A (en) | 1970-04-22 | 1972-10-24 | Hercules Inc | Reaction products of epihalohydrin and polymers of diallylamine and their use in paper |
US3695921A (en) | 1970-09-09 | 1972-10-03 | Nat Patent Dev Corp | Method of coating a catheter |
US3844989A (en) | 1971-12-23 | 1974-10-29 | Toray Industries | Shampooer with rotary foam generating means anti-thrombogenic polymer compositions with internally bound heparin |
US3892696A (en) | 1972-05-12 | 1975-07-01 | Grace W R & Co | Polyureas and preparation thereof |
US3975350A (en) | 1972-08-02 | 1976-08-17 | Princeton Polymer Laboratories, Incorporated | Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles |
US3813695A (en) | 1973-02-21 | 1974-06-04 | D Podell | Surgical glove |
US3900672A (en) | 1973-04-04 | 1975-08-19 | Hoya Lens Co Ltd | Process for coating an optical material and the resulting product |
US3861396A (en) | 1973-08-08 | 1975-01-21 | Hydro Med Sciences Inc | Drainage tube |
SE400173B (sv) | 1975-03-20 | 1978-03-20 | Aminkemi Ab | Forfarande vid stabilisering av en hepariniserad yta innehallande vid blodkontakt utlosbart heparin |
FR2306243A1 (fr) | 1975-04-03 | 1976-10-29 | Asahi Dow Ltd | Composition de revetement hydrophyle |
DE2614662A1 (de) | 1975-04-07 | 1977-01-27 | Dow Chemical Co | Zusammensetzung zur herstellung von in wasser quellbaren gegenstaenden |
US4154898A (en) | 1976-09-27 | 1979-05-15 | The Dow Chemical Company | Absorbent articles and methods for their preparation |
US4143949A (en) | 1976-10-28 | 1979-03-13 | Bausch & Lomb Incorporated | Process for putting a hydrophilic coating on a hydrophobic contact lens |
US4182822A (en) | 1976-11-08 | 1980-01-08 | Chang Sing Hsiung | Hydrophilic, soft and oxygen permeable copolymer composition |
US4343927A (en) | 1976-11-08 | 1982-08-10 | Chang Sing Hsiung | Hydrophilic, soft and oxygen permeable copolymer compositions |
JPS5413694A (en) | 1977-07-01 | 1979-02-01 | Sumitomo Electric Industries | Composite blood vessel prosthesis and method of producing same |
US4136250A (en) | 1977-07-20 | 1979-01-23 | Ciba-Geigy Corporation | Polysiloxane hydrogels |
US4153641A (en) | 1977-07-25 | 1979-05-08 | Bausch & Lomb Incorporated | Polysiloxane composition and contact lens |
US4189546A (en) | 1977-07-25 | 1980-02-19 | Bausch & Lomb Incorporated | Polysiloxane shaped article for use in biomedical applications |
FR2402525A1 (fr) | 1977-09-12 | 1979-04-06 | Toray Industries | Procede de fabrication de compositions de lentilles de contact molles et nouveaux produits ainsi obtenus |
US4168112A (en) | 1978-01-05 | 1979-09-18 | Polymer Technology Corporation | Contact lens with a hydrophilic, polyelectrolyte complex coating and method for forming same |
US4298715A (en) | 1978-03-01 | 1981-11-03 | Monsanto Company | Polyamine/epihalohydrin reaction products |
US4217038A (en) | 1978-06-05 | 1980-08-12 | Bausch & Lomb Incorporated | Glass coated polysiloxane contact lens |
US4191596A (en) | 1978-09-06 | 1980-03-04 | Union Carbide Corporation | Method and compositions for coating aluminum |
US4280970A (en) | 1979-01-19 | 1981-07-28 | Puropore Inc. | Polyoxyethylene grafted membrane materials with grafting links derived from a diisocyanate |
US4261875A (en) | 1979-01-31 | 1981-04-14 | American Optical Corporation | Contact lenses containing hydrophilic silicone polymers |
US4298639A (en) | 1979-03-19 | 1981-11-03 | Monsanto Company | Wet strength polymers |
US4263188A (en) | 1979-05-23 | 1981-04-21 | Verbatim Corporation | Aqueous coating composition and method |
US4254248A (en) | 1979-09-13 | 1981-03-03 | Bausch & Lomb Incorporated | Contact lens made from polymers of polysiloxane and polycyclic esters of acrylic acid or methacrylic acid |
US4276402A (en) | 1979-09-13 | 1981-06-30 | Bausch & Lomb Incorporated | Polysiloxane/acrylic acid/polcyclic esters of methacrylic acid polymer contact lens |
US4312575A (en) | 1979-09-18 | 1982-01-26 | Peyman Gholam A | Soft corneal contact lens with tightly cross-linked polymer coating and method of making same |
US4260725A (en) | 1979-12-10 | 1981-04-07 | Bausch & Lomb Incorporated | Hydrophilic contact lens made from polysiloxanes which are thermally bonded to polymerizable groups and which contain hydrophilic sidechains |
US4259467A (en) | 1979-12-10 | 1981-03-31 | Bausch & Lomb Incorporated | Hydrophilic contact lens made from polysiloxanes containing hydrophilic sidechains |
US4293642A (en) | 1980-05-13 | 1981-10-06 | Gaf Corporation | In photographic emulsion adhesion to a polyester film base |
JPS5774369A (en) | 1980-10-28 | 1982-05-10 | Mitsui Petrochem Ind Ltd | Coating composition |
US4462665A (en) | 1981-01-29 | 1984-07-31 | The Kendall Company | Composite hydrogel-forming lens and method of making same |
US4327203A (en) | 1981-02-26 | 1982-04-27 | Bausch & Lomb Incorporated | Polysiloxane with cycloalkyl modifier composition and biomedical devices |
US4341889A (en) | 1981-02-26 | 1982-07-27 | Bausch & Lomb Incorporated | Polysiloxane composition and biomedical devices |
US4355147A (en) | 1981-02-26 | 1982-10-19 | Bausch & Lomb Incorporated | Polysiloxane with polycyclic modifier composition and biomedical devices |
US4495313A (en) | 1981-04-30 | 1985-01-22 | Mia Lens Production A/S | Preparation of hydrogel for soft contact lens with water displaceable boric acid ester |
US4373009A (en) | 1981-05-18 | 1983-02-08 | International Silicone Corporation | Method of forming a hydrophilic coating on a substrate |
US4379893A (en) | 1981-08-26 | 1983-04-12 | Diamond Shamrock Corporation | Surface-treated soft contact lenses |
DE3135830A1 (de) | 1981-09-10 | 1983-03-24 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von wasserloeslichen, stickstoffhaltigen kondensationsprodukten und deren verwendung bei der papierherstellung |
US4444711A (en) | 1981-12-21 | 1984-04-24 | Husky Injection Molding Systems Ltd. | Method of operating a two-shot injection-molding machine |
US4661575A (en) | 1982-01-25 | 1987-04-28 | Hercules Incorporated | Dicyclopentadiene polymer product |
SE8200751L (sv) | 1982-02-09 | 1983-08-10 | Olle Larm | Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter |
SE456347B (sv) | 1982-02-09 | 1988-09-26 | Ird Biomaterial Ab | Ytmodifierat fast substrat samt forfarande for framstellning derav |
US4487808A (en) | 1982-04-22 | 1984-12-11 | Astra Meditec Aktiebolag | Medical article having a hydrophilic coating |
US4499154A (en) | 1982-09-03 | 1985-02-12 | Howard L. Podell | Dipped rubber article |
US4460534A (en) | 1982-09-07 | 1984-07-17 | International Business Machines Corporation | Two-shot injection molding |
US4973493A (en) | 1982-09-29 | 1990-11-27 | Bio-Metric Systems, Inc. | Method of improving the biocompatibility of solid surfaces |
US5217492A (en) | 1982-09-29 | 1993-06-08 | Bio-Metric Systems, Inc. | Biomolecule attachment to hydrophobic surfaces |
US5002582A (en) | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
US4486577A (en) | 1982-10-12 | 1984-12-04 | Ciba-Geigy Corporation | Strong, silicone containing polymers with high oxygen permeability |
US4543398A (en) | 1983-04-28 | 1985-09-24 | Minnesota Mining And Manufacturing Company | Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols |
US4527293A (en) | 1983-05-18 | 1985-07-09 | University Of Miami | Hydrogel surface of urological prosthesis |
US4521564A (en) | 1984-02-10 | 1985-06-04 | Warner-Lambert Company | Covalent bonded antithrombogenic polyurethane material |
US4695608A (en) | 1984-03-29 | 1987-09-22 | Minnesota Mining And Manufacturing Company | Continuous process for making polymers having pendant azlactone or macromolecular moieties |
EP0166998B1 (en) | 1984-06-04 | 1991-05-08 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Medical instrument and method for making |
US4959074A (en) | 1984-08-23 | 1990-09-25 | Gergory Halpern | Method of hydrophilic coating of plastics |
US4605712A (en) | 1984-09-24 | 1986-08-12 | Ciba-Geigy Corporation | Unsaturated polysiloxanes and polymers thereof |
AT380897B (de) | 1984-12-10 | 1986-07-25 | Koller Anton | Mischung zur pflege und reinigung von kontaktlinsen |
US4833218A (en) | 1984-12-18 | 1989-05-23 | Dow Corning Corporation | Hydrophilic silicone-organic copolymer elastomers containing bioactine agent |
US4546123A (en) | 1984-12-28 | 1985-10-08 | Alcon Laboratories, Inc. | Polymer hydrogels adapted for use as soft contact lenses, and method of preparing same |
JPH0674369B2 (ja) | 1985-03-14 | 1994-09-21 | 大日本インキ化学工業株式会社 | ビニル共重合体樹脂水分散液の製法 |
DE3517615C2 (de) | 1985-05-15 | 1987-04-09 | Titmus Eurocon Kontaktlinsen GmbH, 8750 Aschaffenburg | Verfahren zur Hydrophilierung eines Siliconkautschukformkörpers an seiner Oberfläche |
US4684538A (en) | 1986-02-21 | 1987-08-04 | Loctite Corporation | Polysiloxane urethane compounds and adhesive compositions, and method of making and using the same |
US4786556A (en) | 1986-03-24 | 1988-11-22 | Becton, Dickinson And Company | Polymeric articles having enhanced antithrombogenic activity |
US4720512A (en) | 1986-03-24 | 1988-01-19 | Becton, Dickinson And Company | Polymeric articles having enhanced antithrombogenic activity |
DE3708308A1 (de) | 1986-04-10 | 1987-10-22 | Bayer Ag | Kontaktoptische gegenstaende |
US4791175A (en) | 1986-08-04 | 1988-12-13 | Ciba-Geigy Corporation | Particulate hydroperoxidized poly-n-vinyl lactam, its preparation and use thereof |
DE3778446D1 (de) | 1986-08-18 | 1992-05-27 | Mueller Lierheim Wolfgang G K | Kontaktlinse. |
US4979959A (en) | 1986-10-17 | 1990-12-25 | Bio-Metric Systems, Inc. | Biocompatible coating for solid surfaces |
US5263992A (en) | 1986-10-17 | 1993-11-23 | Bio-Metric Systems, Inc. | Biocompatible device with covalently bonded biocompatible agent |
US4734475A (en) | 1986-12-15 | 1988-03-29 | Ciba-Geigy Corporation | Wettable surface modified contact lens fabricated from an oxirane containing hydrophobic polymer |
US5712327A (en) | 1987-01-07 | 1998-01-27 | Chang; Sing-Hsiung | Soft gas permeable contact lens having improved clinical performance |
US5108776A (en) | 1987-04-10 | 1992-04-28 | University Of Florida | Ocular implants and methods for their manufacture |
US5290548A (en) | 1987-04-10 | 1994-03-01 | University Of Florida | Surface modified ocular implants, surgical instruments, devices, prostheses, contact lenses and the like |
JP2551580B2 (ja) | 1987-04-30 | 1996-11-06 | ホ−ヤ株式会社 | コンタクトレンズの親水化方法 |
US4837289A (en) | 1987-04-30 | 1989-06-06 | Ciba-Geigy Corporation | UV- and heat curable terminal polyvinyl functional macromers and polymers thereof |
US5059659A (en) | 1987-05-29 | 1991-10-22 | Harry P. Gregor | Surface treatments to impart hydrophilicity |
US4978713A (en) | 1987-12-16 | 1990-12-18 | Ciba-Geigy Corporation | Polyvinyl alcohol derivatives containing pendant vinylic monomer reaction product units bound through ether groups and hydrogel contact lenses made therefrom |
US4943460A (en) | 1988-02-19 | 1990-07-24 | Snyder Laboratories, Inc. | Process for coating polymer surfaces and coated products produced using such process |
US5070170A (en) | 1988-02-26 | 1991-12-03 | Ciba-Geigy Corporation | Wettable, rigid gas permeable, substantially non-swellable contact lens containing block copolymer polysiloxane-polyoxyalkylene backbone units, and use thereof |
KR900700550A (ko) | 1988-03-23 | 1990-08-16 | 제임스 제이. 플린 | 마찰계수가 낮은 표면 |
JP2561309B2 (ja) | 1988-03-28 | 1996-12-04 | テルモ株式会社 | 医療用材料およびその製造方法 |
US5061738A (en) | 1988-04-18 | 1991-10-29 | Becton, Dickinson And Company | Blood compatible, lubricious article and composition and method therefor |
US4954587A (en) | 1988-07-05 | 1990-09-04 | Ciba-Geigy Corporation | Dimethylacrylamide-copolymer hydrogels with high oxygen permeability |
US5019393A (en) | 1988-08-03 | 1991-05-28 | New England Deaconess Hospital Corporation | Biocompatible substance with thromboresistance |
US5079093A (en) | 1988-08-09 | 1992-01-07 | Toray Industries, Inc. | Easily-slippery medical materials and a method for preparation thereof |
JPH0651795B2 (ja) | 1988-09-16 | 1994-07-06 | 信越化学工業株式会社 | メタクリル官能性ジメチルポリシロキサン |
US5053048A (en) | 1988-09-22 | 1991-10-01 | Cordis Corporation | Thromboresistant coating |
US5270046A (en) | 1988-09-27 | 1993-12-14 | Ube Industries, Ltd. | Heparin bound anti-thrombotic material |
EP0362137A3 (en) | 1988-09-28 | 1991-09-04 | Ciba-Geigy Ag | Molded polymers with hydrophilic surfaces, and process for making them |
US4983702A (en) | 1988-09-28 | 1991-01-08 | Ciba-Geigy Corporation | Crosslinked siloxane-urethane polymer contact lens |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5039459A (en) | 1988-11-25 | 1991-08-13 | Johnson & Johnson Vision Products, Inc. | Method of forming shaped hydrogel articles including contact lenses |
DE58908944D1 (de) | 1988-12-19 | 1995-03-09 | Ciba Geigy Ag | Hydrogele auf der Basis von fluorhaltigen und Saccharid-Monomeren. |
US5214452A (en) | 1988-12-19 | 1993-05-25 | Ciba-Geigy Corporation | Hydrogels based on fluorine-containing and saccharide monomers |
US4973359A (en) | 1989-01-04 | 1990-11-27 | Nippon Paint Co., Ltd. | Surface treatment chemical and bath for forming hydrophilic coatings and method of surface-treating aluminum members |
US4978481A (en) | 1989-01-13 | 1990-12-18 | Ciba-Geigy Corporation | Process for the encapsulation of preformed substrates by graft copolymerization |
US4968532A (en) | 1989-01-13 | 1990-11-06 | Ciba-Geigy Corporation | Process for graft copolymerization on surfaces of preformed substrates to modify surface properties |
US4954586A (en) | 1989-01-17 | 1990-09-04 | Menicon Co., Ltd | Soft ocular lens material |
US5091205A (en) | 1989-01-17 | 1992-02-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydrophilic lubricious coatings |
US5262484A (en) | 1989-04-10 | 1993-11-16 | Minnesota Mining And Manufacturing Company | Azlactone graft copolymers |
DK0393532T3 (da) | 1989-04-14 | 1996-08-19 | Jessen Wesley Corp | Fremgangsmåde til farvning af kontaktlinser |
US5080924A (en) | 1989-04-24 | 1992-01-14 | Drexel University | Method of making biocompatible, surface modified materials |
US4990357A (en) | 1989-05-04 | 1991-02-05 | Becton, Dickinson And Company | Elastomeric segmented hydrophilic polyetherurethane based lubricious coatings |
US5034461A (en) | 1989-06-07 | 1991-07-23 | Bausch & Lomb Incorporated | Novel prepolymers useful in biomedical devices |
US5272012A (en) | 1989-06-23 | 1993-12-21 | C. R. Bard, Inc. | Medical apparatus having protective, lubricious coating |
EP0443005A4 (en) | 1989-09-14 | 1992-02-19 | Sing-Hsiung Chang | Soft gas permeable contact lens having improved clinical performance |
US5049403A (en) | 1989-10-12 | 1991-09-17 | Horsk Hydro A.S. | Process for the preparation of surface modified solid substrates |
US5010141A (en) | 1989-10-25 | 1991-04-23 | Ciba-Geigy Corporation | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof |
US5079319A (en) | 1989-10-25 | 1992-01-07 | Ciba-Geigy Corporation | Reactive silicone and/or fluorine containing hydrophilic prepolymers and polymers thereof |
US5135516A (en) | 1989-12-15 | 1992-08-04 | Boston Scientific Corporation | Lubricious antithrombogenic catheters, guidewires and coatings |
GB9009097D0 (en) | 1990-04-23 | 1990-06-20 | Lrc Products | Method of making dipped rubber articles |
DE4026978A1 (de) | 1990-08-25 | 1992-02-27 | Bayer Ag | Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung |
JPH0783761B2 (ja) | 1990-10-04 | 1995-09-13 | テルモ株式会社 | 医療用具 |
US5160790A (en) | 1990-11-01 | 1992-11-03 | C. R. Bard, Inc. | Lubricious hydrogel coatings |
US5132108A (en) | 1990-11-08 | 1992-07-21 | Cordis Corporation | Radiofrequency plasma treated polymeric surfaces having immobilized anti-thrombogenic agents |
KR100191144B1 (ko) | 1990-11-27 | 1999-06-15 | 스티븐 에이 헬렁 | 표면-활성 매크로단량체 |
US5135297A (en) | 1990-11-27 | 1992-08-04 | Bausch & Lomb Incorporated | Surface coating of polymer objects |
US5112900A (en) | 1990-11-28 | 1992-05-12 | Tactyl Technologies, Inc. | Elastomeric triblock copolymer compositions and articles made therewith |
US5407715A (en) | 1990-11-28 | 1995-04-18 | Tactyl Technologies, Inc. | Elastomeric triblock copolymer compositions and articles made therewith |
AU649287B2 (en) | 1990-12-19 | 1994-05-19 | Novartis Ag | Process for rendering contact lenses hydrophilic |
US5270415A (en) | 1990-12-21 | 1993-12-14 | Allergan Inc. | Balanced charge polymer and hydrophilic contact lens manufactured therefrom |
US5739236A (en) | 1991-04-24 | 1998-04-14 | Biocompatibles Limited | Biocompatible zwitterion polymers |
US5397848A (en) | 1991-04-25 | 1995-03-14 | Allergan, Inc. | Enhancing the hydrophilicity of silicone polymers |
US5443907A (en) | 1991-06-18 | 1995-08-22 | Scimed Life Systems, Inc. | Coating for medical insertion guides |
GB9113875D0 (en) | 1991-06-27 | 1991-08-14 | Biointeractions Ltd | Polymer coatings |
US6284854B1 (en) | 1991-07-05 | 2001-09-04 | Biccompatibles Limited | Polymeric surface coatings |
CA2313676C (en) | 1991-07-05 | 2006-10-10 | Biocompatibles Limited | Polymeric surface coatings |
US5705583A (en) | 1991-07-05 | 1998-01-06 | Biocompatibles Limited | Polymeric surface coatings |
US6743878B2 (en) | 1991-07-05 | 2004-06-01 | Biocompatibles Uk Limited | Polymeric surface coatings |
US6225431B1 (en) | 1991-07-05 | 2001-05-01 | Biocompatibles Limited | Biocompatibilizing process |
US6090901A (en) | 1991-07-05 | 2000-07-18 | Biocompatibles Limited | Polymeric surface coatings |
US5210111A (en) | 1991-08-22 | 1993-05-11 | Ciba-Geigy Corporation | Crosslinked hydrogels derived from hydrophilic polymer backbones |
EP0603268B1 (en) | 1991-09-12 | 1996-12-18 | BAUSCH & LOMB INCORPORATED | Wettable silicone hydrogel compositions and methods |
WO1993005825A1 (en) | 1991-09-20 | 1993-04-01 | Baxter International Inc. | Processes for reducing the thrombogenicity of biomaterials |
EP0537972B1 (en) | 1991-10-14 | 1996-07-10 | Nof Corporation | Treating solution for contact lenses |
JP3093375B2 (ja) | 1991-11-01 | 2000-10-03 | 株式会社東海メディカルプロダクツ | 抗血栓性物質の固定化方法 |
US5352714A (en) | 1991-11-05 | 1994-10-04 | Bausch & Lomb Incorporated | Wettable silicone hydrogel compositions and methods for their manufacture |
HK1001564A1 (zh) | 1991-11-05 | 1998-06-26 | Bausch & Lomb Incorporated | 可濕聚硅氧烷水凝膠組合物及其制備方法 |
GB9124353D0 (en) | 1991-11-15 | 1992-01-08 | Albright & Wilson | Immobilisation of metal contaminants from a liquid to a solid metal |
EP0572624A4 (en) | 1991-12-18 | 1994-07-06 | Scimed Life Systems Inc | Lubricous polymer network |
US6314199B1 (en) | 1991-12-18 | 2001-11-06 | Novartis Ag | Process and apparatus for examining optical components, especially optical components for the eye and device for illuminating clear-transparent |
IL100443A (en) | 1991-12-20 | 1995-03-30 | Dotan Gideon | Inspection system for detecting surface flaws |
US5470944A (en) | 1992-02-13 | 1995-11-28 | Arch Development Corporation | Production of high molecular weight polylactic acid |
WO1993016176A1 (en) | 1992-02-13 | 1993-08-19 | Bio-Metric Systems, Inc. | Immobilization of chemical species in crosslinked matrices |
JPH05285164A (ja) | 1992-04-03 | 1993-11-02 | Unitika Ltd | 抗血栓性眼内レンズ |
US5358995A (en) | 1992-05-15 | 1994-10-25 | Bausch & Lomb Incorporated | Surface wettable silicone hydrogels |
US5805264A (en) | 1992-06-09 | 1998-09-08 | Ciba Vision Corporation | Process for graft polymerization on surfaces of preformed substates to modify surface properties |
EP0574352A1 (en) | 1992-06-09 | 1993-12-15 | Ciba-Geigy Ag | Process for graft polymerization on surfaces of preformed substrates to modify surface properties |
DK172393B1 (da) | 1992-06-10 | 1998-05-18 | Maersk Medical As | Fremgangsmåde til fremstilling af en genstand med friktionsnedsættende overfladebelægning, belægningsmateriale til anvendelse ved fremstilling af en sådan genstand samt anvendelse af en osmolalitetsforøgende forbindelse i opslæmmet eller emulgeret form i belægningsmaterialet |
US5292514A (en) | 1992-06-24 | 1994-03-08 | Minnesota Mining And Manufacturing Company | Azlactone-functional substrates, corneal prostheses, and manufacture and use thereof |
JP3195662B2 (ja) | 1992-08-24 | 2001-08-06 | 株式会社メニコン | 眼用レンズ材料 |
JP2774233B2 (ja) | 1992-08-26 | 1998-07-09 | 株式会社メニコン | 眼用レンズ材料 |
US5310571A (en) | 1992-09-01 | 1994-05-10 | Allergan, Inc. | Chemical treatment to improve oxygen permeability through and protein deposition on hydrophilic (soft) and rigid gas permeable (RGP) contact lenses |
IL106922A (en) | 1992-09-14 | 1998-08-16 | Novartis Ag | Composite materials with one or more wettable surfaces and process for their preparation |
KR0122741B1 (ko) | 1992-09-23 | 1997-11-17 | 배순훈 | 병렬 구조를 갖는 기억 장치 |
US5409731A (en) | 1992-10-08 | 1995-04-25 | Tomei Sangyo Kabushiki Kaisha | Method for imparting a hydrophilic nature to a contact lens |
EP0672084B2 (en) | 1992-11-30 | 2007-03-07 | Bulk Chemicals, Inc. | A method and composition for treating metal surfaces |
IL107605A (en) | 1992-12-21 | 1998-01-04 | Johnson & Johnson Vision Prod | Lens inspection system |
IL107603A (en) | 1992-12-21 | 1997-01-10 | Johnson & Johnson Vision Prod | Ophthalmic lens inspection method and apparatus |
IL107602A0 (en) | 1992-12-21 | 1994-02-27 | Johnson & Johnson Vision Prod | Method of inspecting ophthalmic lenses |
NZ250042A (en) | 1992-12-21 | 1997-01-29 | Johnson & Johnson Vision Prod | Robotic inspection of ophthalmic lenses |
IL107601A (en) | 1992-12-21 | 1997-09-30 | Johnson & Johnson Vision Prod | Illumination and imaging subsystems for a lens inspection system |
GB9226791D0 (en) | 1992-12-23 | 1993-02-17 | Biocompatibles Ltd | New materials |
US5308641A (en) | 1993-01-19 | 1994-05-03 | Medtronic, Inc. | Biocompatibility of solid surfaces |
US5350800A (en) | 1993-01-19 | 1994-09-27 | Medtronic, Inc. | Method for improving the biocompatibility of solid surfaces |
US5750245A (en) | 1993-01-29 | 1998-05-12 | Minnesota Mining And Manufacturing Company | Thermally induced phase separated azlactone membrane |
CA2114697C (en) | 1993-02-08 | 2006-06-13 | Kenichi Shimura | Medical tool having lubricious surface in a wetted state and method for production thereof |
WO1994021308A1 (en) | 1993-03-18 | 1994-09-29 | Cedars-Sinai Medical Center | Drug incorporating and releasing polymeric coating for bioprosthesis |
US5531715A (en) | 1993-05-12 | 1996-07-02 | Target Therapeutics, Inc. | Lubricious catheters |
TW328535B (en) | 1993-07-02 | 1998-03-21 | Novartis Ag | Functional photoinitiators and their manufacture |
US6800225B1 (en) | 1994-07-14 | 2004-10-05 | Novartis Ag | Process and device for the manufacture of mouldings and mouldings manufactured in accordance with that process |
TW325744U (en) | 1993-07-21 | 1998-01-21 | Ciba Geigy Ag | Two-sided contact lens mold |
US5578675A (en) | 1993-07-21 | 1996-11-26 | Basf Corporation | Non-isocyanate basecoat/clearcoat coating compositions which may be ambient cured |
DE69416680T2 (de) | 1993-07-29 | 1999-06-24 | Wesley-Jessen Corp., Des Plaines, Ill. | Vorrichtung zur untersuchung von optischen elementen |
TW272976B (zh) | 1993-08-06 | 1996-03-21 | Ciba Geigy Ag | |
TW253849B (zh) | 1993-08-09 | 1995-08-11 | Ciba Geigy | |
US5408002A (en) | 1993-09-09 | 1995-04-18 | Minnesota Mining And Manufacturing Company | Azlactone-functional polymer blends, articles produced therefrom and methods for preparing both |
US5514478A (en) | 1993-09-29 | 1996-05-07 | Alcan International Limited | Nonabrasive, corrosion resistant, hydrophilic coatings for aluminum surfaces, methods of application, and articles coated therewith |
US5723145A (en) | 1993-09-30 | 1998-03-03 | Takiron Co., Ltd. | Transdermal absorption preparation |
US5936703A (en) | 1993-10-13 | 1999-08-10 | Nof Corporation | Alkoxysilane compound, surface processing solution and contact lens |
GB9321714D0 (en) | 1993-10-21 | 1993-12-15 | Sandoz Ltd | Improvements in or relating to organic compounds |
US5712356A (en) | 1993-11-26 | 1998-01-27 | Ciba Vision Corporation | Cross-linkable copolymers and hydrogels |
EP0655470B1 (de) | 1993-11-26 | 1999-05-12 | Novartis AG | Vernetzbare Copolymere und Hydrogele |
US5894002A (en) | 1993-12-13 | 1999-04-13 | Ciba Vision Corporation | Process and apparatus for the manufacture of a contact lens |
JP3734512B2 (ja) | 1993-12-27 | 2006-01-11 | 株式会社メニコン | コンタクトレンズ外観検査方法および外観検査装置 |
CN1150218C (zh) | 1994-04-11 | 2004-05-19 | 赫希斯特人造丝公司 | 超吸收性聚合物及其制品 |
US5476665A (en) | 1994-04-13 | 1995-12-19 | Minnesota Mining And Manufacturing Company | Azlactone functional particles incorporated in a membrane formed by solvent phase inversion |
US5626000A (en) | 1994-06-10 | 1997-05-06 | Johnson & Johnson Vision Products, Inc. | Packaging arrangement |
US5500732A (en) | 1994-06-10 | 1996-03-19 | Johnson & Johnson Vision Products, Inc. | Lens inspection system and method |
US5843346A (en) | 1994-06-30 | 1998-12-01 | Polymer Technology Corporation | Method of cast molding contact lenses |
US5670558A (en) | 1994-07-07 | 1997-09-23 | Terumo Kabushiki Kaisha | Medical instruments that exhibit surface lubricity when wetted |
US7468398B2 (en) | 1994-09-06 | 2008-12-23 | Ciba Vision Corporation | Extended wear ophthalmic lens |
US5760100B1 (en) | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
US5509899A (en) | 1994-09-22 | 1996-04-23 | Boston Scientific Corp. | Medical device with lubricious coating |
IT1270125B (it) | 1994-10-05 | 1997-04-28 | Spherilene Srl | Processo per la ( co) polimerizzazione di olefine |
US5681510A (en) | 1994-10-13 | 1997-10-28 | Bausch & Lomb Incorporated | Method for treating plastic mold pieces |
US6342570B1 (en) | 1994-11-14 | 2002-01-29 | Novartis Ag | Cross-linkable copolymers and hydrogels |
JP3647093B2 (ja) | 1994-11-17 | 2005-05-11 | 株式会社メニコン | 親水性化酸素透過性コンタクトレンズ及びその製造法 |
US5665840A (en) | 1994-11-18 | 1997-09-09 | Novartis Corporation | Polymeric networks from water-soluble prepolymers |
EP0712867B1 (de) | 1994-11-18 | 1999-07-14 | Novartis AG | Polymere Netzwerke aus wasserlöslichen Präpolymeren |
US5510004A (en) | 1994-12-01 | 1996-04-23 | Hercules Incorporated | Azetidinium polymers for improving wet strength of paper |
SE503711C2 (sv) | 1994-12-14 | 1996-08-12 | Medicarb Ab | Flerstegsförfarande för beläggning av en intraokulär lins |
US5700559A (en) | 1994-12-16 | 1997-12-23 | Advanced Surface Technology | Durable hydrophilic surface coatings |
TW353086B (en) | 1994-12-30 | 1999-02-21 | Novartis Ag | Method for multistep coating of a surface |
US5995213A (en) | 1995-01-17 | 1999-11-30 | Johnson & Johnson Vision Products, Inc. | Lens inspection system |
US5532311A (en) | 1995-02-01 | 1996-07-02 | Minnesota Mining And Manufacturing Company | Process for modifying surfaces |
TW349967B (en) | 1995-02-03 | 1999-01-11 | Novartis Ag | Process for producing contact lenses and a cross-linkable polyvinylalcohol used therefor |
JP3785599B2 (ja) | 1995-02-03 | 2006-06-14 | ノバルティス アクチエンゲゼルシャフト | エステル又はアミド基を含む架橋ポリマー |
US5599576A (en) | 1995-02-06 | 1997-02-04 | Surface Solutions Laboratories, Inc. | Medical apparatus with scratch-resistant coating and method of making same |
HU219815B (hu) | 1995-02-07 | 2001-08-28 | Fidia Advanced Biopolymers S.R.L. | Eljárás tárgyak hialuronsavval, hialuronsavszármazékokkal és félszintetikus polimerekkel történő bevonására |
US6179817B1 (en) | 1995-02-22 | 2001-01-30 | Boston Scientific Corporation | Hybrid coating for medical devices |
US5702754A (en) | 1995-02-22 | 1997-12-30 | Meadox Medicals, Inc. | Method of providing a substrate with a hydrophilic coating and substrates, particularly medical devices, provided with such coatings |
US5869127A (en) | 1995-02-22 | 1999-02-09 | Boston Scientific Corporation | Method of providing a substrate with a bio-active/biocompatible coating |
JPH08239639A (ja) | 1995-03-02 | 1996-09-17 | Sekisui Chem Co Ltd | 粘着剤組成物及びそれを用いた粘着加工品 |
US5633504A (en) | 1995-03-30 | 1997-05-27 | Wesley-Jessen Corporation | Inspection of optical components |
US5674942A (en) | 1995-03-31 | 1997-10-07 | Johnson & Johnson Vision Products, Inc. | Interpenetrating polymer networks for contact lens production |
TW585882B (en) | 1995-04-04 | 2004-05-01 | Novartis Ag | A method of using a contact lens as an extended wear lens and a method of screening an ophthalmic lens for utility as an extended-wear lens |
SI0819258T1 (en) | 1995-04-04 | 2002-04-30 | Novartis Ag | Extended wear ophthalmic lens |
TW393498B (en) | 1995-04-04 | 2000-06-11 | Novartis Ag | The preparation and use of Polysiloxane-comprising perfluoroalkyl ethers |
US5688855A (en) | 1995-05-01 | 1997-11-18 | S.K.Y. Polymers, Inc. | Thin film hydrophilic coatings |
AU5630796A (en) | 1995-05-25 | 1996-12-11 | Minnesota Mining And Manufacturing Company | Process for producing biocompatible surfaces |
US5583463A (en) | 1995-05-30 | 1996-12-10 | Micron Technology, Inc. | Redundant row fuse bank circuit |
US5731087A (en) | 1995-06-07 | 1998-03-24 | Union Carbide Chemicals & Plastics Technology Corporation | Lubricious coatings containing polymers with vinyl and carboxylic acid moieties |
US6087462A (en) | 1995-06-07 | 2000-07-11 | Biocompatibles Limited | Polymeric surface coatings |
US5620738A (en) | 1995-06-07 | 1997-04-15 | Union Carbide Chemicals & Plastics Technology Corporation | Non-reactive lubicious coating process |
AUPN354595A0 (en) | 1995-06-14 | 1995-07-06 | Ciba-Geigy Ag | Novel materials |
TW428018B (en) | 1995-06-29 | 2001-04-01 | Ciba Sc Holding Ag | Aminosilane salts and silanamides of carboxylic acids as corrosion inhibitors |
RU2163246C2 (ru) | 1995-06-30 | 2001-02-20 | Коммонвелт Сайентифик Энд Индастриал Рисерч Организейшн | Способ модификации, по меньшей мере, части поверхности полимера |
US5874127A (en) | 1995-08-16 | 1999-02-23 | Ciba Vision Corporation | Method and apparatus for gaseous treatment |
US5672638A (en) | 1995-08-22 | 1997-09-30 | Medtronic, Inc. | Biocompatability for solid surfaces |
DE69617637T2 (de) | 1995-09-06 | 2002-07-18 | Menicon Co., Ltd. | Verfahren zur herstellung von kontaktlinsen und die so hergestellten kontaktlinsen |
US5789462A (en) | 1995-09-13 | 1998-08-04 | Seikagaku Kogyo Kabushiki Kaisha (Seikagaku Corporation) | Photocured crosslinked-hyaluronic acid contact lens |
AU698522B2 (en) | 1995-09-29 | 1998-10-29 | Johnson & Johnson Vision Products, Inc. | Lens parameter measurement using optical sectioning |
US6007526A (en) | 1995-10-12 | 1999-12-28 | Hollister Incorporated | Male external catheter with short annular sealing flap |
US5804318A (en) | 1995-10-26 | 1998-09-08 | Corvita Corporation | Lubricious hydrogel surface modification |
US6509098B1 (en) | 1995-11-17 | 2003-01-21 | Massachusetts Institute Of Technology | Poly(ethylene oxide) coated surfaces |
US5710302A (en) | 1995-12-07 | 1998-01-20 | Bausch & Lomb Incorporated | Monomeric units useful for reducing the modules of silicone hydrogels |
US5922249A (en) | 1995-12-08 | 1999-07-13 | Novartis Ag | Ophthalmic lens production process |
DE69636460T2 (de) | 1995-12-08 | 2007-03-29 | Novartis Ag | Plasmainduzierte polymere beschichtungen |
PT876165E (pt) | 1995-12-18 | 2006-10-31 | Angiotech Biomaterials Corp | Composicoes de polimeros reticulados e processos para a sua utilizacao |
EP0780419A1 (en) | 1995-12-22 | 1997-06-25 | Holland Biomaterials Group B.V. | Multi-functional site containing polymers, and applications thereof |
EP0868457B1 (en) | 1995-12-22 | 2002-09-11 | Novartis AG | Polyurethanes made from polysiloxane/polyol macromers |
EP0879268A1 (en) | 1996-02-09 | 1998-11-25 | Surface Solutions Laboratories, Inc. | Water-based hydrophilic coating compositions and articles prepared therefrom |
US5792531A (en) | 1996-02-20 | 1998-08-11 | Tactyl Technologies, Inc. | Readily donned, powder free elastomeric article |
US5779943A (en) | 1996-03-19 | 1998-07-14 | Johnson & Johnson Vision Products, Inc. | Molded polymeric object with wettable surface made from latent-hydrophilic monomers |
US6096138A (en) | 1997-04-30 | 2000-08-01 | Bausch & Lomb Incorporated | Method for inhibiting the deposition of protein on contact lens |
US5811151A (en) | 1996-05-31 | 1998-09-22 | Medtronic, Inc. | Method of modifying the surface of a medical device |
EP0814116A1 (de) | 1996-06-19 | 1997-12-29 | Hüls Aktiengesellschaft | Hydrophile Beschichtung von Oberflächen polymerer Substrate |
US5807944A (en) | 1996-06-27 | 1998-09-15 | Ciba Vision Corporation | Amphiphilic, segmented copolymer of controlled morphology and ophthalmic devices including contact lenses made therefrom |
US6174326B1 (en) | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
US6169127B1 (en) | 1996-08-30 | 2001-01-02 | Novartis Ag | Plasma-induced polymer coatings |
US5800412A (en) | 1996-10-10 | 1998-09-01 | Sts Biopolymers, Inc. | Hydrophilic coatings with hydrating agents |
WO1998017704A1 (en) | 1996-10-21 | 1998-04-30 | Novartis Ag | Crosslinkable polymers |
US6639007B2 (en) | 1996-11-15 | 2003-10-28 | Tactyl Technologies, Inc. | Elastomeric copolymer compositions and articles made therewith |
AR009439A1 (es) | 1996-12-23 | 2000-04-12 | Novartis Ag | Un articulo que comprende un sustrato con un recubrimiento polimerico primario que porta grupos reactivos predominantemente en su superficie, unmetodo para preparar dicho articulo, un articulo que posee un recubrimiento de tipo hibrido y una lente de contacto |
US6306514B1 (en) | 1996-12-31 | 2001-10-23 | Ansell Healthcare Products Inc. | Slip-coated elastomeric flexible articles and their method of manufacture |
US5882687A (en) | 1997-01-10 | 1999-03-16 | Allergan | Compositions and methods for storing contact lenses |
US6018001A (en) | 1997-01-23 | 2000-01-25 | Menicon Co., Ltd. | Process for producing contact lens with hydrophilic surface and contact lens obtained thereby |
US5997517A (en) | 1997-01-27 | 1999-12-07 | Sts Biopolymers, Inc. | Bonding layers for medical device surface coatings |
TW425403B (en) | 1997-02-04 | 2001-03-11 | Novartis Ag | Branched polyurethane (meth)acrylate prepolymers, opthal-mic mouldings derived therefrom and processes for their manufacture |
EP0867456A1 (de) | 1997-02-04 | 1998-09-30 | Novartis AG | Ophthalmischer Formkörper |
US5818573A (en) | 1997-02-06 | 1998-10-06 | Pbh, Inc. | Opthalmic lens inspection system |
US5801822A (en) | 1997-02-06 | 1998-09-01 | Pbh, Inc. | Ophthalmic lens inspection system |
AU6821898A (en) | 1997-02-21 | 1998-09-09 | Novartis Ag | Ophthalmic mouldings |
US5879697A (en) | 1997-04-30 | 1999-03-09 | Schneider Usa Inc | Drug-releasing coatings for medical devices |
US6221467B1 (en) | 1997-06-03 | 2001-04-24 | Scimed Life Systems, Inc. | Coating gradient for lubricious coatings on balloon catheters |
GB9711818D0 (en) | 1997-06-06 | 1997-08-06 | Bausch & Lomb | Contact lens packing solutions and methods for improving the comfort of disposable contact lenses |
US6866938B2 (en) | 1997-07-22 | 2005-03-15 | Nissha Printing Co., Ltd. | Foil-detecting sheet and method of producing a foil-decorated resin article using the same |
US6165322A (en) | 1997-07-29 | 2000-12-26 | Hercules Incorporated | Polyamidoamine/epichlorohydrin resins bearing polyol sidechains as dry strength agents |
DE69807509T2 (de) | 1997-09-16 | 2003-04-24 | Novartis Ag, Basel | Vernetzbare polyharnstoffpolymere |
AU9627298A (en) | 1997-09-23 | 1999-04-12 | Novartis Ag | Method for hydrogel surface treatment and article formed therefrom |
US5858653A (en) | 1997-09-30 | 1999-01-12 | Surmodics, Inc. | Reagent and method for attaching target molecules to a surface |
TW429327B (en) | 1997-10-21 | 2001-04-11 | Novartis Ag | Single mould alignment |
US6054504A (en) | 1997-12-31 | 2000-04-25 | Hydromer, Inc. | Biostatic coatings for the reduction and prevention of bacterial adhesion |
CA2314078C (en) | 1998-01-09 | 2009-09-08 | Novartis Ag | Coating of polymers |
US6451871B1 (en) | 1998-11-25 | 2002-09-17 | Novartis Ag | Methods of modifying surface characteristics |
JPH11223901A (ja) | 1998-02-06 | 1999-08-17 | Fuji Photo Film Co Ltd | 熱現像記録材料 |
US7052131B2 (en) | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US5998498A (en) | 1998-03-02 | 1999-12-07 | Johnson & Johnson Vision Products, Inc. | Soft contact lenses |
US6822016B2 (en) | 2001-09-10 | 2004-11-23 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US6367929B1 (en) | 1998-03-02 | 2002-04-09 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
US5962548A (en) | 1998-03-02 | 1999-10-05 | Johnson & Johnson Vision Products, Inc. | Silicone hydrogel polymers |
US6096726A (en) | 1998-03-11 | 2000-08-01 | Surface Solutions Laboratories Incorporated | Multicomponent complex for use with substrate |
EP0949290B1 (en) | 1998-04-09 | 2006-12-27 | Nippon Shokubai Co., Ltd. | Crosslinked polymer particle and its production process and use |
US6686054B2 (en) | 1998-04-22 | 2004-02-03 | Sri International | Method and composition for the sizing of paper using azetidinium and/or guanidine polymers |
TW473488B (en) | 1998-04-30 | 2002-01-21 | Novartis Ag | Composite materials, biomedical articles formed thereof and process for their manufacture |
CA2328897A1 (en) | 1998-05-05 | 1999-11-11 | Bausch & Lomb Incorporated | Plasma surface treatment of silicone hydrogel contact lenses |
AU3786699A (en) | 1998-05-05 | 1999-11-23 | Bausch & Lomb Incorporated | Surface treatment of silicone hydrogel contact lenses |
US6500481B1 (en) | 1998-06-11 | 2002-12-31 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with amid-containing coatings |
US6087415A (en) | 1998-06-11 | 2000-07-11 | Johnson & Johnson Vision Care, Inc. | Biomedical devices with hydrophilic coatings |
US6106889A (en) | 1998-06-11 | 2000-08-22 | Biocoat Incorporated | Method of selective coating of articles |
US6039913A (en) | 1998-08-27 | 2000-03-21 | Novartis Ag | Process for the manufacture of an ophthalmic molding |
US6099852A (en) | 1998-09-23 | 2000-08-08 | Johnson & Johnson Vision Products, Inc. | Wettable silicone-based lenses |
US6149842A (en) | 1998-11-12 | 2000-11-21 | Novartis Ag | Methods and compositions for manufacturing tinted ophthalmic lenses |
US6207796B1 (en) | 1998-11-18 | 2001-03-27 | Nippon Shokubai Co., Ltd. | Production process for hydrophilic polymer |
EP1002807A1 (en) | 1998-11-20 | 2000-05-24 | Novartis AG | Functionalized resin derived from polyallylamine |
US5981675A (en) | 1998-12-07 | 1999-11-09 | Bausch & Lomb Incorporated | Silicone-containing macromonomers and low water materials |
TW480246B (en) | 1998-12-18 | 2002-03-21 | Kimberly Clark Co | Cationically charged coating on glass fibers and method for making the same |
US6537614B1 (en) | 1998-12-18 | 2003-03-25 | Kimberly-Clark Worldwide, Inc. | Cationically charged coating on hydrophobic polymer fibers with poly (vinyl alcohol) assist |
US6550915B1 (en) | 1998-12-21 | 2003-04-22 | Bausch & Lomb Incorporated | Surface treatment of fluorinated contact lens materials |
US6896769B2 (en) | 1999-01-25 | 2005-05-24 | Kimberly-Clark Worldwide, Inc. | Modified condensation polymers containing azetidinium groups in conjunction with amphiphilic hydrocarbon moieties |
US6517678B1 (en) | 2000-01-20 | 2003-02-11 | Kimberly-Clark Worldwide, Inc. | Modified polysaccharides containing amphiphillic hydrocarbon moieties |
US6340465B1 (en) | 1999-04-12 | 2002-01-22 | Edwards Lifesciences Corp. | Lubricious coatings for medical devices |
US6630243B2 (en) | 1999-05-20 | 2003-10-07 | Bausch & Lomb Incorporated | Surface treatment of silicone hydrogel contact lenses comprising hydrophilic polymer chains attached to an intermediate carbon coating |
US6586520B1 (en) | 1999-07-08 | 2003-07-01 | Hercules Incorporated | Compositions for imparting desired properties to materials |
US7344607B2 (en) | 1999-07-08 | 2008-03-18 | Ge Betz, Inc. | Non-chromate conversion coating treatment for metals |
CA2379244C (en) | 1999-07-27 | 2007-09-18 | Jay F. Kunzler | Contact lens material |
WO2001020997A1 (fr) | 1999-09-20 | 2001-03-29 | Menicon Co., Ltd. | Preparation liquide pour lentilles de contact |
US6478423B1 (en) | 1999-10-12 | 2002-11-12 | Johnson & Johnson Vison Care, Inc. | Contact lens coating selection and manufacturing process |
JP2001163933A (ja) | 1999-10-27 | 2001-06-19 | Novartis Ag | 材料表面を改質する方法 |
JP2001163932A (ja) | 1999-10-27 | 2001-06-19 | Novartis Ag | 材料表面を改質する方法 |
JP2001158813A (ja) | 1999-10-27 | 2001-06-12 | Novartis Ag | 材料表面を被覆する方法 |
JP2003512513A (ja) | 1999-10-27 | 2003-04-02 | ノバルティス アクチエンゲゼルシャフト | コーティング方法 |
AU779729B2 (en) | 1999-12-16 | 2005-02-10 | Coopervision International Limited | Soft contact lens capable of being worn for a long period |
US6465602B2 (en) | 2000-01-20 | 2002-10-15 | Kimberly-Clark Worldwide, Inc. | Modified condensation polymers having azetidinium groups and containing polysiloxane moieties |
US6719929B2 (en) | 2000-02-04 | 2004-04-13 | Novartis Ag | Method for modifying a surface |
AR027348A1 (es) | 2000-02-04 | 2003-03-26 | Novartis Ag | Proceso para recubrir una superficie |
JP3929014B2 (ja) | 2000-02-24 | 2007-06-13 | Hoyaヘルスケア株式会社 | 側鎖にポリシロキサン構造を有するマクロマーからなるコンタクトレンズ材料 |
US7521519B1 (en) | 2000-03-14 | 2009-04-21 | Novartis Ag | Organic compounds |
GB0006891D0 (en) | 2000-03-23 | 2000-05-10 | Arjobex Ltd | Coating composition |
ES2222373T3 (es) | 2000-03-24 | 2005-02-01 | Novartis Ag | Prepolimeros reticulares o polimerizables. |
US6467903B1 (en) | 2000-03-31 | 2002-10-22 | Ocular Sciences, Inc. | Contact lens having a uniform horizontal thickness profile |
US6923538B2 (en) | 2000-07-06 | 2005-08-02 | Coopervision, Inc. | Method for cast moulding contact lenses with a rounded edge form |
US6599559B1 (en) | 2000-04-03 | 2003-07-29 | Bausch & Lomb Incorporated | Renewable surface treatment of silicone medical devices with reactive hydrophilic polymers |
US6689480B2 (en) | 2000-05-10 | 2004-02-10 | Toray Industries, Inc. | Surface-treated plastic article and method of surface treatment |
US6589665B2 (en) | 2000-05-30 | 2003-07-08 | Novartis Ag | Coated articles |
US6428839B1 (en) | 2000-06-02 | 2002-08-06 | Bausch & Lomb Incorporated | Surface treatment of medical device |
US6364934B1 (en) | 2000-07-31 | 2002-04-02 | Bausch & Lomb Incorporated | Method of making ocular devices |
US6482221B1 (en) | 2000-08-21 | 2002-11-19 | Counter Clockwise, Inc. | Manipulatable delivery catheter for occlusive devices (II) |
AU2001280100A1 (en) | 2000-08-22 | 2002-03-04 | Nof Corporation | Lubricating agent and insertion aid solution for contact lens |
US6852353B2 (en) | 2000-08-24 | 2005-02-08 | Novartis Ag | Process for surface modifying substrates and modified substrates resulting therefrom |
WO2002016974A2 (en) * | 2000-08-24 | 2002-02-28 | Novartis Ag | Process for surface modifying substrates and modified substrates resulting therefrom |
CA2420861C (en) | 2000-09-19 | 2007-04-24 | Joseph A. Mcgee | Method for applying polymeric lens coating |
US6551267B1 (en) | 2000-10-18 | 2003-04-22 | Becton, Dickinson And Company | Medical article having blood-contacting surface |
US20020182315A1 (en) | 2000-11-01 | 2002-12-05 | Heiler David J. | Surface treatment of non-plasma treated silicone hydrogel contact lenses |
DE10055762A1 (de) | 2000-11-10 | 2002-06-06 | Woehlk Contact Linsen Gmbh | Hydrogelkontaktlinsen mit hoher Biokompatibilität |
US6531432B2 (en) | 2000-12-07 | 2003-03-11 | Johnson & Johnson Vision Care, Inc. | Contact lens packaging solutions |
JP4043789B2 (ja) | 2001-01-24 | 2008-02-06 | ノバルティス アクチエンゲゼルシャフト | 表面を修飾するための方法 |
US6835410B2 (en) | 2001-05-21 | 2004-12-28 | Novartis Ag | Bottle-brush type coatings with entangled hydrophilic polymer |
JP2003066381A (ja) | 2001-05-23 | 2003-03-05 | Novartis Ag | 流体で物品を処理するためのシステム及び方法 |
US6811805B2 (en) | 2001-05-30 | 2004-11-02 | Novatis Ag | Method for applying a coating |
US7879267B2 (en) | 2001-08-02 | 2011-02-01 | J&J Vision Care, Inc. | Method for coating articles by mold transfer |
US6891010B2 (en) | 2001-10-29 | 2005-05-10 | Bausch & Lomb Incorporated | Silicone hydrogels based on vinyl carbonate endcapped fluorinated side chain polysiloxanes |
TW200407367A (en) | 2001-11-13 | 2004-05-16 | Novartis Ag | Method for modifying the surface of biomedical articles |
TWI255224B (en) | 2002-01-09 | 2006-05-21 | Novartis Ag | Polymeric articles having a lubricious coating and method for making the same |
GB0201165D0 (en) | 2002-01-18 | 2002-03-06 | Unilever Plc | Azetidinium modidfied poymers and fabric treatment composition |
US6936641B2 (en) | 2002-06-25 | 2005-08-30 | Johnson & Johnson Vision Care, Inc. | Macromer forming catalysts |
US7270678B2 (en) | 2002-06-28 | 2007-09-18 | Bausch & Lomb Incorporated | Surface modification of functional group-containing medical devices with catalyst-containing reactive polymer system |
TW200404842A (en) | 2002-07-30 | 2004-04-01 | Nitto Denko Corp | Optical film and manufacturing method thereof |
AU2002950469A0 (en) | 2002-07-30 | 2002-09-12 | Commonwealth Scientific And Industrial Research Organisation | Improved biomedical compositions |
AU2003258609A1 (en) | 2002-08-14 | 2004-03-03 | Novartis Ag | Radiation-curable prepolymers |
US20080299179A1 (en) | 2002-09-06 | 2008-12-04 | Osman Rathore | Solutions for ophthalmic lenses containing at least one silicone containing component |
US6926965B2 (en) | 2002-09-11 | 2005-08-09 | Novartis Ag | LbL-coated medical device and method for making the same |
US6896926B2 (en) | 2002-09-11 | 2005-05-24 | Novartis Ag | Method for applying an LbL coating onto a medical device |
US6740336B2 (en) | 2002-10-04 | 2004-05-25 | Mirus Corporation | Process for generating multilayered particles |
US20040116564A1 (en) | 2002-11-27 | 2004-06-17 | Devlin Brian Gerrard | Stabilization of poly(oxyalkylene) containing polymeric materials |
US8172395B2 (en) | 2002-12-03 | 2012-05-08 | Novartis Ag | Medical devices having antimicrobial coatings thereon |
US7032251B2 (en) | 2002-12-10 | 2006-04-25 | Kimberly-Clark Worldwide, Inc. | Crosslinking agent for coated elastomeric articles |
US7384590B2 (en) | 2002-12-17 | 2008-06-10 | Novartis Ag | System and method for curing polymeric moldings |
US7387759B2 (en) | 2002-12-17 | 2008-06-17 | Novartis Ag | System and method for curing polymeric moldings having a masking collar |
WO2004063795A1 (ja) | 2003-01-10 | 2004-07-29 | Menicon Co., Ltd. | 安全性の高いシリコーン含有眼用レンズ材料およびその製造方法 |
PT1603603E (pt) | 2003-02-28 | 2015-02-24 | Biointeractions Ltd | Sistema de rede polimérica para dispositivos médicos e métodos de utilização |
WO2004097504A1 (en) | 2003-04-24 | 2004-11-11 | Ocular Sciences Inc. | Hydrogel contact lenses and package systems and production methods for same |
GB0322640D0 (en) | 2003-09-26 | 2003-10-29 | 1800 Contacts | Process |
US7977430B2 (en) | 2003-11-25 | 2011-07-12 | Novartis Ag | Crosslinkable polyurea prepolymers |
US7084188B2 (en) | 2003-12-05 | 2006-08-01 | Bausch & Lomb Incorporated | Surface modification of contact lenses |
US7214809B2 (en) | 2004-02-11 | 2007-05-08 | Johnson & Johnson Vision Care, Inc. | (Meth)acrylamide monomers containing hydroxy and silicone functionalities |
US7588334B2 (en) | 2004-05-28 | 2009-09-15 | Menicon Co., Ltd. | Contact lens |
TWI454724B (zh) | 2004-08-27 | 2014-10-01 | Coopervision Int Holding Co Lp | 聚矽氧水凝膠隱形眼鏡 |
US7556858B2 (en) | 2004-09-30 | 2009-07-07 | 3M Innovative Properties Company | Substrate with attached dendrimers |
US20060065138A1 (en) | 2004-09-30 | 2006-03-30 | Tucker Robert C | Pad printing method for making colored contact lenses |
US7247692B2 (en) | 2004-09-30 | 2007-07-24 | Johnson & Johnson Vision Care, Inc. | Biomedical devices containing amphiphilic block copolymers |
US7249848B2 (en) | 2004-09-30 | 2007-07-31 | Johnson & Johnson Vision Care, Inc. | Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents |
JP4782508B2 (ja) | 2004-09-30 | 2011-09-28 | 株式会社シード | 高酸素透過含水性眼用レンズ |
US20080307751A1 (en) | 2004-10-01 | 2008-12-18 | Newman Stephen D | Contact Lens Package Solution |
US7857447B2 (en) | 2004-10-05 | 2010-12-28 | The Board Of Trustees Of The Leland Stanford Junior University | Interpenetrating polymer network hydrogel contact lenses |
US20060100113A1 (en) | 2004-11-05 | 2006-05-11 | Pegram Stephen C | Methods of inhabiting the adherence of lenses to surfaces during their manufacture |
EP1827718B1 (en) | 2004-11-29 | 2011-06-29 | DSM IP Assets B.V. | Method for reducing the amount of migrateables of polymer coatings |
SE0403092D0 (sv) | 2004-12-20 | 2004-12-20 | Amo Groningen Bv | Amphiphilic block copolymers and their use |
CA2593070A1 (en) | 2004-12-29 | 2006-07-06 | Bausch & Lomb Incorporated | Polysiloxane prepolymers for biomedical devices |
DE602005013298D1 (de) | 2004-12-29 | 2009-04-23 | Bausch & Lomb | Polysiloxanprepolymere für biomedizinische vorrichtungen |
WO2006085351A1 (en) | 2005-02-09 | 2006-08-17 | Safilens S.R.L. | Contact lens, method for producing same, and pack for storage and maintenance of a contact lens |
EP4176906A1 (en) | 2005-02-14 | 2023-05-10 | Johnson & Johnson Vision Care, Inc. | A comfortable ophthalmic device and methods of its production |
US7426993B2 (en) | 2005-08-09 | 2008-09-23 | Coopervision International Holding Company, Lp | Contact lens package |
US7671156B2 (en) | 2005-08-10 | 2010-03-02 | Novartis Ag | Silicone hydrogels |
EP1752816A1 (en) | 2005-08-11 | 2007-02-14 | CooperVision Inc. | Contact lenses and methods for reducing conjunctival pressure in contact lens wearers |
EP1754731A1 (en) | 2005-08-16 | 2007-02-21 | Nederlandse Organisatie voor Toegepast-Natuuurwetenschappelijk Onderzoek TNO | Method of modifying materials surfaces |
BRPI0618567A2 (pt) | 2005-11-14 | 2011-09-06 | Ciba Holding Inc | preparação de polìmeros catiÈnicos funcionalizados e sua preparação e aplicação no cuidado pessoal |
WO2007064594A2 (en) | 2005-11-29 | 2007-06-07 | Bausch & Lomb Incorporated | New coatings on ophthalmic lenses |
US20070149428A1 (en) | 2005-12-14 | 2007-06-28 | Bausch & Lomb Incorporated | Method of Packaging a Lens |
US7825273B2 (en) | 2006-01-06 | 2010-11-02 | Bausch & Lomb Incorporated | Process for making cationic hydrophilic siloxanyl monomers |
US8044112B2 (en) | 2006-03-30 | 2011-10-25 | Novartis Ag | Method for applying a coating onto a silicone hydrogel lens |
WO2007121513A1 (en) | 2006-04-20 | 2007-11-01 | Aortech Biomaterials Pty Ltd | Gels |
US7789509B2 (en) | 2006-06-01 | 2010-09-07 | Advanced Vision Science, Inc. | Non- or reduced glistenings intraocular lens and method of manufacturing same |
US7858000B2 (en) | 2006-06-08 | 2010-12-28 | Novartis Ag | Method of making silicone hydrogel contact lenses |
US7572841B2 (en) | 2006-06-15 | 2009-08-11 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US8231218B2 (en) | 2006-06-15 | 2012-07-31 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US7540609B2 (en) | 2006-06-15 | 2009-06-02 | Coopervision International Holding Company, Lp | Wettable silicone hydrogel contact lenses and related compositions and methods |
US7960465B2 (en) | 2006-06-30 | 2011-06-14 | Johnson & Johnson Vision Care, Inc. | Antimicrobial lenses, processes to prepare them and methods of their use |
US20080003259A1 (en) | 2006-06-30 | 2008-01-03 | Salamone Joseph C | Modification of surfaces of polymeric articles by Michael addition reaction |
MX2009000316A (es) | 2006-07-12 | 2009-01-26 | Novartis Ag | Copolimeros actinicamente reticulables para la fabricacion de lentes de contacto. |
US8459445B2 (en) | 2006-07-21 | 2013-06-11 | Menicon, Co., Ltd. | Colored contact lens primary packaging |
EP1905415B1 (de) | 2006-09-27 | 2009-07-01 | Ivoclar Vivadent AG | Polymerisierbare Zusammensetzungen mit Acylgermanium-Verbindungen als Initiatoren |
HUE027342T2 (en) | 2006-10-30 | 2016-09-28 | Novartis Ag | Method for applying a hydrophilic coating to a contact lens of silicone hydrogel |
KR101454041B1 (ko) | 2006-11-06 | 2014-10-27 | 노파르티스 아게 | 안구 장치 및 그의 제조 및 사용 방법 |
US20080110770A1 (en) | 2006-11-10 | 2008-05-15 | Bausch & Lomb Incorporated | Packaging solutions |
GB0623299D0 (en) | 2006-11-22 | 2007-01-03 | Sauflon Cl Ltd | Contact lens |
TWI434926B (zh) | 2006-12-11 | 2014-04-21 | Alcon Res Ltd | 眼用組成物中聚氧化乙烯-聚氧化丁烯(peo-pbo)嵌段共聚物之使用 |
AR064286A1 (es) | 2006-12-13 | 2009-03-25 | Quiceno Gomez Alexandra Lorena | Produccion de dispositivos oftalmicos basados en la polimerizacion por crecimiento escalonado fotoinducida |
CA2671740C (en) | 2006-12-13 | 2015-08-11 | Novartis Ag | Actinically curable silicone hydrogel copolymers and uses thereof |
WO2008076528A1 (en) | 2006-12-15 | 2008-06-26 | Bausch & Lomb Incorporated | Surface treatment of biomedical devices |
US20080142038A1 (en) | 2006-12-15 | 2008-06-19 | Bausch & Lomb Incorporated | Surface treatment of medical devices |
US20080141628A1 (en) | 2006-12-15 | 2008-06-19 | Bausch & Lomb Incorporated | Packaging Solutions |
US7832856B2 (en) | 2006-12-20 | 2010-11-16 | Bausch & Lomb Incorporated | Coatings and solutions for contact lenses |
US20080148689A1 (en) | 2006-12-20 | 2008-06-26 | Bausch & Lomb Incorporated | Packaging solutions |
MY148313A (en) | 2006-12-21 | 2013-03-29 | Novartis Ag | Process for the coating of biomedical articles |
US20080152540A1 (en) | 2006-12-22 | 2008-06-26 | Bausch & Lomb Incorporated | Packaging solutions |
WO2008088733A2 (en) | 2007-01-12 | 2008-07-24 | Dow Corning Corporation | Silicone-containing composition |
KR101375460B1 (ko) | 2007-02-09 | 2014-03-18 | 노파르티스 아게 | 콘택트 렌즈용 가교형 다이온성 코팅재 |
EP2126614B1 (en) | 2007-03-22 | 2019-04-24 | Novartis AG | Silicone-containing prepolymers with hydrophilic polymeric chains |
JP5484916B2 (ja) | 2007-03-22 | 2014-05-07 | ノバルティス アーゲー | ダングリングポリシロキサン含有ポリマー鎖を有するプレポリマー |
US7691917B2 (en) | 2007-06-14 | 2010-04-06 | Bausch & Lomb Incorporated | Silcone-containing prepolymers |
US20080314767A1 (en) | 2007-06-22 | 2008-12-25 | Bausch & Lomb Incorporated | Ophthalmic Solutions |
US7868071B2 (en) | 2007-07-30 | 2011-01-11 | Georgia-Pacific Chemicals Llc | Method of stabilizing aqueous cationic polymers |
ATE540327T1 (de) | 2007-08-31 | 2012-01-15 | Novartis Ag | Kontaktlinsenverpackungslösungen |
US8490782B2 (en) | 2007-10-23 | 2013-07-23 | Bausch & Lomb Incorporated | Packaging solutions |
US20090111942A1 (en) | 2007-10-25 | 2009-04-30 | Bausch & Lomb Incorporated | Method for Making Surface Modified Biomedical Devices |
WO2009070429A1 (en) | 2007-11-29 | 2009-06-04 | Bausch & Lomb Incorporated | Process for making biomedical devices |
WO2009070443A1 (en) | 2007-11-29 | 2009-06-04 | Bausch & Lomb Incorporated | Process for making biomedical devices |
US7934830B2 (en) | 2007-12-03 | 2011-05-03 | Bausch & Lomb Incorporated | High water content silicone hydrogels |
US20090145091A1 (en) | 2007-12-11 | 2009-06-11 | Richard Connolly | Method for treating ophthalmic lenses |
US20090145086A1 (en) | 2007-12-11 | 2009-06-11 | Reynolds Ger M | Method for treating ophthalmic lenses |
US7780879B2 (en) | 2007-12-20 | 2010-08-24 | Novartis Ag | Method for making contact lenses |
US20090171049A1 (en) | 2007-12-27 | 2009-07-02 | Linhardt Jeffrey G | Segmented reactive block copolymers |
US20090173045A1 (en) | 2008-01-09 | 2009-07-09 | Yu-Chin Lai | Packaging Solutions |
US7837934B2 (en) | 2008-01-09 | 2010-11-23 | Bausch & Lomb Incorporated | Packaging solutions |
US20090173643A1 (en) | 2008-01-09 | 2009-07-09 | Yu-Chin Lai | Packaging Solutions |
JP5622589B2 (ja) | 2008-01-14 | 2014-11-12 | クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ | 重合性コンタクトレンズ配合物及びそれから得られるコンタクトレンズ |
CN101925451B (zh) | 2008-01-23 | 2013-08-21 | 诺瓦提斯公司 | 涂布有机硅水凝胶的方法 |
US7781554B2 (en) | 2008-03-05 | 2010-08-24 | Bausch & Lomb Incorporated | Polysiloxanes and polysiloxane prepolymers with vinyl or epoxy functionality |
EP2263108B1 (en) | 2008-03-18 | 2019-11-27 | Novartis AG | Coating process for ophthalmic lenses |
US8470906B2 (en) | 2008-09-30 | 2013-06-25 | Johnson & Johnson Vision Care, Inc. | Ionic silicone hydrogels having improved hydrolytic stability |
US8246168B2 (en) | 2008-11-10 | 2012-08-21 | Bausch & Lomb Incorporated | Methacrylate-based bulky side-chain siloxane cross linkers for optical medical devices |
US20100149482A1 (en) | 2008-12-12 | 2010-06-17 | Ammon Jr Daniel M | Contact lens |
RU2499288C2 (ru) | 2008-12-18 | 2013-11-20 | Новартис Аг | Способ изготовления силиконовых гидрогелевых контактных линз |
US8534031B2 (en) | 2008-12-30 | 2013-09-17 | Bausch & Lomb Incorporated | Packaging solutions |
WO2010077708A1 (en) | 2008-12-30 | 2010-07-08 | Bausch & Lomb Incorporated | Packaging solutions |
WO2010135481A1 (en) | 2009-05-22 | 2010-11-25 | Novartis Ag | Actinically-crosslinkable siloxane-containing copolymers |
WO2010133680A1 (en) | 2009-05-22 | 2010-11-25 | Novartis Ag | Actinically-crosslinkable siloxane-containing copolymers |
US7915323B2 (en) | 2009-07-09 | 2011-03-29 | Bausch & Lamb Incorporated | Mono ethylenically unsaturated polycarbosiloxane monomers |
JP5800369B2 (ja) | 2009-07-09 | 2015-10-28 | ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated | モノエチレン系不飽和重合性基含有ポリカルボシロキサンモノマー |
WO2011056761A1 (en) | 2009-11-04 | 2011-05-12 | Novartis Ag | A silicone hydrogel lens with a grafted hydrophilic coating |
TWI483996B (zh) | 2009-12-08 | 2015-05-11 | Novartis Ag | 具有共價貼合塗層之聚矽氧水凝膠鏡片 |
SG187632A1 (en) | 2010-07-30 | 2013-03-28 | Novartis Ag | Amphiphilic polysiloxane prepolymers and uses thereof |
TWI875491B (zh) | 2010-07-30 | 2025-03-01 | 瑞士商愛爾康公司 | 水合隱形鏡片 |
US9623614B2 (en) | 2010-11-10 | 2017-04-18 | Novartis Ag | Method for making contact lenses |
US8772367B2 (en) | 2011-03-21 | 2014-07-08 | Momentive Performance Materials Inc. | Siloxane monomers containing hydrolysis resistance carbosiloxane linkage, process for their preparation and thin films containing the same for contact lens application |
US10391179B2 (en) | 2011-03-21 | 2019-08-27 | Momentive Performance Materials Inc. | Organomodified carbosiloxane monomers containing compositions and uses thereof |
EP2780748B1 (en) * | 2011-11-15 | 2016-01-13 | Novartis AG | A silicone hydrogel lens with a crosslinked hydrophilic coating |
EP3134420B1 (en) | 2014-04-25 | 2019-01-30 | Novartis AG | Carbosiloxane vinylic monomers |
CA2940207C (en) | 2014-04-25 | 2019-09-10 | Novartis Ag | Hydrophilized carbosiloxane vinylic monomers |
-
2015
- 2015-08-24 WO PCT/US2015/046471 patent/WO2016032926A1/en active Application Filing
- 2015-08-24 KR KR1020177007084A patent/KR102366047B1/ko active Active
- 2015-08-24 SG SG10201901379TA patent/SG10201901379TA/en unknown
- 2015-08-24 EP EP15762843.9A patent/EP3186070B1/en active Active
- 2015-08-24 SG SG11201700232SA patent/SG11201700232SA/en unknown
- 2015-08-24 MY MYPI2017700027A patent/MY183678A/en unknown
- 2015-08-24 US US14/833,378 patent/US11002884B2/en active Active
- 2015-08-24 CN CN201580045379.0A patent/CN106715101B/zh active Active
- 2015-08-24 HU HUE15762843A patent/HUE046948T2/hu unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3171752A (en) * | 1962-07-11 | 1965-03-02 | Burton Parsons Chemicals Inc | Contact lens treating solution |
CN1376270A (zh) * | 1999-05-20 | 2002-10-23 | 博士伦公司 | 用反应性亲水聚合物进行的医疗器件的表面处理 |
Also Published As
Publication number | Publication date |
---|---|
US20160062142A1 (en) | 2016-03-03 |
CN106715101A (zh) | 2017-05-24 |
KR20170046691A (ko) | 2017-05-02 |
SG10201901379TA (en) | 2019-03-28 |
KR102366047B1 (ko) | 2022-02-23 |
HUE046948T2 (hu) | 2020-03-30 |
MY183678A (en) | 2021-03-08 |
EP3186070B1 (en) | 2019-09-25 |
WO2016032926A1 (en) | 2016-03-03 |
US11002884B2 (en) | 2021-05-11 |
SG11201700232SA (en) | 2017-03-30 |
EP3186070A1 (en) | 2017-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106715101B (zh) | 用于在硅酮水凝胶接触镜片上施用稳定的涂层的方法 | |
TWI782962B (zh) | 接觸鏡片 | |
CN106661224B (zh) | 聚(噁唑啉-共-乙烯亚胺)-表氯醇共聚物及其用途 | |
CA2777961C (en) | A silicone hydrogel lens with a covalently attached coating | |
CA2855820C (en) | A silicone hydrogel lens with a crosslinked hydrophilic coating | |
CN107532038A (zh) | 用于生产在其上具有耐用润滑涂层的接触镜片的方法 | |
CN105334640B (zh) | 具有富水表面的硅水凝胶透镜 | |
CA2992173C (en) | Soft silicone medical devices with durable lubricious coatings thereon | |
CA2838242C (en) | Silicone hydrogel lenses with nano-textured surfaces | |
SG173578A1 (en) | Wettable hydrogel materials for use in ophthalmic applications and methods | |
CN104871036A (zh) | 制备改进的uv吸收性眼用透镜的方法 | |
CN102498431A (zh) | 适于制造紫外吸收接触透镜的预聚物 | |
MX2011004959A (es) | Copolimeros de polisiloxano con cadenas terminales de polimero hidrofilico. | |
CA3035490C (en) | Amphiphilic branched polydiorganosiloxane macromers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200108 Address after: Fribourg Patentee after: Alcon Company Address before: Basel Patentee before: Novartis Co., Ltd. |